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Abstract 
 
 
 
 
 
 
Hexacyclinic acid is a polyketide isolated from Streptomyces cellulosae bacteria in 2001. It 
possesses a complex and challenging hexacyclic ring system with various oxygen 
functionalities throughout. Hexacyclinic acid has also demonstrated some cytotoxic 
activity, making it an attractive target for total synthesis. However to date no full synthesis 
has been reported. 
 Previously within the group significant progress had been made towards the 
synthesis of hexacyclinic acid, with construction of the ABC 5/6/5 tricyclic core being 
achieved via a diastereoselective Michael addition and Snider radical cyclisation. The 
synthesis ran into difficulties however when hydrolysis of the ethyl ester could not be 
accomplished and removal of the superfluous carboxylic acid moiety could not be realised. 
 The approach within the group for the formation of the ABC tricycle was to 
continue the current strategy, joining the A and C-rings via the diastereoselective Michael 
reaction, and the closure of the 6-membered B-ring by Snider radical cyclisation. Progress 
was made using the tert-butyl and 2,2,2-trimethylsilylethyl ester analogues in an attempt to 
improve diastereoselectivities 
 Progress was also made on the synthesis of the CDEF tricyclic system, utilising 
(R)-isopropylcyclopentenone as a C-ring model system. The DEF framework was attached 
to the model by a Michael addition, with further functionalisation setting up the necessary 
functionalities for cyclisation. Conditions were attempted to effect a challenging aldol 
condensation to form the 9-membered ring, however all attempts effect this transformation 
were fruitless. 
 It was discovered that 2,2,2-trifluoromethylacetophenone can act as a replacement 
for benzaldehyde in the synthesis of protected syn-1,3-diols from homoallylic alcohols, 
with comparable yields and easier purification. 
Finally, an investigation was also made into the use of a bispidine ligand as a 
replacement for (−)-sparteine in Crimmins asymmetric aldol reactions, with the bispidine 
shown to give superior yields and diastereoselectivity when compared to TMEDA. 
7 
 
Abbreviations 
 
Ac acetyl 
AIBN azobisisobutyronitrile 
BHT butylhydroxytoluene 
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DIPEA N-diisopropylethylamine 
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EDCI 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
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LDA lithium diisopropylamide 
LiHMDS lithium hexamethyldisilazide 
mCBPA meta-chloroperoxybenzoic acid 
Me methyl 
NMO N-methylmorpholine N-oxide 
MOM methoxymethyl ether 
NMP N-methylpyrrolidone 
Nu nucleophile 
PE petroleum ether (40-60) 
Pg protecting group 
PMP para-methoxyphenyl 
PPTS pyridinium p-toluenesulfonate 
Py pyridine 
RCM ring-closing metathesis 
TBAB tetrabutylammonium bromide 
TBAF tetrabutylammonium fluoride 
TBAI tetrabutylammonium iodide 
TBD 1,5,7-triazabicyclo[4.4.0]dec-5-ene 
TBDPS tert-butyldiphenylsilyl 
TBS tert-butyldimethylsilyl 
t-Bu tert-butyl 
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TLC thin layer chromatography 
TMANO trimethylamine N-oxide 
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1 - Introduction 
 
In 2000, the OSMAC (one strain, many compounds) technique was utilised by Zeeck et al. 
on Streptomyces cellulosae subsp. griseorubiginosus (strain S 1013).
1
 By altering certain 
parameters, production of secondary metabolites can be induced and/or increased. Using 
this method, a compound was isolated, which after extensive spectroscopic and X-ray 
studies, was shown to be the polyketide natural product hexacyclinic acid (Fig 1).
2
 
 
 
 
 
 
 
Fig 1: Structure of hexacyclinic acid 1 
 
Labelling studies were performed by feeding the growth medium with 
13
C labelled acetic 
and propionic acid so as to incorporate these isotopic labels within the structure of 1. From 
these experiments, it was hypothesised that 1 is constructed from seven acetic acid and 
three propionic acid units (Fig 2). 
 
 
 
 
 
Fig 2: Labelling study performed by Zeeck 
 
The proposed biosynthesis by Zeeck involved an intramolecular Diels-Alder reaction to set 
up the AB bicyclic ring system, with a vinylogous Prins reaction theorised to form the C 
ring. As reported by Kalesse et al., it was shown that the hemiketal oxygen was not from 
any of the acid subunits, but from an external source such as H2O (Scheme 1).
3
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Scheme 1: Proposed biosynthesis of 1  
 
Compound 1 was shown to exhibit some cytotoxic activity with an IC50 of 14 µmol
-1
 
against three cell lines (HM02, HEPG2, MCF7).
2
 Moreover 1 possesses a unique 
hexacyclic carbon skeleton which poses a significant challenge for the modern synthetic 
organic chemist. To date no complete synthesis of 1 has been published, however the 
synthesis of 1 is underway in many groups with several partial syntheses published so far.
3-
4
  
 
1.1 - Hexacyclinic Acid 1 and (-)-FR182877 2 
A related compound to 1, (−)-FR182877 2, was also isolated from Streptomyces bacteria 
by the Fujisawa Chemical company in 1998. Compound 2 possesses a remarkably similar 
structure to 1, though there are some key differences; namely the stereochemistry at the 
ABC ring junctions and the lack of the hemiketal, carboxylic acid and acetate groups (Fig 
3). Owing to their structural similarities, it could be assumed that both 1 and 2 could be 
accessed from a common intermediate. To date, three complete total syntheses of 2 have 
been reported;
5
 this is attributed to its greater cytotoxic activity in comparison to 1, making 
it a more attractive target. It has been postulated that the activity of 2 may be due to the 
presence of the strained alkene, as when the alkene is oxidised by molecular oxygen, a 
significant drop in activity is observed. This strained olefin was also shown to be an 
efficient Michael acceptor, reacting with a variety of nucleophiles, such as amines, thiols 
and even imidazole (Scheme 2). The driving force for this reaction is due to the release of 
strain with no elimination product ever observed.
5a 
Despite this, other differences such as 
the lack of acetate or carboxylic acid groups cannot be ignored for the effect they might 
have on the activity of 2.   
11 
 
 
 
 
 
 
 
Fig 3: Structural differences between Hexacyclinic Acid 1 and (−)-FR182877 2.  
 
 
 
 
 
 
 
 
 
 
 
Scheme 2: Reactivity of the strained alkene of 2 
 
Compound 2 has been shown to have similar activity in vitro to Taxol for microtubule 
stabilisation (IC50 21 to 73 nmolL
−1
). A biosynthesis of 2 was postulated by Sorensen,
5a, 6
 
involving an intramolecular Diels-Alder reaction to form the AB ring system and setting 
up the 4 new stereocentres at the ring junctions (Scheme 3). This is followed by a 
Knoevenagel condensation between the β-ketoester functionality and the aldehyde 
position, and a trans-annular hetero-Diels-Alder setting up the CDF ring system. A final 
lactonisation closes the E ring and forms 2. 
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Scheme 3: Proposed biosynthesis of 2 by Sorensen 
13 
 
1.2 - Literature syntheses of (−)-FR182877 
 
1.2.1 – Sorensen 
Originally basing their retrosynthesis of ent-2 on their proposed biosynthesis (Scheme 3), 
Sorensen et al. had to make an alteration to their synthetic strategy. Their synthesis was 
based on the enantiomer ent-2, and not 2 because only the relative stereochemistry had 
been determined, and not the absolute stereochemistry. They planned the use of a tandem 
intramolecular Diels-Alder/Hetero-Diels-Alder to form the ABCDF ring system, with a 
lactonisation forming the E ring (Scheme 4). In contrast to the condensation reaction used 
in the biosynthesis, it was proposed to use a Tsuji-Trost alkylation to form the 19-
membered macrocycle 3. β-Ketoester 4 was to be synthesised by a Stille coupling of 
stannane 5 and allylic acetate 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4: Retrosynthesis of ent-2 by Sorensen group 
 
Synthesis of fragment 5 began by an asymmetric aldol reaction of aldehyde 7 (synthesised 
in two steps from cis-2-butene-1,4,-diol)
7 
with Evans auxiliary to form adduct 8 (Scheme 
5). Transformation to the Weinreb amide 9 proceeded smoothly with a 75% yield over the 
2 steps. Protection of the secondary alcohol with TMSCl, followed by reaction with 
dimethyl lithiomethylphosphonate provided the β-phosphonate 10. This reacted in a 
Horner-Wadsworth-Emmons reaction with 3-iodomethacrolein and activated Ba(OH)2,
8 
followed by removal of the silyl protecting groups to afford the triene 11 with an 
exceptional 79% yield over 4 steps. Chelation-controlled reduction of the ketone provided 
14 
 
the cis-diol exclusively, which was then protected as the bis-TES ether. Finally a 
palladium-catalysed stannylation with hexadimethyltin completed the synthesis of 5 with 
an 83% yield over the final 3 steps. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5: Synthesis of stannane 5 
 
As with the other fragment, synthesis of 6 began with an asymmetric aldol with aldehyde 
12 (Scheme 6),
9
 to form 13. This adduct was then converted to the Weinreb amide and 
protected as a trimethylsilyl ether, forming 6 with an 87% yield over 3 steps. Efficient 
coupling of 5 and 6 was accomplished using a relatively high (10 mol%) catalyst loading 
of Pd2dba3, with the use of DIPEA being vital for obtaining 14 in an 85% yield. 
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Scheme 6: Synthesis of 6 and Stille coupling 
 
Reaction of Weinreb amide 14 with the lithium enolate of tert-butyl acetoacetate accessed 
the β-ketoester functionality of 15 in one step (Scheme 7).10 Selective deprotection of the 
primary TES and secondary TMS silyl groups was achieved with 2 equivalents of TBAF. 
The primary alcohol then reacted with methyl chloroformate forming the carbonate ester 4. 
Reprotection of the secondary hydroxyl using TMSCl proceeded smoothly giving the 
necessary Tsuji-Trost substrate 4 with 88% yield over the 2 steps. Ring closure of the 19-
membered macrocycle was accomplished using catalytic Pd2dba3 in a dilute solution of 
THF to furnish the Tsuji-Trost product 16 in an 80% yield as a single diastereomer. 
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Scheme 7: Formation of cycloaddition precursor 16 by Tsuji-Trost alkylation 
 
For the desired IMDA/IMHDA to occur it was necessary to introduce the enone double 
bond. This was achieved by formation of the enolate using KHMDS and addition of 
PhSeBr to form the α-selenoproduct in excellent yield in a 3:1 mixture of diastereomers 
(Scheme 8). Efficient oxidation and elimination of the selenoxide was achieved using 
mCPBA in CH2Cl2 forming the enone functionality as an equimolar mixture of E/Z 
isomers. The cycloaddition cascade of 3 was found to be accelerated by warming in 
chloroform buffered with NaHCO3 to give 17 as the major product formed in a modest 
40% yield after 4 hours. Removal of the silyl protecting groups using PPTS, cleavage of 
the tert-butyl ester with TFA and EDC mediated lactonisation furnished ent-2. 
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Scheme 8: Completion of ent-2 
 
The Sorensen synthesis of ent-2 was achieved in 22 steps with a 2% overall yield. Key 
steps were the Tsuji-Trost alkylation to form the macrocycle and the tandem 
IMDA/IMHDA reaction to efficiently form the pentacyclic ring system. One limitation of 
the synthesis is the selenoxide elimination which gives a 1:1 mixture of the E-isomer with 
the undesired Z-isomer which does not cyclise. Nonetheless the synthesis was very 
successful in producing grams of ent-2. 
 
1.2.2 - Evans 
 
Evans et al. embarked on a synthesis of 1 and 2, believing that they both could be accessed 
via the macrolide precursor 18 (Scheme 9).
5d
 Evans planned sequential double [4+2] 
cycloaddition reaction to form the carbocyclic skeleton. The initiating Diels-Alder reaction 
would form the AB rings, with this step differentiating which product would be formed. 
The exo- transition state of the initial Diels-Alder reaction would form 1, while the endo- 
variant would give 2, though it was unknown which would be favoured. An ensuing 
hetero-Diels-Alder cycloaddition would then construct the CDF rings. As it was unknown 
which product would be formed, Evans included a bromide functional group allowing for 
conversion to either product. 
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Scheme 9: Evans retrosynthesis of 1 and 2 from macrolide 18 and proposed DA transition states 
 
The macrolide 18 could be formed by the coupling of the iodide 19 and the dibromoalkene 
20, making use of a Suzuki coupling and alkylation to join the terminal positions (Scheme 
10). 
 
 
 
 
 
 
 
 
Scheme 10: Retrosynthesis of macrocycle 18 
 
The synthesis of fragment 19 began by an asymmetric aldol reaction of aldehyde 21 
(synthesised in two steps from cis-2-butene-1,4-diol)
11
 with Evans oxazolidinone chiral 
auxiliary using dibutylboron triflate, forming the syn aldol adduct 22 in an excellent 88% 
yield (Scheme 11). Conversion to the Weinreb amide using standard conditions proceeded 
in near quantitative yield, and reaction of the amide with ethynylmagnesium bromide 
furnished the alkynone in good yield. Reduction of the ketone using Dibal-H formed the 
19 
 
1,3-diol 23 in near quantitative yield with the desired diastereomer being formed in 20:1 
dr. Double TBS protection of diol 23, followed by hydroboration with catecholborane 
(HBcat) and hydrolysis of the resulting boronic ester with 1 M aqueous NaOH solution 
gave the boronic acid fragment 24 in a 97% crude yield.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 11: Synthesis of boronic acid 24 
 
The synthesis of fragment 28 began as before utilising an aldol reaction of aldehyde 25 
(synthesised in 3 steps from 3-buten-1-ol) and Evans auxiliary mediated by dibutylboron 
triflate giving the Evans-syn product 26 (Scheme 12). Conversion to the Weinreb amide, 
followed by protection of the secondary alcohol as a TBS ether and deprotection of the 
primary alcohol furnished 27 with excellent yields in 3 steps. Oxidation of 27 with DMP, 
and Corey-Fuchs olefination of the resulting aldehyde using tetrabromomethane and 
triphenylphosphine yielded the dibromoalkene 28.   
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 12: Synthesis of fragment 28 
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Suzuki coupling of 24 and 28 using the unusual Tl2CO3 as a base afforded exclusively the 
diene 29 in an excellent 84% yield (Scheme 13).
12
 Thallium bases were found to have a 
positive effect in Suzuki cross couplings, increasing the reactivity of palladium by 
generating open coordination sites.
13
 Dibal-H reduction of the Weinreb amide formed the 
corresponding aldehyde, which was followed by a Roskamp homologation to form the 1,3-
dicarbonyl moiety. Selective deprotection of the primary alcohol using 
tetrabutylammonium fluoride yields the cyclisation precursor 30. Iodination of the allylic 
alcohol followed by treatment with Cs2CO3 induced cyclisation to form the macrolide 31 
as a 1:1 mixture of diastereomers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 13: Coupling of fragments to form macrolide 31 
 
Oxidation of 31 with Ph2Se2O3 and heating to 50 °C induced the cycloaddition cascade 
resulting in the formation of the pentacycle of 2 in a single diastereomer in a good yield 
(Scheme 14). It was shown that the endo transition state was preferred with 32 being 
formed exclusively. It was stated that attempts were being made to manipulate the reaction 
pathway to access the exo product, however it appears that this has been unsuccessful. 
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Scheme 14: Tandem DA/HDA reactions to form 32 
Subsequent steps continue to successfully complete the synthesis of (−)-FR182877 2 in a 
total of 17 linear steps with a 6.0% overall yield. Of particular mention in the synthesis was 
the tandem DA/HDA reaction setting up the ABCDF ring system and 6 stereocentres with 
an impressive 63% yield. Disappointingly attempts to synthesise 1 by this method were 
unsuccessful, nonetheless the synthesis of 2 is an impressive total synthesis. 
 
1.2.3 - Nakada 
 
The most recent complete synthesis of 2 was reported by Nakada et al. in 2009. Similar to 
Evans’ and Sorensen’s syntheses, Nakada also planned a tandem intramolecular Diels-
Alder/Hetero Diels-Alder for the construction of the AB and CD ring systems respectively, 
starting from 35 (Scheme 15). In contrast to the other syntheses however it was planned to 
close the F ring by an intramolecular Heck reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 15: Retrosynthesis of 2 by Nakada group 
 
Starting from 35 (synthesised in 9 steps over longest linear sequence),
14
 the free hydroxyl 
group was protected as a TES ether, followed by removal of the acetyl group in a 75% 
yield over the 2 steps (Scheme 16). Slow oxidation of the resulting primary alcohol by 
heating MnO2 in toluene furnished the tetracyclic IMDA/IMHDA product 36 as a single 
22 
 
diastereomer in a modest 28% yield. The low yield was attributed to the successive 
IMHDA reaction, with previous work showing a 32% yield for a IMHDA reaction in 
which the substrate incorporates AB bicyclic ring system.
14 
It can be seen that the 
stereochemistry of the OTES group is incorrect; however this anti-stereochemistry of the 
protected diols is necessary to achieving the right stereochemistry at the ring junctions, 
with syn-diols giving rise to poor stereocontrol. This diastereocontrol is attributed allylic 
1,3-strain in their transition state models.
15
 To achieve the correct stereochemistry, it was 
necessary to invert the stereogenic centre at the OTES group. This was achieved by 
cleavage of the TES ether, oxidation of the resultant alcohol using DMP, followed by 
reduction of the ketone with borane resulting in inversion and giving the correct 
stereochemistry in a 25:1 dr. The free hydroxyl was then protected as a TBS ether giving 
37 with good yields over all steps. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 16: Synthesis of ABCD-ring system 37 
 
Treatment of 37 with LDA followed by iodine formed the desired iodoalkene in an 
excellent yield (Scheme 17). Removal of the primary TBS group and DMP oxidation of 
the resultant primary alcohol afforded the corresponding aldehyde. This was followed by 
reaction with vinylzinc bromide to furnish 33 as a 1:1 mixture of diastereomers at the 
allylic alcohol position. 
 
 
 
 
 
 
 
Scheme 17: Synthesis of Heck precursor 33 
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Optimised conditions for the intramolecular Heck reaction required treatment of 33 with 
Pd2(dba)3 (using a high catalyst loading of 50 mol%) and dppf in toluene at 100 °C to 
furnish the 7-exo-trig product 34 in an 88% yield (Scheme 18). Isomerisation of the allylic 
alcohol to the α-methyl ketone 35 was mediated using IrCl(cod)2 affording the product as a 
mixture of diastereomers. Treatment with 5 equivalents of DBU epimerised this 
stereogenic centre giving the α-methyl ketone of the necessary stereochemistry. Reduction 
from the less hindered face using NaBH4 formed 36 as a single diastereomer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 18: Completion of 2 by Nakada group 
 
Using the same method as Evans (deprotection of the silyl protecting groups using HF.Py, 
cleavage of the methyl ester using TMSOK and lactonisation with Mukaiyama’s reagent) 
completed the synthesis of 2. While a successful synthesis, the Nakada synthesis of 2 lacks 
novelty, utilising a similar DA/HDA approach as Sorensen and Evans. There are also 
numerous steps required to correct stereochemistry making for a less graceful synthesis. 
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1.3 - Literature syntheses of Hexacyclinic acid 1 
 
1.3.1 – Clarke - ABC tricycle  
 
Clarke’s retrosynthetic strategy for the formation of hexacyclinic acid 1 is outlined below 
(Scheme 19). Disconnection of the lactone and the hemiketal gives a highly functionalised 
9-membered ring in 37 which could cyclise utilising a novel iodocyclisation through the 
oxygen of the ketone to form the DEF tricycle in 1. Further disconnections reveal ABC 
tricycle 38. The approach for formation of 38 involved a radical mediated 5-exo-trig 
cyclisation to form the A ring, and  a key intramolecular ester tethered Diels-Alder reaction 
of 42 to construct the B-ring skeleton, which, depending on the product formed, could then 
be used in the synthesis of both 1 and 2.
4b
  The bromine functionality was also included for 
this reason. The Diels-Alder precursor 42 in turn could be accessed from fragments 43 and 
44. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 19: Retrosynthesis of 1 by Clarke group 
 
The racemic synthesis of 38 began with the esterification of diene 43 (synthesised in 5 
steps from cis-butene-1,4-diol)
4d
 and propiolic acid 44 under Mitsunobu conditions 
affording 42 in excellent yield (Scheme 20). This was then cyclised under thermal 
conditions by refluxing in toluene with catalytic BHT, forming Diels-Alder product 45 in 
25 
 
80% yield. Copper catalysed conjugate addition of vinylmagnesium bromide to the α,β-
unsaturated lactone furnished 41 in excellent yield with approach exclusively from the less 
hindered top face. 
 
 
 
 
 
 
 
 
 
 
Scheme 20: Synthesis of B-ring system 41 
 
Reduction of 41 using Dibal-H formed the corresponding lactol, which was followed by 
formation of the dithiolane 46 using 1,2-ethanedithiol and TiCl4 (Scheme 21). Oxidation of 
the primary alcohol was accomplished under Parikh-Doering conditions, while use of any 
other oxidising conditions led to isomerisation of the alkene. Addition of the vinyl group to 
aldehyde 47 was performed by addition of vinylmagnesium bromide to form allylic alcohol 
48 in an 80% yield giving the necessary diastereomer in a 30:1 ratio. Protection of the 
secondary alcohol as a TBS ether to give 49 proceeded quantitatively, and was followed by 
removal of the dithiolane group, with the use of methyl iodide and Ag2CO3 necessary for 
efficient removal to furnish the aldehyde 40 in an excellent 89% yield. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 21: Formation of cyclisation precursor 40 
26 
 
Following synthesis of the aldehyde 40, the key 5-exo-trig reductive cyclisation was 
achieved by treatment of 40 with SmI2, using HMPA and H2O as an additive, to form 
stereoselectively two new stereocentres and to afford the AB bicyclic system 50 in 59% 
yield (Scheme 22). A further TBS protection of the resulting hydroxyl group proceeded 
quantitatively forming 39. 
 
 
 
 
 
Scheme 22: SmI2 radical cyclisation to form A-ring 
 
Removal of the benzyl group was completed using BCl3.SMe2, and the subsequent alcohol 
51 was oxidised using DMP, forming aldehyde 52 (Scheme 23). Addition of 
propynylmagnesium bromide to the aldehyde forms the propargylic alcohol 53 in a 4:1 
mixture with the diastereomer 53’. Diastereomer 53 was then protected with TMSCl to 
furnish 54 quantitatively. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 23: Further functionalisations to form 54 
 
An enyne ring-closing metathesis of 54 was attempted, using 10 mol% of Grubbs’ 2nd 
generation catalyst in toluene at reflux, aiming to form the 5-membered C-ring as in 55 
(Scheme 24). However it was found that none of the desired product was isolated, with the 
6-membered ring being formed preferentially, affording 56 in a 90% yield. 
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Scheme 24: Attempted enyne metathesis of 54 
 
With the planned enyne metathesis proving unsuccessful for the formation of the C-ring, it 
was decided to proceed through more straightforward ring-closing metathesis of a diene. 
Addition of vinylmagnesium bromide to aldehyde 52 gave the allylic alcohol 57 as a 
mixture of diastereomers (Scheme 25), which was then subjected to Grubbs’ 2nd generation 
catalyst (10 mol%) generating 58 which contains the desired 5-membered C ring and the 
ABC ring system of hexacyclinic acid 1. 
 
 
 
 
 
 
Scheme 25: Completion of ABC model 58 by Clarke group 
 
Clarke’s racemic synthesis of the ABC tricycle 58 was achieved in 15 steps with a 6% 
overall yield. Construction of the B-ring is efficiently achieved by a tethered 
intramolecular Diels-Alder rection, while the A-ring is completed by a highly 
stereocontrolled SmI2 radical reaction. While the desired enyne metathesis was 
unsuccessful, the C-ring formed has sufficiently functionality to allow further construction 
on the C-ring. 
 
1.3.2 – Clarke - DEF tricycle 
 
Clarke envisaged that due to the unique hexacyclic structure shared by 1 and 2, they would 
share a common biosynthetic route. Furthermore he reasoned that they could be 
synthesised from the same intermediate as he showed in his model studies of their DEF 
tricycle – the retrosynthetic route is shown below (Scheme 26).4a, 4c, 16 It was thought that 
the DF rings of 1 and 2 could be formed from the oxocarbenium ion by addition of H2O or 
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loss of H
+
 respectively, followed by deprotection and subsequent lactonisation to form the 
E-ring. The oxocarbenium ion would be formed by a transannular cationic cyclisation of 
the carbonyl onto the olefin moiety of the 9-membered precursor. 
 
 
 
  
 
 
 
 
 
 
 
Scheme 26: Clarke’s strategy for formation of the DEF tricycle of 1 and 2 
 
A model 9-membered ring precursor was cleanly accessed over 5 steps using nerol 59 as 
the starting material (Scheme 27). Acetylation of the primary alcohol, followed by 
epoxidation of the isoprenyl double bond and subsequent cleavage using periodic acid 
formed 60 in good yields for all steps. Aldehyde 60 was then used in a Mukaiyama aldol 
reaction with the bis-silyl enol ether of tert-butyl acetoacetate, forming the aldol product in 
79% yield. The resulting hydroxyl was protected as a TBS ether using TBSOTf to form 61. 
 
 
 
 
 
 
 
 
Scheme 27: Formation of 61 
 
For the formation of the 9-membered ring, Clarke utilised a Pd(0)-catalysed intramolecular 
π-allyl substitution reaction using Pd(PPh3)4, wherein the β-ketoester nucleophile attacks 
the allylic position forming the 9-membered ring (Scheme 28). Initial results were poor, 
with only trace amounts of 62 being formed, however further optimisation by using 1,2-
bis(diphenylphosphino)ethane as the ligand resulted in formation of 62 in a 2:1 ratio with 
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the elimination by-product 63. While separation of the two products was difficult, it was 
achieved by using silica gel impregnated with AgNO3.
17
  
 
 
 
 
 
 
 
 
Scheme 28: Cyclisation to form 9-membered ring 62 
 
With the synthesis of 62 in hand, attempts were made to induce cyclisation to form the DF 
model 64 using Hg(OTf)2;
18
 however this resulted in a complex mixture of products, with 
no sign of 64.  Instead focus shifted to the use of iodine reagents, with treatment of 62 with 
I2 and silver acetate in acetic acid forming compound 64 in 61% yield (Scheme 29). This 
compound is analogous to the DF ring system of 1. This reaction was thought to proceed 
via an iodonium ion formed from the top face leading to the desired product. Treatment of 
64 with HF to remove the TBS protecting group, followed by trifluoroacetic acid to induce 
lactonisation formed the DEF model system 65.
17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 29: Cyclisation to give DEF model 65 
 
Together with their ABC tricycle synthesis, the work published by Clarke et al. represents 
the closest attempt at the synthesis of hexacyclinic acid 1. Clarke’s DEF model synthesis 
utilised an impressive iodocyclisation, efficiently constructing the DF ring system, 
however it must be noted that the model system lacks the methyl group necessary in 1 and 
2. It was later reported by Clarke that when the 9-membered 66 was subjected to the 
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iodocyclisation conditions, the desired product 67 was not formed (Scheme 30). Instead 68 
was isolated in an 11% yield, with mostly starting material recovered. This product can be 
rationalised by deprotection of the TBS ether, with cyclisation occurring through the free 
hydroxyl as opposed to the desired ketone. Modelling studies of 66 revealed an eclipsing 
interaction between the methyl and OTBS group which they believe inhibits cyclisation to 
form 67. To date no synthesis of the model 67 has been published. 
 
 
 
 
 
Scheme 30: Attempted iodocyclisation of 66 
 
1.3.3 – Landais – ABC tricycle 
 
Landais et al developed a methodology involving the radical cyclisation of 3-silylhepta-
1,6-dienes for the formation of highly substituted cyclopentane rings in a stereocontrolled 
manner (Scheme 31).
4g 
The cyclisation was built on the idea that sterically bulky 
substituents would limit the number of conformations available in the transition state, 
affording greater diastereocontrol. This was confirmed experimentally, with the smaller 
methyl substituent giving a mixture of 4 diastereomers, while the cyclisation with the 
larger tert-butyl group gives a dr of > 98:2. The reaction was also shown to proceed with 
silyl and protected hydroxyl substituents, where both steric and electronic factors induced 
excellent control. 
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Scheme 31: 5-exo-trig cyclisations with a variety of substituents 
The reaction proceeds by addition of a tosyl radical (generated from p-TolSO2SePh) to the 
terminal alkene. This is followed by the 5-exo-trig cyclisation to form the cyclopentane 
ring and β-fragmentation to form the new terminal alkene and regenerate the radical to 
propagate the reaction. 
 
The stereochemical outcome can be rationalised using the Beckwith-Houk model, with the 
major product resulting from a chair-like transition state, all the substituents in pseudo 
equatorial positions (Scheme 32). This transition state also allows overlap between the 
developing partial positive charge and the silicon sp3 orbitals. The silicon contributes to 
the stereocontrol by the “silicon effect”, stabilising the partial positive charge. 
 
Scheme 32: Proposed transition states for radical cyclisation 
 
The β-silicon effect is an observation where β-carbocations are stabilised due to silicon 
hyperconjugation (Fig 4). Electron donation into the carbocation due to the overlap 
between the larger silicon sp3 orbital and the empty p-orbital stabilises the positive charge. 
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Fig 4: β-silicon effect 
 
To prove the synthetic worth of their method, they envisaged that it could be used to build 
the A-ring of 1 and set about the synthesis of the ABC tricycle of 1 (Scheme 33).
19 
An 
intramolecular Pauson-Khand reaction to form the BC-ring system and a 5-exo-trig radical 
cyclisation to build the densely functionalised A ring. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 33: Retrosynthesis of 1 by Landais group 
 
Aldol reaction of the β-silane ester 74 and aldehyde 73 (prepared in 3 steps from butyn-
1,4-diol) using LDA required a mixture of THF and HMPA to furnish the aldol adducts 
75/75’ in a 65:35 dr and modest yield (Scheme 34). 
 
 
 
 
 
Scheme 34: Formation of dienes 75/75’ 
 
The allylic acetate 75 underwent a palladium-catalysed substitution reaction with sodium 
p-toluenesulfonate to form sulfone 76 in excellent yield (Scheme 35). Compound 76 was 
then submitted to the sulfonyl radical cyclisation conditions to furnish the highly 
substituted cyclopentane 77 in good yield and excellent diastereocontrol. Compound 77 is 
33 
 
then reduced using Dibal-H, and the resulting hydroxyl groups are protected as MOM 
ethers. Alkylation with 3-trimethylsilylpropargyl bromide, optimised using Schlosser’s 
superbase, furnished enyne 70 in 65% yield (brsm). This was then cyclised in a 
trimethylamine N-oxide (TMANO) promoted Pauson-Khand reaction to give the tricyclic 
ring system 69 in a 74% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 35: Formation of ABC tricycle 69 
 
The synthesis by Landais contains some interesting methods, building up the complex 
tricyclic skeleton in only 7 steps. Of particular note is the 5-exo-trig radical cyclisation, 
setting up the stereochemistry of the AB ring junctions with excellent control. However his 
tricycle 69 would require several more steps, such as formation of the double bond in the B 
ring and installation of the hydroxyl in the A ring, as well as forming an additional 
stereocentre at the B/C-ring junction, to access a fully functionalised ABC tricycle. While 
some functionality is included on the C-ring, no mention is made of their strategy for 
completion of 1.  
 
1.3.4 – Kalesse – ABC tricycle 
 
Retrosynthesis of Kalesse’s ABC tricycle 78 utilised an intramolecular Michael addition 
for the formation of the C ring from 79 (Scheme 36).
3
 The enone moiety was to be added 
by conjugate addition and subsequent cross metathesis from diene 80. In a similar fashion 
to Clarke’s route, the Kalesse group also utilised an intramolecular Diels-Alder reaction for 
the formation of the B ring, with the Diels-Alder precursor 81 being produced by an aldol 
reaction with aldehyde 82. 
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Scheme 36: Retrosynthesis of ABC tricycle of 1 by Kalesse group 
 
Protection of alcohol 83 with TBSCl, followed by cleavage of the alkene by ozonolysis 
gave the aldehyde 84, and a subsequent HWE reaction with the phosphonate ester gave the 
corresponding enone ester in 70% yield over the 3 steps (Scheme 37). Reduction with 
Dibal-H followed by oxidation of the resulting alcohol using MnO2 gave aldehyde 82 in 
excellent yield for both steps. 
 
 
 
 
 
Scheme 37: Synthesis of aldehyde 82 
 
An Evans aldol reaction of 82 with Evans auxiliary formed the aldol adduct in near 
quantitative yield, efficiently setting up the 2 new stereogenic centres of the A ring 
(Scheme 38). Formation of the Weinreb amide, followed by TBS protection of the 
secondary alcohol and Dibal-H reduction of the Weinreb amide afforded the corresponding 
aldehyde 85 with good yield over all steps. Addition of ethynylmagnesium bromide and 
oxidation of the resulting alcohol using DMP formed the Diels-Alder precursor 81. 
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Scheme 38: Synthesis of ketone 81 
 
Diels-Alder reaction of 81 proceeded well in toluene at reflux to afford the adduct 80 with 
the desired diastereomer being formed exclusively (Scheme 39). This is imagined to 
proceed via the favoured transition state shown, with the bulky OTBS group taking a 
pseudo equatorial position. The alternate conformation is disfavoured due to the 1,3-allylic 
strain between the diene and the OTBS group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 39: Diels-Alder reaction to from AB bicycle and proposed Transition state 
 
In another parallel to the Clarke synthesis, Kalesse’s group used a copper-catalysed 
conjugate addition to deliver selectively the vinyl group onto the top face of the B ring, 
setting up the correct stereochemistry and generating a synthetic handle for use in the C 
ring synthesis as seen in 86 (Scheme 40). Reduction of the ketone using LiAlH4 resulted in 
delivery of the hydride from the lower face being favoured, with alcohol 87 being formed 
in excellent yield. Cross-metathesis reaction of the new exocyclic vinyl group using 4 
36 
 
equivalents of methyl acrylate and Hoveyda-Grubbs’ 2nd generation catalyst formed the 
enone for use as an acceptor in the Michael reaction in very good yield. Protection of the 
cyclic alcohol, followed by deprotection and oxidation of the acyclic alcohol resulted in 
formation of 79. Treatment with TMSI resulted in TMS-enol ether formation, which 
cyclised and formed the cyclopentane C ring, along with a highly strained cyclobutane ring 
as seen in 88. Deprotection of the TMS group opened this 4-membered ring and furnished 
the ABC tricycle model 78 as an inseparable 4:1 mixture of diastereomers in a 68% yield 
for the last 2 steps. 
Scheme 40: Completion of ABC model 78 
 
Kalesse’s asymmetric synthesis of the model ABC tricycle 78 showed a high degree of 
stereocontrol, utilising an Evans aldol reaction and intramolecular Diels-Alder reaction as 
key stereoselective steps, forming the model system in 20 steps from 83 with 10.7% 
overall yield. This model is comparable to the ABC tricycle of 1; however it is missing the 
carboxylic acid function, with no mention of how it could be installed. However it could be 
possible to include the methyl group earlier on in the synthesis, with the carboxylic acid 
being made by an allylic oxidation. 
 
1.3.5 – Nakada – DEF tricycle 
 
The most recent literature relating to 1 and 2 is the synthesis of the DEF tricycle reported 
by Nakada et al.
 
Interested in the biological activity of this fragment, they set about the 
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synthesis of the tricycle 89 (Scheme 41).
20
 Their retrosynthetic strategy involved a 
challenging inverse electron demand hetero-Diels Alder (IMHDA) reaction to construct the 
ring systems, with the final ring being closed by lactonisation. The stereogenic centres 
would be installed by an asymmetric aldol reaction with aldehyde 94. 
 
 
 
 
 
 
 
 
 
 
Scheme 41: Retrosynthesis of DEF tricycle of FR182877 by Nakada group 
 
Aldehyde 94 (prepared in 2 steps from ethyl 4-methyl-pent-4-en-1-oate)
21
 was reacted with 
Evans auxiliary using dibutylboron triflate and triethylamine to furnish the aldol adduct 95 
in an excellent yield (Scheme 42). Conversation to the Weinreb amide, followed by TES 
protection of the hydroxyl group formed 96 near quantitatively over the 2 steps. This was 
followed by Dibal-H reduction of the amide to the corresponding aldehyde 93. The 
reaction between ethyl propiolate and Dibal-H generated a reactive vinylaluminium 
species, which underwent nucleophilic addition to the aldehyde to form the enone 97.
22 
Oxidation of the resultant hydroxyl group using DMP produced the diene necessary for the 
hetero-Diels-Alder. The inverse electron demand IMHDA reaction was achieved using a 
catalytic amount of BHT and heating to 100 °C in toluene. This reaction proceeded very 
slowly, requiring 4 days of heating to complete, however it afforded 91 as a single 
diastereomer in a good 63% yield.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 42: Synthesis of DF bicycle 91 
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Removal of the TES ether of 91 was achieved using TBAF in THF to form the vinylogous 
carbonate 98 in 94% yield (Scheme 43). Unfortunately all attempts to hydrolyse the ester 
were unsuccessful, with the presumed stability of the vinylogous carbonate system 
attributed to its lack of reactivity. Consequently it was attempted to reduce and then 
oxidise the ester to the corresponding aldehyde 99, followed by a further oxidation to the 
acid 90, however this was also unsuccessful. Subsequently the group decided to change the 
methyl ester to a PMB ester, which could be removed by DDQ or acid, and bring about the 
lactonisation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 43: Failed attempts to access lactonisation precursor 90 
 
Conversion of the methyl ester 97 to the PMB ester 100 was achieved by transesterification 
using PMBOH and Otera’s catalyst,23 followed by oxidation using DMP (Scheme 44). 
Using the same conditions as before the IMHDA reaction proceeded smoothly giving the 
product 101 as a single diastereomer with a slightly improved 70% yield. The PMB and 
TES groups were easily removed using TFA to form the cyclisation precursor 90. 
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Scheme 44: Transesterification and subsequent lactonisation 
 
Lactonisation was achieved using 2-chloromethylpyridinium iodide (Mukaiyama’s 
reagent), however the isolated product was found not to be 89 but the hemiketal 102, 
forming the DEF tricycle of hexacyclinic acid 1 instead. Compound 102 is thought to be 
formed during the workup, with the addition of H2O to the distorted alkene in the highly 
reactive 89. Nakada’s synthesis of the DEF tricycle of 1 is achieved in 8 steps from 
aldehyde 94. Of particular mention is the inverse electron demand IMHDA reaction which 
efficiently constructs the ring system. 
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2 - Previous work in the Prunet group towards Hexacyclinic acid 1 
 
In contrast to strategies by other groups, the approach to 1 within the Prunet group did not 
utilise a Diels-Alder for the construction of the AB ring system, instead involving a more 
convergent route (Scheme 45). Opening the lactone to the pentacyclic system 103, 
followed by breaking the C-O bond of 103 would give the 9-membered ring in 104. 
Formation of the DF ring system in 103 would be accomplished by an intramolecular oxa-
Michael addition. The next disconnection would be the enone double bond of 104 to the 
diketone 105. It was planned to access the 9-membered ring by a challenging aldol 
condensation between these two ketones from precursor 105. Functional group 
interconversion of the methyl ketone to a terminal alkene reveals 105 could be afforded 
from 106 by Wacker oxidation. C-C disconnection shows the DEF framework 108 would 
be grafted onto the C ring of the ABC tricycle 107 by a Michael addition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 45: Prunet group retrosynthesis of 1 
 
The retrosynthesis of the ABC tricycle 107 involved various functional group 
interconversion of 107 to 109. A Wharton rearrangement would flip the position of the C 
ring oxygen. Decarboxylation, isomerisation of the exo-cyclic double bond and a retro-
Diels-Alder would furnish 107 (Scheme 46). A C-C disconnection to open the 6-membered 
B-ring would give 110. Construction of the B-ring will be achieved by a 6-endo-trig Snider 
radical cyclisation of 110. A further C-C disconnection between the two rings would give 
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the 5-membered enone A-ring and enol ether C-ring. Grafting of these two rings would 
utilise a highly selective diastereoselective Michael reaction for the synthesis of 110, 
uniting the A-ring 111 and C-ring 112. This reaction would be a key step in the synthesis, 
joining the two fragments and forming 3 new stereocentres, with the addition occurring 
anti to the isopropenyl group on the C-ring. 
 
 
 
 
 
 
 
 
Scheme 46: Retrosynthesis of ABC tricycle 107 
 
Development of the diastereoselective Michael addition involved screening a wide variety 
of conditions. Ultimately the optimal Lewis acid was found to be ZnCl2, with the use of n-
BuLi to generate the lithium enolate from silyl enol ether 112 (Scheme 47). Unfortunately 
the maximum yield obtained for the formation of adduct 114 was 27%, although the 
diastereoselectivity was excellent: the product was obtained as a single diastereomer, the 
stereochemistry of which was unassigned. Attempts to increase the yield by increasing the 
number of equivalents (up to 5 equiv) of silyl enol ether 112 were unsuccessful. Snider 
radical cyclisation using Mn(OAc)3 closed the B ring in 37% yield, although the conditions 
were unoptimised. 
 
 
 
Scheme 47: Diastereoselective Michael addition of 112 to 113b 
 
While the desired product was obtained, the low yield was unacceptable for such a key 
synthetic step. This modest yield was attributed to the low reactivity of the enolate due to 
the steric bulk of the bridged cyclic system. It was decided to proceed using a less 
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sterically encumbered chiral acetonide. The revised retrosynthesis of 107 proceeds as 
before, although the enone functionality on the C-ring would be introduced from 116 by a 
Corey-Winter olefination instead of a retro Diels-Alder (Scheme 48). The 
diastereoselective Michael-type addition would be used to form 117, from the double 
acceptor 111 and silyl enol ether 118, which contains the acetonide moiety.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 48: Revised retrosynthesis of 107 
 
The Michael addition proceeded using 3 equivalents of acetonide 118, giving a mixture of 
diastereomers (Scheme 49). Interestingly it was observed that the nature of the solvent 
used had a dramatic effect on the diastereoselectivity of the reaction. When diethyl ether 
was employed as the solvent, the yield was a good 60%, with the diastereoselectivity 
favouring the undesired diastereomer 119’ in a 7:1 ratio. A THF/toluene mix gave 
reasonable yields but with low selectivities. Switching to a highly polar 4:1 DMF/THF 
solvent mixture gave a good yield as well as favouring the desired diastereomer 119 in a 
7:1 ratio (Table 1). 
 
 
 
 
 
 
Scheme 49: Diastereoselective Michael-type additions of 118 to 113 
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R = Et 
Solvent Yield 119b/119’b 
Et2O 60% 1:7 
1:4 THF/Toluene 50% 1:2.5 
4:1 THF/Toluene 46% 2.5:1 
4:1 DMF/THF 60% 7:1 
 
Table 1: Solvent effect on yields and diastereoselectivities 
 
The reaction is proposed to go through one of two transition states; an open transition state 
with attack anti to the OTBS forming the product 119, and a cyclic transition state with 
attack anti to the methyl group forming 119’. When the highly polar DMF is used, it 
coordinates to the zinc and disrupts the cyclic transition state, instead favouring the open 
transition state (Fig 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5: Proposed transition states for Michael-type addition 
 
Attempts were made to favour the open transition state by using additives that would 
increase the solvent complexation of the zinc metal, such as HMPA and TMEDA; however 
this gave no improvement.  
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From the proposed transition state, there is also a visible steric effect between the ester and 
the acetonide in the cyclic transition state. It can be assumed that a larger R group would 
also disrupt this transition state and favour the desired diastereomer 119. This effect can be 
observed when the methyl ester 113a is used, reducing the dr to 3:1. Conversely the bulky 
tert-butyl ester 113c gives a single diastereomer 119c in a 55% yield (Table 2). 
 
 
R Yield 119/119’ 
Me 30-40% 3:1 
Et 60% 7:1 
t-Bu 55% 1 diastereomer 
 
Table 2: Effects of varying R group of ester 
 
 
While this postulated transition state goes some way towards explanation of the 
diastereoselectivity observed in the Michael addition, it has yet to be confirmed, with no 
further experiments or modelling having been performed in the Prunet group. If the 
reaction was proceeding through the proposed transition states, use of a highly 
coordinating additive would be expected to improve diastereoselectivities. However there 
is precedent for similar transition states, with Heathcock’s model for predicting the 
diastereoselectivity of Michael additions assuming a bridging lithium coordinated by the 
two oxygen functionalities as in TS1 (Scheme 50).
24
 The anti product could be formed via 
TS2, however this is disfavoured due to the undesirable steric interaction. Recent 
computational studies by Evans et al. validate Heathcock’s model,25 wherein these closed 
transition states effectively predicted the product of the intermolecular Michael additions.  
 
 
 
 
 
 
 
Scheme 50: Heathcock’s model for predicting the stereochemistry of Michael additions 
 
In their synthesis of Englerin A,
26
 the Chain group utilised a diastereoselective Michael 
addition proceeding through an 8-membered closed transition state. In their synthesis both 
the enolate and Michael acceptor are coordinated through their respective oxygens to a 
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lithium centre. Using the mildly coordinating solvent THF they obtain their desired 
diastereomer as the major product, in a 2:1 ratio with a number of others. It could be 
assumed that using a highly coordinating solvent such as DMF, the selectivity would be 
completely altered. 
 
 
Using the ethyl ester of the Michael-type adduct 119b, Snider radical cyclisation was 
achieved by treatment with manganese(III) acetate, with the optimal solvent found to be a 
10:1 mixture of 2,2,2-trifluoroethanol/acetic acid, forming the ABC ring system 120 in 
50% yield (Scheme 50). Luche reduction of the ketone of the A-ring proceeded exclusively 
from the lower face, setting up 121 with the necessary stereochemistry in a 40% yield. This  
also protects the ketone of the C-ring as a hemiacetal in the same step. Unfortunately at this 
stage all attempts to form the carboxylic acid 122 from the ethyl ester were unsuccessful; 
therefore the required decarboxylation could not be achieved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 51: Snider radical cyclisation and further transformations 
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3 - Results and Discussion 
 
3.1 - Project Aim 
 
3.1.1 - Total synthesis of hexacyclinic acid 
 
Despite having its detractors, total synthesis still has an important and necessary role in 
modern organic chemistry. Total synthesis remains one of the best methods to trial and 
develop new methodologies – such as Clarke’s iodocyclisation in his synthesis of the DEF 
model or Landais’ radical cyclisation of the A-ring. Natural products often pose synthetic 
challenges which many a chemist seeks to overcome, pushing the boundaries of synthetic 
organic chemistry. 
Another important role of total synthesis is the structural reassignment of 
misassigned structures and/or stereocentres. With modern analytical techniques constantly 
improving, it is often possible to completely characterise newly isolated natural product, 
though often, due to their complexity, this is not always possible and it is here that total 
synthesis can be of use. One of the most famous and controversial examples of this was in 
the structural reassignment of hexacyclinol (Fig 6). The originally postulated structure was 
reported by Gräfe et al.,
27
 who isolated hexacyclinol as a secondary metabolite from Panus 
rudus fungus. The proposed structure of hexacyclinol contained an unusual strained 
endoperoxide motif and was assigned by extensive NMR and mass spectroscopy. The total 
synthesis of this postulated structure was reported by La Clair.
28
 However Rychnovsky 
followed this with a structural reassignment of hexacyclinol, with the endoperoxide absent 
and the revised structure containing diepoxide moieties. This reassignment was based on 
computationally calculated 
13
C NMR.
29
 It wasn’t until this reassigned structure was 
synthesised by Porco et al. and compared with the sample of natural hexacyclinol that the 
structure of hexacyclinol could finally be confirmed,
30
 with the La Clair paper later being 
retracted. 
As an X-ray structure and Mosher’s ester analogue of 1 was obtained, there are no 
structural ambiguities or misassigned stereocentres to rectify. Nonetheless the total 
synthesis of 1 is still rightfully viewed as an important task. 
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Fig 6: Original postulated structure and reassigned structure of hexacyclinol 
 
Finally, isolated natural products are often viewed as a source of inspiration in the 
synthesis of novel therapeutic agents. While the structural complexity and low natural 
abundance of 1 may preclude its use as a therapeutic agent, its synthesis could allow 
analogues to be made and the active pharmacophore probed, which could potentially aid in 
the synthesis of a new generation of cytotoxic drugs. Artemisinin is a sesquiterpene natural 
product isolated from the plant Artemisia annua, and is used as a treatment for malaria (Fig 
7). The structure contains an unusual peroxide, which is believed to be responsible for its 
activity. Various semi-synthetic analogues of artemisinin containing this bridging peroxide, 
such as artesunate, have given rise to a new generation of antimalarials. With the active 
pharmacophore identified, various entirely synthetic drug candidates containing such a 
peroxide functional group have been developed, such as arterolane.
31
 
 
 
 
 
 
 
Fig 7: Structures of artemisinin, artersunate and arterolane 
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ABC tricycle 
 
Following on from previous work within the Prunet group, the current strategy for the 
synthesis of the ABC tricycle remains largely unchanged. The route developed within the 
group, joining the A-ring 111 and the C-ring 118 by a diastereoselective Michael addition 
and closing the B-ring by a Snider radical cyclisation (Scheme 52). This route is highly 
convergent, building the chiral A and C-rings before their combination. Another feature of 
this approach is its novelty, with other groups building the AB or ABC ring systems 
utilising the Diels-Alder reaction (with the exception of Landais). 
 
 
 
 
 
 
 
 
 
 
Scheme 52: Strategy for synthesis of ABC tricycle within Prunet group 
 
The diastereoselective Michael addition will be performed using the tert-butyl ester 113c 
as this was previously found to give the best diastereoselectivities and an acceptable yield 
(Scheme 53). Due to the difficulties previously encountered when trying to hydrolyse the 
ethyl ether, it is hoped the tert-butyl ester will easily removed under acidic conditions. It is 
also planned to make a 2,2,2-trimethylsilylethanol ester analogue, believing this could be 
more easily removed using TBAF. 
 
 
 
 
 
Scheme 53: Strategy for synthesis of ABC tricycle within Prunet group 
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DEF tricycle  
The first work towards the DEF tricycle within the Prunet group will be untaken during 
this project. Current retrosynthetic strategy in the Prunet group is the same as had been 
mentioned previously (Scheme 45). The approach for the synthesis of the DEF tricycle is 
to build the framework 108 utilising the Crimmins aldol reaction to build the stereocentres. 
Again this highlights the convergent route, building 108 and then grafting it onto the C-
ring of the ABC tricycle 107 (Scheme 54). The method features a challenging 9-membered 
ring 104 (similar to that seen in Clarke’s retrosynthesis), with plans to form this ring via an 
aldol condensation, though due to the inherent difficulties in forming rings of this size, it 
will be investigated whether this is possible by this method.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 54: Strategy for synthesis of DEF tricycle within Prunet group 
 
3.2 - Synthesis of ABC system 
 
3.2.1 - Synthesis of A-ring 113c/113d 
 
Retrosynthesis 
 
Disconnecting the C=C enone double bond of 111 affords the dialkene 123. The electron 
deficient enone in 111 will be formed by a challenging ring-closing metathesis reaction 
from enone 123 (Scheme 55). Again disconnecting this C=C enone in 123 gives the β-
ketoester 124. This enone 123 can be accessed by a Knoevenagel condensation from β-
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ketoester 124 and acetaldehyde. A C-C disconnection in compound 124, yields aldehyde 
125. This transformation will achieved by Roskamp homologation with aldehyde 125. C-C 
cleavage shows the stereochemistry of the A-ring can be installed by an asymmetric aldol 
reaction using Crimmins auxiliary 127 and acrolein to form the Evans-type adduct 126. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 55: Retrosynthesis of A-ring 111 
 
Attempted transesterification of A-ring 
 
Due to the quantities of the methyl ester of the A-ring 113a available within the group, it 
was thought that it could participate in a transesterification reaction to the more 
synthetically useful tert-butyl ester 113c (see Scheme 51). 
 
The use of ZnO as an effective catalyst for the transesterification of β-ketoesters was 
reported by Vallribera et al.
32 
The transesterification of methyl 3-(3,4-dimethoxyphenyl)-3-
oxopropanoate 128 was achieved using 20 mol% of ZnO in toluene under reflux with 10 
equivalents of the alcohol (Scheme 56). The reaction was seen to proceed with a primary, 
secondary and tertiary alcohol furnishing the transesterification product 129 in excellent 
yields (81—99%) with typical reaction times of 5 hours, though if a volatile alcohol was 
used, longer reaction times was required for full conversion. 
 
 
 
 
Scheme 56: Transesterifications using ZnO by Vallribera group 
 
While the reaction was optimised with 128, which contains an aromatic substituent, the 
reaction scope was extended to aliphatic compounds; ethyl 2-oxocyclopentylcarboxylate 
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130 undergoes transesterification using 10 equivalents of 3-pentanol, affording product 131 
in only 2 hours in 98% yield (Scheme 57). 
 
 
 
 
 
 
Scheme 57: Transesterification of aliphatic substrates by Vallribera group 
 
An attempt was made to access the more useful tert-butyl 113c or 2-(trimethylsilyl)ethyl 
ester 113d by transesterification of available 113a using these conditions (Scheme 58); 
however after several days of reaction time no product was observed with only starting 
material being recovered. It is likely that the alcohol is attacking the electron deficient 
alkene, resulting in an oxa-Michael adduct, which could then undergo a reversible Michael 
reaction. This would account for the lack of desired product. 
 
 
 
 
 
Scheme 58: Attempted transesterifications of A-ring 113a 
 
Synthesis of Crimmins chiral auxiliary 127 
 
Synthesis of Crimmins chiral auxiliary 127 utilised D-phenylalanine as the starting 
material, and started by reducing the carboxylic acid group with BH3, generated in situ 
with NaBH4 and I2 (Scheme 59).
33
 This formed amino alcohol 132 very efficiently in a 
quantitative yield. Cyclisation to form the thiazolidinethione 133 was achieved by 
refluxing CS2 in a highly basic aqueous KOH solution in an excellent yield.
34 
Acylation of 
the nitrogen of the dithiocarbamate moiety was achieved using propionyl chloride 
furnishing 127 in good yields over all 3 steps. 
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Scheme 59: Synthesis of Crimmins auxiliary 127 
 
Crimmins asymmetric aldol reaction 
 
Asymmetric aldol reactions are an essential part of the modern synthetic chemists’ toolkit, 
being utilised in a number of syntheses. David A. Evans has been a pioneer in this field, 
demonstrating the use of dibutylboron enolates of acyl oxazolidinones in asymmetric aldol 
reactions.
35
 This method has been used to prepare a variety of β-hydroxycarbonyl 
compounds with a high degree of optical purity, often with diastereomeric ratios of >250:1 
being achieved. Titanium enolates of oxazolidinones have also been investigated; however 
these were seen to be less selective than the boron equivalents. Diastereoselectivities were 
found to be lower (88%–96% de), with a much greater drop observed with α,β-unsaturated 
aldehydes. In addition, to achieve good reaction rates and conversion, it is necessary to use 
2–5 equivalents of aldehyde, which precludes the use of expensive or synthetically 
complex aldehydes. 
 
The proposed transition state I for the formation of the Evans syn product is shown in 
Scheme 60. Following formation of the Z-enolate, the molecule reacts via a 6-membered 
chair transition state to form the Evans syn product. If the titanium loses a chloride ion, the 
reaction could proceed through transition state II, with the titanium coordinated to both the 
aldehyde and the auxiliary. The molecule takes either of these two conformations in order 
to minimise the dipole interaction. This pathway provides the non-Evans syn product, due 
to the change in π-facial selectivity – reducing the overall diastereoselectivity. 
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Scheme 60: Transition states of the Evans and Crimmins aldol reactions 
 
Crimmins set about to induce a more highly ordered transition state and greatly increase 
the diastereoselectivity, investigating the use of an acyl thiazolidinethione or 
oxazolidinethione auxiliary.
36
 Due to the greater affinity of sulfur for titanium (compared 
to oxygen),
37 
it was theorised that the reactions would proceed exclusively through the 
more rigid transition state II (Scheme 60). 
 
The titanium enolates of N-acyloxazolinethiones and N-acylthiazolinethiones were tested 
under a variety of different conditions with a diverse range of aldehydes (Scheme 61). It 
was observed that the yields, conversions and diastereoselectivities were highly dependent 
on the nature and number of equivalents of the base, as well as the amount of TiCl4 used to 
generate the titanium enolate. However, it was observed that the best yields and 
selectivities were obtained using 2.5 equivalents of (−)-sparteine (Fig 8), with the reaction 
often being complete in 30 seconds to 1 minute. Diastereoselectivities were shown to be 
exceptional (>98:2 Evans/non-Evans and >99:1 syn/anti). The reason for this is unclear, 
though the improved kinetics is possibly due to some effect of the bidentate coordination 
of (−)-sparteine on the titanium metal (Table 3). 
  
 
 
 
Fig 8: Structure of (−)-sparteine 
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Because of the high cost of (−)-sparteine, the required 2.5 equivalents posed a problem for 
Crimmins, particularly if the reaction is to be performed on a large scale. However, the use 
of 1.0 equivalent of N-methylpyrrolidone as an additive allows the number of equivalents 
of (−)-sparteine to be lowered to 1.0, greatly reducing the cost of the reaction (Table 3). 
The more Lewis basic amide functionality is able to occupy the coordination sphere of the 
titanium, while maintaining excellent yields and diastereoselectivities. N-
Acylthiazolidinethiones were shown to be superior to N-acyloxazolidinethiones, in terms 
of yields and selectivities, and also were more easily cleaved.  
 
 
 
 
 
Scheme 61: Generation of titanium enolate and subsequent aldol reaction 
 
Conditions R Yield Evans/non-Evans 
1 equiv TiCl4 
2.5 equiv (−)-sparteine 
PhCH=CH 66% 99:1 
MeCH=CH 64% >99:1 
CH2=CH 77% >99:1 
Me2CH 75% 97:3 
Me2CHCH2 71% 98:2 
1.05 equiv TiCl4  
1 equiv (−)-sparteine 
1 equiv NMP 
PhCH=CH 77% 99:1 
MeCH=CH 84% 98:2 
CH2=CH 84% 94:6 
Me2CH 79% 98:2 
Me2CHCH2 74% 96:4 
 
Table 3: Yields and selectivities for Crimmins aldol reactions using (−)-sparteine 
 
It is also possible to use TMEDA as the diamine, mimicking the bidentate effect of (−)-
sparteine. While the diastereoselectivities remain excellent, the yields and reaction rate are 
observed to decrease. However due to the cost and diminishing availability of (−)-
sparteine, the use of TMEDA remains a viable reagent for asymmetric aldol reactions 
(Table 4). 
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Scheme 62: Generation of titanium enolate and subsequent aldol reaction 
 
Conditions R Yield Evans/non-Evans 
1.0 equiv TiCl4 
2.5 equiv (−)-sparteine 
PhCH=CH 80% 96:4 
MeCH=CH 66% >99:1 
CH2=CH 72% >99:1 
Me2CH 84% 95:5 
Me2CHCH2 81% 97:3 
1.0 equiv TiCl4  
2.5 equiv TMEDA 
PhCH=CH 75% 98:2 
MeCH=CH 53% >99:1 
CH2=CH 42% >99:1 
Me2CH 57% 96:4 
Me2CHCH2 60% 96:4 
 
Table 4: Comparison of TMEDA to (−)-sparteine in Crimmins aldol reactions 
 
As with the equivalent oxazolidinone aldol adduct, a variety of methods can be used for the 
cleavage of the thiazolidinethione auxiliary. Of particular mention however is the direct 
transformation to the aldehyde by treatment with Dibal-H; with the equivalent 
oxazolidinone it is necessary to convert the group to a Weinreb amide before reduction 
with Dibal-H (Scheme 63). 
 
 
 
 
 
 
 
 
 
Scheme 63: Methods for cleavage of Crimmins auxiliary 
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It is interesting to note that excellent yields and diastereoselectivities were also observed 
for the syn non-Evans product by altering the reagent quantities, with the use of 2.0 
equivalents of TiCl4 and 1 equivalent of (−)-sparteine favouring the non-Evans aldol 
adduct. Based on the proposed transition states for the asymmetric aldol reactions, an 
excess of TiCl4 in relation to the diamine forms the non-Evans product, proceeding through 
the more rigid transition state where the titanium is coordinated to the sulfur of the 
auxiliary. With an excess of diamine the titanium is chelated, favouring the ‘open’ 
transition state and the Evans type product (Scheme 64). 
 
 
 
 
 
 
 
 
 
 
Scheme 64: Effect of number of equivalents of base on diastereocontrol 
 
As was done previously within the group, synthesis of the A-ring began with an 
asymmetric aldol reaction of auxiliary 127 with acrolein (Scheme 65). However, utilising 
the conditions that had been used previously, with 1 equivalent of TMEDA and NMP, the 
reaction was sluggish, with yields of around 40% for the formation of 134.  
 
 
 
 
 
 
 
Scheme 65: Crimmins aldol of 127 and acrolein 
 
Due to the modest yields using TMEDA, and the cost/unavailability of (−)-sparteine, it was 
necessary to find an improved procedure for asymmetric aldol reactions. Fortunately 
substituting TMEDA for DIPEA, and using a slight excess (1.1 equivalents) of acrolein, 
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the reaction proceeded smoothly in CH2Cl2 at −78 °C, giving the desired adduct 134 in a 
78% yield with a 96:4 ratio of the Evans/non-Evans product (Scheme 66).
38
 
 
 
 
 
 
Scheme 66: Crimmins aldol 127 and acrolein using DIPEA 
 
It should be noted that chiral auxiliary 127 is synthesised from D-phenylalanine, which is 
the more expensive enantiomer. When the aldol reaction was performed using an auxiliary 
prepared from the natural enantiomer (L-phenylalanine), 2 equivalents of TiCl4 and 1 
equivalent of TMEDA very poor yields of product were obtained. However, these 
reactions were performed towards the beginning of the project, and repeating the reaction 
using DIPEA as a base should allow the aldol reaction to be done in a more cost effect 
manner. 
 
Protection and Cleavage of auxiliary 
 
Protection of the aldol adduct 134 as a TBS ether with TBSCl forming 135 proceeded near 
quantitatively (Scheme 67), followed by Dibal-H cleavage of the auxiliary to furnish 
aldehyde 136 in 85% yield, along with the recovered auxiliary 133 (85%). 
 
 
 
 
Scheme 67: TBS protection and Dibal-H reduction to form aldehyde 136 
 
Roskamp Homologation and Knoevenagel reactions 
 
For the formation of the alkyl diazoacetate reagents required for the Roskamp 
homologation, it was necessary to synthesise N-acetylsulfanilyl azide 138 as the diazo 
transfer reagent (Scheme 68). This was achieved by reaction of N-acetylsulfanilyl chloride 
137 with NaN3 in acetone, with addition of water precipitating 138 in a 36% yield.
39
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Scheme 68: Synthesis of N-sulfanilylazide 138 
 
Using previous conditions for the synthesis of diazoacetates, treatment of tert-butyl 
acetoacetate 139 with N-acetylsulfanilyl azide in pentane/H2O with 1.8 equivalents of 
NaOH and a substoichiometric amount of TBAB as a phase transfer catalyst gave the 
desired diazoacetate 140 along with the byproduct 141 (Scheme 69) in a 1:1 ratio. 
 
 
 
 
 
Scheme 69: Attempted formation of diazoacetate 140 
 
However a simple alteration of the procedure, increasing the number of equivalents of 
NaOH to 2.8, gave only one product, the desired diazoacetate 140 in a 60% yield (Scheme 
70).
40
 
 
 
 
Scheme 70: Improved formation of diazoacetate 140 
 
 
Roskamp homologation of aldehyde 136 was accomplished using 2 equivalents of tert-
butyl diazoacetate 140 with 0.5 equivalents of SnCl2 in dichloromethane, affording β-
ketoester 142 in 73% yield (Scheme 71). Further functionalisation to the cyclisation 
precursor was achieved by a Knoevenagel condensation; formation of the titanium enolate 
using TiCl4, which then condensed with acetaldehyde, led to the α,β-unsaturated moiety in 
143 as an inseparable 1.5:1 mixture of geometric isomers in an excellent 88% yield. 
 
 
 
 
 
Scheme 71: Formation of cyclisation precursor 143 
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The mechanism for the Roskamp homologation begins with coordination of the aldehyde 
to the Lewis acidic SnCl2, which enhances the electrophilicity of this substrate (Scheme 
72). It is then attacked from the α-position of the alkyl diazoacetate. Removal of SnCl2 to 
reform the ketone results in a 1,2-hydride shift, eliminating a molecule of N2 to form the 
desired β-ketoester product. 
 
 
 
Scheme 72: Mechanism of Roskamp homologation 
 
Ring-closing metathesis to form 113c 
 
Ring-closing metathesis of 143 using Grubbs’ 2nd generation catalyst in dichloromethane at 
reflux afforded the A-ring 113c in 67% yield (Scheme 73). This reaction was observed to 
be slower using the tert-butyl ester compared to the methyl or ethyl analogues, requiring 
two days for complete conversion. It is thought that the methyl group of the trisubstituted 
alkene leads to a more electron rich alkene for the ring closing metathesis. However due to 
the high amount of Grubbs catalyst required - 5 mol%, although up to 10 mol% of catalyst 
may be required - the hindered alkene may be hampering the reaction.  
 
 
 
 
 
 
Scheme 73: Ring-closing metathesis of 143 forming A-ring 113c 
 
Structural assignment of 113c was relatively straightforward, with the characteristic 
doublet at 7.67 ppm of the electron deficient alkene indicating cyclisation has occurred. 
(Appendix – page 163). 
 
Synthesis of 2-(trimethylsilyl)ethyl A-ring 113d 
 
Due to the failed transesterifications using the A-ring 113a, it was decided to introduce the 
2-(trimethylsilyl)ethyl ester at an earlier stage. Roskamp homologation of aldehyde 136 
with methyl diazoacetate 144 gave the methyl β-ketoester 145 in a 70% yield (Scheme 74). 
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Treatment of 145 with 10 equivalents of 2-(trimethylsilyl)ethanol and 20 mol% of ZnO in 
toluene at 110 °C for 12 hours successfully formed the transesterification product 146 in 
79% yield. As before, Knoevenagel condensation and ring-closing metathesis from 147 
formed the 2-(trimethylsilyl)ethyl A-ring 113d in good yields for both steps. 
 
 
Scheme 74: Synthesis of 2-(trimethylsilyl)ethyl ester 113d 
 
3.2.2 - Synthesis of C-ring 12 
 
Retrosynthesis 
 
Functional group interconversion of the silyl enol ether, followed by C-C cleavage shows 
that the silyl enol ether 118 will be formed by a conjugate addition of 
isopropenylmagnesium bromide to chiral cyclopentenone 148, trapping the enolate with 
TMSCl (Scheme 75). Synthesis of 148 follows reported literature procedures, using a 
chiral pool synthesis from D-(−)-ribose.41 
 
 
 
 
 
 
 
 
 
 
Scheme 75: Retrosynthesis of silyl enol ether 118 
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Synthesis of diene 149 
 
Protection of D-(−)-ribose using acetone and catalytic H2SO4 provided the acetonide 152, 
which was used in the next step without further purification (Scheme 76).
42
 Wittig reaction 
of the aldose form of 152 using methyltriphenylphosphonium bromide and KO-tBu 
afforded the diol 151 in 68% yield. Cleavage of the vicinal diol using sodium periodate in a 
CH2Cl2/H2O solvent mixture formed the corresponding aldehyde 150, although the yield 
was not reproducible varying between 40% and 60%. This was attributed to volatility and 
instability of the aldehyde; because of this the aldehyde was used straight away in the next 
step, and reacted with vinylmagnesium bromide to form allylic alcohol 149 as an 
inseparable 2:3 mixture of diastereomers.
41a, 42
  
 
 
 
 
 
 
 
 
 
 
Scheme 76: Synthesis of diene 149 from D-(−)-ribose 
 
Ring-closing metathesis and oxidation 
 
 
Formation of the C-ring was accomplished by ring-closing metathesis of 149, with a very 
low catalyst loading of 0.5 mol% of Grubbs’ 1st generation catalyst, effecting closure of the 
cyclopentenone ring in 4 hours (Scheme 77).
43
 The crude allylic alcohol 153 was carried 
over to the next step without purification. Oxidation of 153 using MnO2, as reported in the 
literature, was unsuccessful leading only to product degradation. Swern oxidation gave the 
desired product in a 93% yield;
44
 however when the reaction scale was increased, the yield 
was not reproducible, dropping to 47%. It was reported by Finney et al., that IBX 
oxidations could be performed in common organic solvents, taking advantage of the partial 
solubility of IBX at higher temperatures.
45
 The IBX residue could then just be filtered off, 
simplifying the product purification. Ultimately oxidation using IBX was found to be the 
best solution, forming the desired enone 148 in a scalable 90% yield (Table 5).  
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Scheme 77: RCM and oxidation to form 148 
 
Conditions Yield 
10 equiv MnO2, CH2Cl2 Decomposition 
5 equiv MnO2 (activated), CH2Cl2 Decomposition 
2.5 equiv DMSO, 1.4 equiv oxalyl chloride, 5 equiv NEt3, CH2Cl2, 
−78 °C 
93% 
2.5 equiv DMSO, 1.4 equiv oxalyl chloride, 5 equiv NEt3, CH2Cl2, 
−78 °C* 
47% + unidentified side product 
3 eq. IBX, EtOAc 90% 
 
Table 5: Oxidation conditions - * on large scale (>10 g) 
 
An improved synthesis of IBX was reported from 2-iodobenzoic acid 154 using Oxone
® 
as 
the oxidant (Scheme 78). This proceeds well under fairly mild conditions, without the need 
for KBrO3 and a highly acidic environment. The IBX 155 formed is also of a higher purity 
with less shock sensitive impurities.
46
 
 
 
 
 
 
Scheme 78: Synthesis of IBX 155 
 
Conjugate addition 
 
Introduction of the isopropenyl group in 118 by in situ generation of the lithium 
isopropenyl reagent using 2-bromopropene and tert-BuLi,
47
 and using CuI as the copper 
source, resulted in very poor yields. Using commercially available isopropenylmagnesium 
bromide gave improved yields, with CuBr.SMe2 found to be the optimal copper source. 
The best yield was obtained using HMPA as an additive; however, due to its high toxicity, 
TMEDA was used instead for larger scale reactions (Table 6). To isolate the highly labile 
silyl enol ether 118, it was necessary to use oven-dried silica gel (dried in the oven for 3 
days at 120 °C) for column chromatography, with humid silica leading to rapid hydrolysis 
of the silyl group. 
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Scheme 79: Conjugate addition of isopropenyl group to 148 
 
Conditions Yield –118/118’ 
2 equiv 2-bromopropane, 4 equiv t-BuLi, 1 equiv CuI, Et2O, −78 
°C 
- 
1.4 equiv isopropenylmagnesium bromide, 0.1 equiv CuBr.SMe2, 
2.8 equiv HMPA, 3 equiv TMSCl, THF , −78 °C 
41%/60% 
1.4 equiv isopropenylmagnesium bromide, 0.1 equiv CuBr.SMe2, 
2.8 equiv TMEDA, 3 equiv TMSCl, THF , −78 °C 
34%/59% 
 
Table 6: Conditions for conjugate addition to 148 
 
Transformation of 118’ to 118 was easily achieved by treatment with LDA, trapping the 
resulting enolate with TMSCl (Scheme 80). When the reaction was repeated using 
LiHMDS instead of LDA, only trace amounts of the desired product were isolated. 
 
 
 
 
 
 
Scheme 80: Conversion of 118’ to 118 using LDA 
 
 
3.2.3 - Diastereoselective Michael addition 
 
With both optically pure partners in hand, attempts could be made for the 
diastereoselective conjugate addition of 118 to 113c (Scheme 81). As has previously been 
mentioned, a highly polar 4:1 DMF/THF solvent mixture favours formation of the desired 
diastereomer, with the use of THF necessary for the formation of the lithium enolate of 118 
and to ensure the solution is liquid at −78 °C. Using the ethyl ester, satisfactory yields and 
diastereoselectivities were obtained, however hydrolysis of the ethyl ester could not be 
achieved. The methyl ester was too reactive and gave poor yields and selectivities, 
however, the tert-butyl ester forms only a single diastereomer, which could then potentially 
be cleaved under acidic conditions. The 2-(trimethylsilyl)ethyl ester was expected to give 
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results similar to the ethyl ester; however removal of the ester can be achieved by treatment 
with TBAF. 
 
Using the tert-butyl ester 113c, attempts were made utilising the conditions previously 
optimised in the group. Using 1.05 equivalents of ZnCl2 as the Lewis acid and slowly 
adding 3.3 equivalents of the lithium enolate of donor 118, poor yields of less than 20% of 
the Michael product were obtained. In addition, the major product of the reaction was 
found to be 156, a dimer of the C-ring (Fig 9). These low yields and formation of the dimer 
156 were attributed to traces of water in the reaction, quenching the enolate of 118 
prematurely. A dramatic improvement in yield was obtained by changing the order of 
addition of the reagents, switching to the slow addition of the A-ring 113c DMF solution to 
the solution containing the lithium enolate. The best results were obtained by slowly 
increasing the temperature from −78 °C to −10 °C over 4 hours, with the reaction seen to 
begin around −40 °C, giving the adduct 119c in 50% yield. However, contrary to work 
previously performed in the group, the product was isolated as a 3:1 mixture 119c to the 
undesired diastereomer 119’c (Scheme 81).  
 
 
 
 
 
 
Scheme 81: Diastereoselective Michael addition of 113c 
 
 
 
 
 
 
 
Fig 9: C-ring dimer 156 
 
The
 1
H NMR spectra indicated the product formed contained two alkenic protons, with 
COSY data showing these signals coupling exclusively to each other – consistent with the 
terminal alkene in the product (Appendix, page 165). The product was seen to contain two 
tert-butyl groups as would be expected. All three methyl groups are seen indicating 
coupling of the A and C-rings. Disappearance of the electron deficient A-ring alkene and 
formation of a new ddd signal corresponding to the C
3
 C-H confirms Michael addition of 
the two rings. NOESY spectra confirms the desired product as the major diastereomer. On 
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the A-ring the syn relationship between the H
2
/H
4 
and the H
3
/H
5 
hydrogens can be seen. 
Similarly this syn relationship is seen on the C-ring the H
14
/H
16
/H
17
 hydrogens. 
 
 
 
 
 
 
Fig 10: NOESY interactions of 119c 
 
Diastereoselective reaction of the 2-(trimethylsilyl)ethyl ester 113d using the original 
conditions gave only impure trace amounts of the desired Michael product 119d (Scheme 
82), with the major product being the dimer 156. However this reaction was performed 
early on in the project before the tert-butyl analogue 119c had been accessed. Using the 
altered conditions (addition of the Michael acceptor to the enolate solution) it should be 
possible to afford 119d in a practical yield.  
 
 
 
 
 
 
 
Scheme 82: Diastereoselective Michael-type addition of ester 113d 
 
 
3.2.4 - Formation of the B ring – 6-endo-trig radical cyclisation 
 
Closure of the B-ring will be achieved as before by a Snider radical cyclisation from 119c, 
which is accessed from the Michael-type addition as a mixture of diastereomers. It had 
been shown previously in the group that the solvent used had a large effect on the yield of 
the reaction, with the more acidic solvent such as acetic acid giving improved yields.
48
 
However, due to the presence of the acid sensitive acetonide, these yields were not 
reproducible. After further experimentation, the optimal solvent was found to be 2,2,2-
trifluoroethanol using acetic acid as a co-solvent in a 10:1 mixture, which was necessary to 
give full dissolution of the copper. Snider radical cyclisation was achieved by dissolving 
119c in a 10:1 solvent mixture of 2,2,2-trifluoroethanol/acetic acid and 2 equivalents each 
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of Mn(OAc)3.3H2O and Cu(OAc)2.H2O (Scheme 83). The reaction was seen to be 
complete after 2 hours and ABC tricyclic system 157 was isolated in 48% yield.  
 
 
 
 
 
 
Scheme 83: Snider radical cyclisation of 119c 
 
Although the cyclisation has been achieved, purification of the product proved to be 
exceedingly difficult, with a large number of impurities that could not be removed 
(Appendix, page 168), making assignment of peaks complicated. A new signal was also 
observed at 2.90 ppm, with a large germinal coupling (J = 14.8 Hz) corresponding to the 
H
20
 position of the 6-membered B-ring. Disappearance of the H
2 
doublet was also 
observed, indicating cyclisation occurring from this position. Following tentative 
assignment of signals, the structure was supported by mass spectrometry showing the 
desired mass. 
 
Mechanism 
 
Snider et al, reported the radical cyclisation of β-ketoesters onto olefins; the mechanism 
takes place as follows (Scheme 84). Using Mn(OAc)3.2H2O as a source of manganese(III), 
this generates the manganese enolate 158, with an elimination of manganese(II) forming 
the α-radical species 159. This radical then reacts in a 6-endo-trig fashion to form the 6-
membered B-ring, forming the tertiary radical 160. According to Baldwin’s rules, a 5-exo-
trig cyclisation is also possible, however this is disfavoured due to the highly strained 
system that would be formed. Without Cu(OAc)2.H2O, oxidation of the primary radical 
species is slow, with the saturated product 161 being formed instead by proton abstraction 
from the solvent. However, when the copper is present in the reaction, the tertiary radical is 
trapped forming the copper(III) intermediate 162. Elimination of Cu(OAc) and AcOH 
generates the exocyclic double bond, forming 157 in 48% yield.
49
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Scheme 84: Mechanism of Snider radical cyclisation 
 
3.2.5 – Attempted removal of tert-butyl ester 
 
As use of the ethyl ester led to difficulties, with all attempts to hydrolyse it unsuccessful, it 
was believed that the tert-butyl ester could be easily removed under acidic conditions. 
Attempts to remove the ester group using TMSOTf were unsuccessful, leading to product 
degradation (Scheme 85). Using a 2:1 mixture of trifluoroacetic acid and CH2Cl2 at 0 °C, a 
new product was seen by TLC. As this was more polar than the startng material 157 it was 
hoped to be the carboxylic acid 163. Unfortunately the new product turned out to be the 
elimination product 164 isolated, with the doublet at 7.10 ppm indicating elimination had 
occurred, with formation of the electon deficient alkene. Dilution of the TFA had no effect 
on the yield (Table 7). Although the removal of the tert-butyl ester was unsuccessful, the 
reaction was trialled on a very small scale (~10 mg), and the conditions used were by no 
means exaustive. The use of triethylsilane to trap the formed carbocation is the reaction 
mix might also lead to improved yields. However it must be considered that the ester is too 
hindered to be removed.
50
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Scheme 85: Removal of t-butyl ester from 157 
 
Conditions 163/164 
1.5 equiv TMSOTf, 3 equiv NEt3, CH2Cl2, −78°C Degradation 
2:1 CH2Cl2/TFA, 0 °C 0%/7% 
10:1 CH2Cl2/TFA, 0 °C 0%/5% 
 
Table 7: Attempted removal of tert-butyl ester 
 
3.2.6 - Conclusions and Future Work 
 
Enantiopure synthesis of tert-butyl double Michael acceptor 113c from Crimmins auxiliary 
127 has been achieved in 7 steps in a 30% overall yield (Scheme 86). Of particular mention 
is the improvement of the Crimmins aldol reaction by substituting TMEDA for DIPEA, 
giving greater and reproducible yields. Silyl enol ether 118 has been prepared from D-(−)-
ribose in 8 steps in 26% overall yield. While this procedure is scalable, it would be ideal if 
the number of steps could be reduced, however for the moment it remains the best method. 
The key diastereoselective Michael-type addition of 118 and 113c to form adduct 119c has 
been achieved in a 50% yield, though modifications of the procedure were required to 
access the product in a reasonable yield. Snider radical cyclisation afforded the ABC 
tricyclic ring system 157 in a 48% yield, although running this reaction on a larger scale 
could give an improvement in the yield and possibly make purification easier. Removal of 
the tert-butyl ester has been trialled on very small scale, giving the elimination product 164 
with OTBS elimination; however the reaction still needs to be optimised. If the removal of 
the tert-butyl ester is unsuccessful, the reaction should be repeated with the 2,2,2-
(trimethylsilyl)ethyl ester analogue, which could hopefully be removed using TBAF or 
another fluorinating agent. However this may also remove the TBS group. 
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Scheme 86:  Summary of work towards ABC tricycle 
 
While some progress has been made towards completion of the ABC tricycle utilising the 
tert-butyl analogue, the synthesis has reached a similar point previously reached within the 
group, with many steps remaining to complete the ABC tricycle. Closure of the B-ring has 
been achieved as before, although the yield remains moderate. Attempts to remove the 
superfluous tert-butyl ester were unsuccessful. 
 
Following removal of ester moiety, the next step would be the decarboxylation to form 165 
(Scheme 87). While many conditions exist to effect this, we would first investigate a 
Barton decarboxylation.
51 
Reduction of the ketone should proceed stereoselectively from 
the lower face, followed by protection of the resulting alcohol a silyl ether. It is necessary 
to isomerise the exocyclic alkene, with the use of RhCl3 showing potential for forming the 
endocyclic alkene 166.
48
 Deprotection of the acetonide would give the corresponding diol, 
which would undergo a Corey-Winter olefination to form the enone 167. An epoxidation to 
168, followed by reaction with hydrazine to form hydrazone 169 would allow a Wharton 
rearrangement to occur, with an oxidation furnishing the enone functionality to form 107,
52
 
giving the correct substrate for grafting of the DEF framework onto the C-ring. 
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Scheme 87: Future work for completion of ABC tricycle 107 
 
Alternatively, transformation of the ester moiety of 119c to an aldehyde as in 170 (Scheme 
88), followed by methylenation (Wittig or Tebbe) would set up the diene 171. Closure of 
the B-ring by ring-closing metathesis would offer a more atom economical method, 
without the need for the decarboxylation and circumventing the low yielding Snider 
cyclisation; however it would be necessary to epimerise the α-vinyl group to give the 
necessary 1,4-cis relationship as seen in 171. The carboxylic acid of hexacyclinic acid 1 
will be introduced at a later stage by an allylic oxidation using SeO2. 
 
 
 
 
 
 
 
 
 
 
Scheme 88:  Alternate closure of B-ring by RCM 
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3.3 - Current work towards DEF tricycle 
 
Retrosynthesis 
 
As previously discussed, the synthesis of the DEF tricycle will be among the final steps for 
the synthesis of 1. The β-ketoester 108 contains the necessary stereocentres and 
functionality required and will be attached to the tricycle 107 by a Michael addition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 89:  Retrosynthesis of DEF tricycle – ABC tricycle omitted 
 
For the synthesis of 108, the β-ketoester functionality will be installed by a Roskamp 
homologation from aldehyde 174. C-C cleavage of 175 to auxiliary 127 and aldehyde 176 
shows that the stereogenic centres will be installed by an asymmetric aldol reaction of 127 
with 176 to form the aldol adduct 175. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 90: Retrosynthesis of β-ketoester 108 
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3.3.1 – Synthesis of β-ketoester 
 
Synthesis of 4-pentenal 176 
 
Oxidation of 4-penten-1-ol 177 under Swern conditions was found to be difficult, due to 
the volatility of 4-pentenal 176, with only trace amounts of product being isolated (Scheme 
91). Oxidation with IBX in either EtOAc or DCE was completed in 3 hours, however 
removal of the solvent in vacuo also removed the product. Using 3 equivalents of IBX in 
CH2Cl2 required up to 3 days reaction time but led to aldehyde 174 in a 45% yield in 
CH2Cl2 (Table 8). 
 
 
 
Scheme 91: Oxidation of 177 
 
Conditions Yield 
Oxalyl chloride, NEt3, DMSO, CH2Cl2, −78 °C - 
1.5 equiv IBX, EtOAc, 80 °C ~5% 
1.5 equiv IBX, DCE, 80 °C ~5% 
3 equiv IBX, CH2Cl2, 40 °C ~45% 
 
Table 8: Conditions for oxidation of 177 
 
An alternative synthesis of 176 employs glycidol 178 as the starting material (Scheme 87). 
The epoxide ring is opened by addition of allylmagnesium bromide forming diol 179 in 
good yield. Cleavage of the diol using sodium periodate furnishes 176 of sufficient purity 
for the Crimmins aldol reaction.
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Scheme 92: 2-step synthesis of 176 
 
Crimmins aldol reaction of 127 with 176 
 
Using the conditions previously utilised within the group for the synthesis of the A-ring 
(1.0 equivalent each of TiCl4, TMEDA and NMP with 1.1 equivalent of aldehyde in 
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CH2Cl2 at −78 °C), the aldol adduct 180 was obtained in a modest 43 % yield with a 97:3 
dr (Scheme 93). Using DIPEA as the base gives an improved yield of 70% (96% brsm). 
 
 
 
 
 
Scheme 93: Crimmins aldol reaction of 127 and 176 
Completion of β-ketoester  
 
Protection of the aldol adduct 180 as a TBS ether required 3 equivalents of TBSCl to 
achieve good conversion, however a near quantitative yield of 181 was obtained (Scheme 
94). Reduction of 181 was performed using 2 equivalents of Dibal-H in CH2Cl2 at −78 °C, 
effecting efficient cleavage of the auxiliary in only 5 minutes, furnishing aldehyde 182 in 
an 85% yield. Recovered auxiliary 133 (85%) can then be recycled and used in further 
aldol reactions. 
 
Scheme 94: TBS protection of 180 and subsequent cleavage of the auxiliary 
 
Treatment of methyl or ethyl acetoacetate with 138 in 3 M aqueous NaOH solution and 
pentane, using TBAB, yielded methyl 144 or ethyl 183 diazoacetate (Scheme 95). Due to 
its volatility methyl diazoacetate 144 could not be accessed neat, and was instead used as a 
solution in ether. 
 
 
 
 
 
Scheme 95: Synthesis of alkyl diazoacetates 
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Due to the relative ease of isolation of ethyl diazoacetate compared to the methyl analogue, 
it was decided to proceed using the ethyl β-ketoester. Roskamp homologation of aldehyde 
182 with 183 proceeded smoothly with SnCl2 in CH2Cl2,
54
 furnishing the desired β-
ketoester 184 as an inseperable 3:1 mixture with the corresponding enol forms 184’. 
 
Scheme 96: Roskamp homologation of 182 
 
3.3.2 – Michael addition of 184 to cyclopentenone 185 
 
Optimisation of the Michael addition of 184 onto the C-ring was performed using 
cyclopentenone 185 as a model system – though it gave the product as a mixture of 4 
diastereomers (Scheme 97). Using traditional Michael addition conditions with the use of 
NaOEt in ethanol gave the desired adduct 186 in a modest 40% yield (Table 9). Increasing 
the number of equivalents of donor 184 or base gave no improvement of the yield, though 
the low yield may be due to the quality of the base, with greater yields possibly being 
obtained by using freshly prepared base. It was shown by Tan et al., that TBD (Fig. 11) 
could act as an effective catalyst for Michael additions,
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but
 
when these conditions were 
used, no real improvement in the yield was observed. However, by increasing the number 
of equivalents of 184, a good 72% yield was obtained, though due to the impracticalities of 
using 4.0 equivalents of 184
 
another method was required. 
 
Greater improvements were 
seen by using K2CO3 in ethanol, generating the ethoxide base in situ. This method allows 
for a decreased number of equivalents of 184 and affording the Michael adduct 186 in 91% 
yield. 
 
 
 
 
 
 
 
Scheme 97: Michael addition of 184 to 185 
 
 
 
 
Fig 11: Structure of TBD 
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Conditions Yield 
2.0 equiv 184, 0.2 equiv NaOEt, EtOH 40% 
2.0 equiv 184, 0.5 equiv NaOEt, EtOH 38% 
3.0 equiv 184, 0.5 equiv NaOEt, EtOH 40% 
1.5 equiv 184, 0.2. equiv TBD, Toluene 40% 
3.0 equiv 184, 0.2. equiv TBD, Toluene 41% 
4.0 equiv 184, 0.2. equiv TBD, Toluene 72% 
2.0 equiv 184, 1 equiv HMPA, 3Å MS, CH2Cl2 - 
2.0 equiv 184, 0.2 equiv K2CO3, EtOH 68% 
2.0 equiv 184, 0.4 equiv K2CO3, EtOH 73% 
1.5 equiv. 184, 0.2 equiv K2CO3, EtOH 88% 
1.5 equiv 184, 0.4 equiv K2CO3, EtOH 91% 
 
Table 9: Conditions for Michael addition of 184 to 185 
 
The Michael adduct 186 was obtained as an inseparable mixture of 4 diastereomers making 
characterisation exceedingly difficult with the 
1
H NMR showing a series of overlapping 
multiplets, however the correct mass was seen by mass spectrometry. Nonetheless the 
structure remains unverified. 
 
3.3.3 – Further functionalisation of 186 
 
Wacker oxidation of the terminal olefin of 186 to 187 was easily achieved using the 
standard Wacker conditions (Scheme 98). Oxidation using stoichiometric PdCl2 in a 4:1 
mixture of DMF and water gave the product in a good 62% yield. Attempts to use catalytic 
amounts of palladium (0.2 equivalents), with 1.2 equivalents of CuCl2 under an oxygen 
atmosphere initially gave a decreased yield (58%). However increasing the catalyst loading 
to 0.4 equivalents of catalyst was found to increase the yield, with a more dilute (0.05 M) 
solution giving the best yield of the tetracarbonyl compound 187 (Table 10). As with the 
Michael adduct, the Wacker product 187 was isolated as a mixture of inseparable 
diastereomers, with full assignment in the 
1
H NMR not possible, however the 
disappearance of the alkene signals and new singlet at 1.98 ppm corresponding to the 
methyl group of the newly formed ketone indicate the oxidation is occurring. The desired 
product mass is also seen by mass spectrometry. 
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Scheme 98: Wacker oxidation of 186 
 
Conditions Yield 
1.05 equiv PdCl2, 4:1 DMF/H2O 62% 
0.2 equiv PdCl2, 1.2 equiv CuCl2, 4:1 DMF/H2O, O2 58% 
0.4 equiv PdCl2, 1.2 equiv CuCl2, 4:1 DMF/H2O (0.1 M), O2 65% 
0.4 equiv PdCl2, 1.2 equiv CuCl2, 4:1 DMF/H2O (0.05 M), O2 72% 
 
Table 10: Conditions for Wacker oxidation of 186 
 
Protection of the β-keto functionality in 187 as a silyl enol ether using TESOTf in CH2Cl2 
at −78 °C gave the product 188 in a quantitative yield; the geometry of the double bond 
was not determined (Scheme 99). 
 
 
 
 
 
 
 
Scheme 99: TES protection of β-ketoester 187 
 
3.3.4 – Aldol condensation attempts 
 
With the silyl enol ether 188 prepared, attempts were made to form the 9-membered ring 
product 189 by aldol condensation (Scheme 100). First attempts were made using KOt-Bu 
in toluene with slight heating, however only starting material was recovered. Increasing the 
equivalents of base and concentration of the solution had no effect.
56
 Using 5 equivalents 
of DBU in a dilute solution of 188 in CH2Cl2 gave no reaction, with only starting material 
recovered. An increase in the number of equivalents of DBU and the temperature gave the 
same result.
57
 Treatment with NaOEt in ethanol gave no result either; only starting material 
was recovered, however the use of freshly prepared reagent might give a better result. The 
use of a 4:1:1 THF/EtOH/10% aqueous NaOH showed some promise on very small 
scale,
58
 with TLC evidence for the formation of a new product. However when appreciable 
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quantities of this product were obtained, it was found to be the tricarbonyl 187 (Fig 12), 
formed by a retro-Michael reaction (Table 11). 
 
 
 
 
 
 
 
Scheme 100: Aldol condensation of 188 
 
Conditions Yield 
1.2 equiv KOt-Bu, toluene, 0.05 M ,0 °C to 50 °C Recovered SM 
5 equiv KOt-Bu, toluene, 0.1 M , 0 °C to 50 °C Recovered SM 
5 equiv DBU, CH2Cl2, 0.05 M, 20 °C Recovered SM 
15 equiv DBU, CH2Cl2, 0.05 M, 40  °C Recovered SM 
1.5 equiv NaOEt, EtOH, 0.01 M, 0 °C to 50 °C Recovered SM 
4:1:1 THF/EtOH/10% aqueous NaOH,  0.01 M, 20 °C 54% 190 
 
Table 11: Conditions for aldol condensation of 188 
 
 
 
 
Fig 12: Structure of retro-Michael product 190 
 
The likely mechanism for the retro-Michael is shown below (Scheme 101). Under these 
conditions the labile TES enol ether is cleaved. The desired enolate is then formed, 
however compound 187 fragments by a retro-Michael reaction to 185 and compound 190. 
The use of a less labile protecting group for the enol ether could potentially allow the 
cyclisation instead. 
 
 
 
 
 
 
 
Scheme 101: Mechanism for retro Michael of 187 
 
It was also attempted to effect the aldol cyclisation using the unprotected product 187, 
however as well as 9-membered product 191, there is also potential for formation of the 
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other medium sized ring products 192-194 (Scheme 102). There is also a risk of 
epimerising the α-methyl group. As was expected both conditions attempted for the 
cyclisation of 187 were unsuccessful, just giving rise to product degradation (Table 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 102: Attempted aldol condensation of 187 
 
Conditions Yield 
KOt-Bu, t-BuOH, 0.01 M, 20 °C Degradation 
4:1:1 THF/EtOH/10% aqueous NaOH, 0.01 M, 20 °C Degradation 
 
Table 12: Conditions for aldol condensation of 187 
 
3.3.5 – Synthesis of chiral model C-ring 
 
While cyclopenten-2-one 185 serves as an effective C-ring model for the Michael addition, 
the formation of 4 inseparable diastereomers makes further steps more difficult to analyse. 
Therefore it was necessary to prepare a model with a chiral substituent that would 
influence the facial selectivity of the Michael addition, so at most only 2 diastereomers 
would be formed. It was decided to synthesise (R)-isopropylcyclopentenone 195 (Fig 13),
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with the bulky isopropyl group forcing  the β-ketoester 184 to attack exclusively from the 
bottom face. 
 
 
 
 
 
Fig 13: (R)-isopropylcyclopentenone 195 
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Heating of dicyclopentadiene to 200 °C initiates a retro Diels-Alder reaction, cracking the 
dicyclopentadiene skeleton into 2 equivalents of cyclopentadiene, which can then be 
isolated by distillation (Scheme 103). Left at room temperature it will slowly dimerise so it 
was used immediately in the next step. 
 
 
 
 
 
Scheme 103: RetroDiels-Alder of dicyclopentadiene 
 
Cyclopentadiene participates in a [4+2]-cycloaddition with singlet oxygen, which is 
generated by UV irradiation whilst bubbling oxygen throughout a solution of methanol, 
with Rose Bengal being used as a sensitiser (Scheme 104). This forms the endoperoxide, 
which is reduced in situ by thiourea to afford the cis-diol 196 in 60% yield. 
 
 
 
 
Scheme 104: UV [4+2] cycloaddition using oxygen 
 
Diacetylation of the diol 196 was effected by acetic anhydride, pyridine and catalytic 
DMAP in THF, furnishing the diacetate 197 in 79% yield (Scheme 105). Enzymatic 
desymmetrisation of 94 was achieved using electric eel acetylcholineesterase in a sodium 
phosphate buffer solution, furnishing allylic alcohol 198 in excellent yield (97%). 
Oxidation of the alcohol with IBX in ethyl acetate formed the enone 199 in high yield. 
 
Scheme 105: Enzymatic desymmetrisation and synthesis of allylic acetate 199 
 
For the completion of the model C-ring 195, it was necessary to deliver an isopropyl group 
anti to the acetate group (Scheme 106). Conjugate addition of isopropylmagnesium 
bromide, with CuBr.SMe2 and HMPA, using TMSCl as a Lewis acid and attempting to 
trap the adduct as a silyl enol ether gave no product, with only starting material being 
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recovered. In the end a modification of the original conditions, substituting TMSCl with 
the stronger Lewis acid BF3.OEt2, allowed access to the adduct, though at least 3 
equivalents were required for complete conversion. Treatment with dilute acetic acid was 
enough to bring about elimination of the acetate functionality and form the enone 92 in 
72% yield (Table 13). 
 
 
 
 
 
Scheme 106: Conjugate addition to form 195 
 
Conditions Yield 
1.4 equiv. isopropylmagnesium bromide, 0.1 equiv CuBr.SMe2, 3 equiv TMSCl, THF , −78 °C - 
3.0 equiv isopropylmagnesium bromide, 1 equiv CuI, Et2O, THF −78 °C - 
1.4 equiv isopropylmagnesium bromide, 0.1 equiv CuBr.SMe2, 2.8 equiv HMPA, 0.5 equiv 
BF3.OEt2, THF , −78 °C then AcOH/CH2Cl2 
11% 
1.4 equiv isopropylmagnesium bromide, 0.1 equiv CuBr.SMe2, 2.8 equiv HMPA,  1.5 equiv 
BF3.OEt2, THF , −78 °C then AcOH/CH2Cl2 
19% 
1.4 equiv isopropylmagnesium bromide, 0.1 equiv CuBr.SMe2,  2.8 equiv HMPA,  3 equiv 
BF3.OEt2, THF , −78 °C then AcOH/CH2Cl2 
72% 
1.4 equiv isopropylmagnesium bromide, 0.1 equiv CuBr.SMe2, 2.8 equiv TMEDA,  3 equiv 
BF3.OEt2, THF , −78 °C then AcOH/CH2Cl2 
59% 
 
Table 13: Conditions for conjugate addition to form 195 
 
3.3.6 – Model CDEF model synthesis 
 
Michael addition of β-ketoester 184 to chiral model 195 using the optimised conditions of 
0.4 equivalents of K2CO3 in ethanol affords the Michael adduct 200 in an excellent 90% 
yield (Scheme 107). Attack of 184 comes exclusively from the bottom face with 200 being 
formed as a 2.5:1 ratio of an inseparable mixture of diastereomers. Wacker oxidation of the 
terminal olefin proceeds smoothly as before to furnish the methyl ketone 201 in 72% yield. 
Scheme 107: Michael addition of 184 to 195 and subsequent Wacker oxidation 
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With only 2 diastereomers being formed, spectroscopic assignment of the 1H NMR spectra 
of 200 is much more straightforward, however, due to there still being the corresponding 
enol forms available, the spectra are still very cluttered (Appendix – page 170). As 
expected, three methyl groups are present, along with an ethyl ester and TBS group. The 
characteristic ddt of the terminal alkene is also seen at 5.57 ppm. Indicative of the Michael 
addition occurring is the doublet at 4.09 ppm corresponding to the double α-protons at the 
H
2 
position. A COSY interaction can be seen between this peak and a dddd, corresponding 
to the H
13
 position. Confirmation of the Wacker oxidation can be seen by the 
disappearance of the alkene protons and formation of the methyl ketone at 2.15 ppm 
(Appendix – page 173). 
 
Using a similar protocol as before, compound 201 was protected as a TES silyl enol ether 
using TESOTf to form 202 quantitatively (Scheme 108). The aldol condensation of 202 
was investigated to see if the presence of the bulky isopropyl group had any effect. Using 
KOt-Bu or NaOEt gave no reaction with only starting material recovered. Using the 4:1:1 
THF/EtOH/10% NaOH solution conditions the same result was observed, with the retro 
Michael reaction occurring to furnish the tricarbonyl compound 190 (Table 14). 
Scheme 108: Protection of 201 and attempted formation of 203 
 
Conditions Yield 
5 equiv KOt-Bu, t-BuOH, 0.01 M , 0 °C to 50 °C Recovered SM 
3.0 equiv NaOEt, EtOH, 0.01 M, 0 °C to 50 °C Recovered SM 
4:1:1 THF/EtOH/10% NaOH, 0.01 M, 20 °C 50% 190 
 
Table 14: Conditions for aldol condensation of 202 
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Attempts were made to effect the aldol reaction in a more controlled manner, believing 
selective formation of the desired enolate of 201, would lead to formation of the aldol 
product 204 (Scheme 109). If the enolate could be trapped as a silyl enol ether, a 
Mukaiyama aldol reaction could potentially occur. While there is little precedent for 
Muikaiyama aldol reactions onto ketones to form medium sized rings, it was decided to 
attempt this approach as a means to utilise remaining material. 
 
 
 
Scheme 109: Addition of desired enolate to methyl ketone  
 
An excess of β-ketoester 190 was added to 195 using the optimised Michael conditions 
with an excess of base (Scheme 110), with the hope that the formed enolate would then 
react with the methyl ketone and furnish 204. However, while complete conversion was 
achieved, no product was isolated. Other attempts to trap the enolate as a TMS silyl enol 
ether 205 were unsuccessful, with only starting material being recovered (Table 15). 
 
 
 
 
 
 
 
Scheme 110: Michael addition of 190 to 195 
 
Conditions Yield 
1.5 equiv 190, 1.5 equiv K2CO3, EtOH - 
1.5 equiv 190, 1.5 equiv NaOEt, 3 equiv TMSCl, THF No reaction 
1.5 equiv 190, 1.5 equiv KOt-Bu, 3 equiv TMSCl, THF No reaction 
 
Table 15: Conditions for Michael addition of 190 with 195 
 
A protocol has been reported for the nucleophilic substitution of 3-tert-
butyldimethylsilyloxyalk-2-enylphosphonium salts to form OTBS enol ethers,
60
 with 
addition of triphenylphosphine to an enone, trapping the intermediate enol as a TBS enol 
ether (Scheme 111). Addition of a nucleophile to leads to displacement of the 
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triphenylphosphine moiety. A variety of nucleophiles were demonstrated, including lithium 
enolates of β-ketoesters. 
 
 
 
 
 
Scheme 111: Nucleophilic displacement of triphenylphosphine 
 
It was hoped that these conditions could be used so synthesise 102, with addition of the 
DEF framework and trapping the desired enolate as a silyl enol ether all achieved in one 
step. Addition of PPh3 and TBSOTf to 195, followed by the lithium enolate of 184, gave 
no product (Scheme 112); however the reaction was only attempted once. It is possible the 
bulky isopropyl group makes addition of the triphenylphosphine difficult. 
 
 
 
 
 
 
Scheme 112: Attempted synthesis of TBS enol ether 205 
 
3.3.7 – Conclusions and Future work 
 
Enantiopure synthesis of β-ketoester 184 was achieved in 4 steps from chiral auxiliary 127, 
with the stereogenic centres being installed by an asymmetric aldol reaction and forming 
the β-ketoester functionality by a Roskamp homologation. Synthesis of the C-ring model 
195 from cyclopentadiene is achieved over 5 steps in a 30% overall yield. The key step in 
the synthesis of 195 is the introduction of chirality by enzymatic desymmetrisation using 
electric eel acetylcholineesterase. Michael addition of 184 to 195 has been been optimised, 
accessing the Michael adduct 200 in 91% yield. Functionalisation of the alkene by Wacker 
oxidation affords 201 in a 72% yield (Scheme 113). While the attempts made to close the 
9-membered ring have been unsuccessful so far, further work is in progress to achieve this 
in the Prunet group. 
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Scheme 113: Summary of work on DEF tricycle 
 
This work represents the first work within the Prunet group on the DEF tricycle of 1, and 
while formation of the stereogenic centres and grafting the DEF framework to the C-ring 
model was optimised, the key cyclisation was unfotunately not realised. While there 
remain other options to try, the cyclisation has proven extremely difficult, it is possible the 
route may need redesigned. 
 
Immediate future work will be focussed on the formation of the 9-membered ring 208 
(Scheme 114). With the formation of the 9-membered ring proving extremely difficult to 
cyclise by an aldol condensation it is necessary to explore other approaches to the 
cyclisation. Bromination of 201 followed by formation of a protected enol ether would 
give 206, this could potentially ease the cyclisation, with a Reformatsky reaction to form 
the 9-membered ring as in 207. It was also shown by Clarke that an increased number of 
sp
2 
centres limits the destabilising transannular interactions and eases cyclisation – 
increasing the number of sp
2 
centres in the chain might allow the cyclisation to occur.
61
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Scheme 114: Potential Reformatsky reaction to close 9-membered ring 
 
Once 208 has been accessed, the CDF-ring system 209 can be closed by an oxa-Michael 
addition of the enolate onto the enone acceptor. Following this, hydration of the alkene, 
lactonisation and deoxygenation of the ketone group will afford the CDEF model 210. It is 
hoped that hydration of the double bond will occur spontaneously by addition of water to 
the strained alkene.
20
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 115: Future work for synthesis of CDEF model 210 
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4 - Diastereoselective synthesis of syn-1,3-diols by intramolecular 
conjugate addition. 
 
4.1 - Introduction 
 
The syn-1,3-diol moiety is a common structural feature in a large number of natural 
products, therefore synthetic methods for their construction are ubiquitous in modern 
synthetic chemistry. One of the most common methods is the formation of C-C bonds, 
such as in a alkylation/allylation reactions and diastereoselective aldol reactions. Knochel 
et al. reported the alkyation of the benzyl protected β-hydroxyaldehyde 211 using a chiral 
titanium catalyst 212 and alkyl zinc reagents (Scheme 116).
62
 This formed the 
monoprotected syn-1,3-diol 213 in a good yield, however the diastereoselectivity was only 
moderate with a ratio of 86:14 syn/anti. This method also requires the in-situ generation of 
the catalyst. 
 
 
 
 
Scheme 116: Conjugate addition using benzaldehyde 
 
Cossy et al. reported the allylation of β-hydroxyaldehydes 214 using stoichiometric 
amounts of the chiral cyclopentadienyldialkoxyallyl titanium complex 215 in ether at −78 
°C (Scheme 117).
63
 The reaction was found to proceed well, with good yield and excellent 
diastereoselectivities for all reported substrates. However, one drawback of this method is 
that the titanium complex 215 used is not commercially available and must be prepared. 
 
 
 
 
 
 
 
Scheme 117: Conjugate addition using benzaldehyde 
 
Diastereoselective aldol reactions are also a useful tool to access syn-1,3-diols. The 
titanium mediated aldol reaction of chiral α-tert-butyldimethylsilyloxyketone 217, 
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followed immediately by stereoselective reduction using LiBH4 to give the diol 218 has 
been reported.
64
 This represents a powerful method, creating up to three new stereocentres 
over 2 steps. This method also precludes the use of expensive chiral reagents, relying on 
substrate and not reagent stereocontrol. 
 
 
 
 
Scheme 118: Diastereoselective aldol reaction and reduction 
 
Another commonly used method is by stereoselective reduction of β-hydroxycarbonyl 
compounds. Narasaka and Pai describe the chelation controlled reduction of 219 by 
addition of tributyl boron, followed by hydride delivery using NaBH4 (Scheme 119).
65
 This 
afforded the syn diol 220 in an excellent yield with good stereocontrol. However this 
method can often give rise to undesired side products.
66
 Due to the large amount of 
literature related to the synthesis of syn-1,3-diols the methods described are by no means 
exhaustive. 
 
 
. 
 
Scheme 119: Conjugate addition using benzaldehyde 
 
A method for the synthesis of syn-1,3-diols was reported by David Evans and Joëlle Prunet
 
using the conjugate addition of a hemiacetal alkoxide, generated by addition of a 
homoallylic alcohol to benzaldehyde, onto a Michael acceptor such as α,β-unsaturated 
esters or Weinreb amides (Scheme 120).
67
 
 
 
 
 
 
 
Scheme 120: Conjugate addition using benzaldehyde  
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The reaction was shown to work well with a variety of substrates under fairly mild 
conditions, proceeding in good yields and diastereoselectivity for the syn protected diol 
(typically >95:5). This reaction also precluded the use of expensive and non commercially 
available catalysts, instead relying on substrate stereocontrol. Because of this, the reaction 
has been applied to a variety of total synthesis targets. 
 
Within the Prunet group, the reaction has been used in the synthesis of the C1-C15 
fragment of dolabelide C (Scheme 121). Treatment of the homoallylic alcohol 221 with 
benzaldehyde and KOt-Bu in THF formed the benzylidene acetal 222 in 74% yield with a 
dr greater than 98:2. Further steps go on to afford the C1-C15 fragment 223.
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Scheme 121: Synthesis of 223 in Prunet group 
 
Uenishi et al., used a similar protocol in their synthesis of (−)-apicularen A, with the 
conjugate addition of benzaldehyde to 224 giving the acetal 225 in a 65% yield; however 
no dr was reported (Scheme 122). They continued with the synthesis to furnish (−)-
apicularen A.
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Scheme 122: Use of oxa-Michael addition in synthesis of (−)-apicularen A 
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The scope of the reaction has been extended to other Michael acceptors such as 
heteroaromatic vinylic sulfones 226 and sulfoxides 229 with good yields and selectivity for 
the syn protected diol (Scheme 123). Protected diol products bearing a heteroaromatic 
sulfone 227 could then be used in modified Julia reactions favouring formation of the E-
alkenes 228. The protected sulfoxides 230 have been shown to give rise to 3-deoxyribose 
analogues 231.  
 
 
 
 
 
 
 
 
 
 
Scheme 123: Conjugate addition using sulfones and sulfoxides 
 
While the conjugate addition reaction with benzaldehyde works well, the reaction is not 
without its disadvantages. The benzaldehyde must be purified by distillation prior to use; it 
is also necessary to do three successive additions, with the excess benzaldehyde making 
purification more difficult. Moreover, no reaction occurs when the electron-withdrawing 
group possesses an α-substituent, which limits its application. 
 
It has been shown by Jung et al that carbon dioxide can be used for the formation of 
asymmetric carbonate esters (Scheme 124).
70
 Deprotonation of the free hydroxyl forms the 
alkoxide anion, which attacks the carbon of CO2. The resulting carbonate anion can then 
participate in an SN2 reaction with an alkyl halide forming the carbonate ester product. The 
scope of this reaction has been shown to be limited to primary halides, although there are a 
few examples with secondary halides. 
 
 
Scheme 124: Use of CO2 in synthesis of carbonate esters 
 
It was investigated whether carbon dioxide could be used as a reagent in the formation of 
protected syn-1,3-diols 234, proceeding by nucleophilic addition of 232 to carbon dioxide, 
with the alkoxide anion then adding to the Michael acceptor in 233 (Scheme 125). The use 
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of carbon dioxide would make the reaction more atom economical and minimise any 
difficulties with purification. 
 
 
 
 
 
 
 
 
 
 
Scheme 125: Proposed synthesis of carbonates using CO2 
 
4.2 - Results and Discussion 
 
Synthesis of substrate  
 
Formation of the substrate began with a Barbier reaction of allyl bromide and 
hydrocinnamaldehyde 235 mediated by zinc metal.
71
 In contrast to other organometallic 
addition reactions, such as the Grignard reaction, the reaction does not require anhydrous 
conditions and is performed in a mixture of THF and saturated aqeuous NH4Cl, furnishing 
homoallylic alcohol 236 in an 80% yield. While this reaction is analogous to the Grignard 
reaction, the mechanism is still not understood, possibly proceeding by a radical process.
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Cross metathesis of 236 with an excess of methyl acrylate using Grubbs’ 2nd generation 
catalyst in dichloromethane under reflux afforded the α,β-unsaturated ester 237 in 93% 
yield exclusively as the E-isomer (Scheme 126). While cross-metathesis reactions are a 
powerful synthetic tool, they can often give rise to a mixture of products. Grubbs 
developed a system to determine the favoured product based upon the type of olefins used. 
According to this model, the homoallylic alcohol 236 is a type I olefin which will rapidly 
dimerise; however these dimers are very reactive and will participate in further metathesis 
reactions. Methyl acrylate is a type II olefin which does not dimerise but will react with 
236 and its dimer. Using an excess of methyl acrylate drives the reaction to completion.
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Scheme 126: Synthesis of substrate 237 
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Conjugate addition reactions with CO2 
 
Using the same conditions reported for the synthesis of carbonate esters, dry CO2 was 
bubbled through a solution containing the substrate, 3 equivalents of Cs2CO3 and 1 
equivalent of TBAI as a phase transfer catalyst. Unfortunately this gave no reaction, with 
only starting material being recovered. Increasing the temperature or removal of TBAI 
gave the same result. Using a stronger base such as KOt-Bu or NaH in THF had no effect 
either, however increasing the number of equivalents of base did form a small amount of 
the alcohol elimination product (Table 16). 
 
 
 
 
 
Scheme 127: Attempted synthesis of substrate 238 
 
Conditions Yield 
3 equiv Cs2CO3, 1 equiv TBAI, DMF, 20 °C Recovered SM 
3 equiv Cs2CO3, DMF, 20 °C Recovered SM 
3 equiv Cs2CO3, 1 equiv TBAI, DMF, 50 °C Recovered SM 
3 equiv Cs2CO3, 1 equiv TBAI, DMF, 80 °C Recovered SM 
0.2 equiv KO-tBu, THF, 20 °C Recovered SM 
0.2 equiv KO-tBu, THF, 50 °C Recovered SM 
1 equiv KO-tBu, THF, 20 °C Recovered SM + Elimination byproduct 
3 equiv KO-tBu, THF, 20 °C Recovered SM + Elimination byproduct 
1 equiv NaH, THF, 20 °C Recovered SM 
 
Table 16: Conditions for conjugate addition using CO2 
 
Conjugate addition reactions with 2,2,2-trifluoroacetophenone 239 
 
While conjugate additions using CO2 were unsuccessful, an interesting result was obtained 
by substituting benzaldehyde for 2,2,2-trifluoroacetophenone 239 (Fig 14), which is similar 
in reactivity to benzaldehyde. The presence of the strongly electron withdrawing 
trifluoromethyl group makes 239 more reactive than benzaldehyde. 
 
 
 
 
Fig 14: Structure of 2,2,2-trifluoroacetophenone 239 
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With 0.2 equivalents of KOt-Bu and 1.1 equivalents of 239 in THF at 20 °C, after 12 hours 
of reaction time, the conversion was found to be 69%, with the protected acetal 240 being 
isolated in 59% yield (Scheme 128). A slight increase in the equivalents of base and 239 
gave an increase in conversion and yield. However when 0.4 equivalents of KOt-Bu and 3 
equivalents of 239 were used, full conversion was achieved within 5 hours, furnishing the 
product 240 in an excellent 85% yield (Table 17). 
 
 
 
 
 
Scheme 128: Synthesis of substrate 240 
 
 
Conditions Conversion/Yield 
0.2 equiv KOt-Bu, 1.1 equiv 239, THF, 20 °C 69%/59% 
0.4 equiv KOt-Bu, 1.1 equiv 239, THF, 20 °C 70%/60% 
0.4 equiv KOt-Bu, 1.5 equiv 239, THF, 20 °C 85%/71% 
0.4 equiv KOt-Bu, 3.0 equiv 239, THF, 20 °C 100%/85% 
 
Table 17: Conditions for conjugate addition using 240 
 
The proposed mechanism for the reaction is based upon the reaction using benzaldehyde. 
The first step is deprotonation of the hydroxyl, with the resulting alkoxide attacking the 
ketone functionality forming the hemiacetal alkoxide. This then attacks the Michael 
acceptor to form the enolate; this step is reversible. This enolate is then basic enough to 
deprotonate the starting alcohol, allowing the use of substoichiometric quantities of base 
and completing the reaction cycle (Scheme 129). 
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Scheme 129: Mechanism of conjugate addition using 2,2,2-trifluoroacetophenone 
  
 
4.3 - Conclusions and future work 
 
Unfortunately it was found that carbon dioxide was not reactive in the conjugate addition 
reactions to form the protected carbonate ester, though the reaction conditions were by no 
means exhausted, there is potential for the reaction using a different set of conditions. 
However it is possible that the alkoxide formed is not nucleophilic enough to attack the 
enone. Conversely the use of 2,2,2-trifluoroacetophenone 239 was found to be an excellent 
replacement for benzaldehyde, giving excellent yields of the syn protected diol. This 
method is more advantageous when compared to using benzaldehyde, as no distillation or 
multiple additions of 239 are required. The product is also more easily purified as 239 can 
be removed by rotary evaporation. Future work will be concentrated on optimisation and 
expansion of the reaction scope, and also on the removal of the acetal masking group. 
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5 - Investigation of a different base for Crimmins Aldol 
 
5.1 - Introduction 
 
Chiral diamines have been used extensively both as bases in asymmetric synthesis and as 
chiral ligands in asymmetric catalysis. For these reactions (−)-sparteine is one of the most 
highly investigated diamines, having been utilised in the asymmetric synthesis of a variety 
of compounds such as alcohols, amines and phosphines.
74
 As had been mentioned 
previously (−)-sparteine is also the ligand of choice for asymmetric Crimmins aldol 
reactions.
36
 However due to the dramatically rising cost and dwindling supply of (−)-
sparteine (1 g for £241.25 from TCI, the only supplier which stocks (−)-sparteine), the 
most commonly used replacement is TMEDA, although Crimmins’ aldol reactions using 
TMEDA tend to suffer with respect to reaction rates, yields and diastereoselectivities. Prior 
to the discovery of the use of DIPEA, experiments were performed to find an effective 
replacement for (−)-sparteine in the Crimmins aldol reactions. 
 
O’Brien et al. has demonstrated the use of s-BuLi and substoichiometric quantities of (−)-
sparteine in the asymmetric deprotonation and trimethylsilylation of N-Boc-pyrrolidine 
(Scheme 130).
74a, 75
 Using the sterically hindered s-BuLi/(−)-sparteine system, it was 
believed that the lithiation of 241 would be fairly slow, allowing for ligand exchange with 
the achiral diamine 243, freeing (−)-sparteine and recycling the chiral diamine. As would 
be expected, inversion of the selectivity was also possible by using the equivalent (+)-
sparteine surrogate.
76
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 130: Use of 243 in asymmetric silylation reactions 
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Following discussion with Prof. Peter O’Brien, it was decided to synthesise bispidine 243 
and investigate its efficacy as a base in Crimmins’ aldol reactions. As the stereocontrol of 
the Crimmins aldol reaction is independent of base used, and the structural similarities of 
bispidine 243 to (−)-sparteine, it was believed that it would give rise to comparable yields 
and diastereoselectivities. 
 
5.2 - Results and Discussion 
 
Bispidine Synthesis 
 
 
Starting from N-isopropyl-4-piperidinone 244, construction of the bicyclic skeleton is 
achieved by a double Mannich reaction using isopropylamine and paraformaldehyde, 
heated under reflux in methanol for 24 hours to furnish the diamine 245 (Scheme 131). 
Removal of the carbonyl group is achieved efficiently using the Huang-Minlon 
modification of the Wolff-Kishner reaction,
77 
allowing a one-pot reduction and forming 
bispidine 243 in excellent yields over 2 steps. 
 
 
 
 
 
 
 
 
Scheme 131: Synthesis of bispidine 243 
 
Aldol reactions using bispidine 243 
 
Using the previously optimised conditions for the Crimmins aldol reaction, 1 equivalent 
each of TiCl4, base and NMP and 1.1 equivalent of the aldehyde in CH2Cl2 at −78 °C, the 
efficacy of the bispidine 243 in the asymmetric aldol reaction was investigated, comparing 
with TMEDA (Scheme 132). In most of the substrates trialled, the use of bispidine 243 
gave rise to improved reaction rates and yields and excellent selectivity for the Evans-type 
product. The exception is when acetaldehyde is used, with the poor yield most likely 
caused by the volatility of the aldehyde (Table 18). 
 
 
 
 
 
Scheme 132: Crimmins aldol reactions using bispidine 243 
96 
 
R Base Yield  Evans/non-Evans 
PhCH2CH2- 
TMEDA 
243 
59% 
72% 
97:3 
98:2 
CH2=CH- 
TMEDA 
243 
40% 
76% 
96:4 
>99:1 
CH3- 
TMEDA 
243 
22% 
23% 
97:3 
97:3 
(CH3)2CH- 
TMEDA 
243 
 40% 
56% 
97:3 
>99:1 
CH2=CHCH2CH2 
TMEDA 
243 
42% 
79% 
96:4 
>99:1 
 
Table 18: Comparison of 243 and TMEDA in Crimmins aldol reactions 
 
 
5.3 - Conclusion 
 
Bispidine 243 was found to be an effective replacement for (−)-sparteine in the Crimmins 
aldol reaction offering better yields and selectivities compared to TMEDA. Compared to 
commercially available DIPEA, the yields are similar, but 243 gives superior 
diastereoselectivity. With only 2 synthetic steps 243 can be made cheaply on a large scale, 
and remains an option in aldol reactions where selectivity is important. However it must be 
said that DIPEA is commercially available and a much more practical base for the 
Crimmins aldol reaction. 
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6 – Experimental 
 
1
H NMR spectra were recorded on a Bruker 400 MHz spectrospin spectrometer . Chemical 
shifts are reported in parts per million (ppm) referenced to chloroform (7.26 ppm). NMR 
signals are described as follows: δ, chemical shift; multiplicity – recorded as singlet (s), 
doublet (d), triplet (t), quartet (q), quintet (quin), septet (sept), multiplet (m) or broad (br) 
or a combination of these; coupling constants (J in Hertz, Hz), integration and assignment. 
 
13
C NMR spectra were recorded on the same instruments at 100.6 MHz. The chemical 
shifts are reported in ppm, reported from the central peak of deuterochloroform (77.16 
ppm). Assignments were obtained using DEPT and when necessary HSQC and COSY. 
 
Infra-red spectra (IR) were recorded using a Golden Gate
®
 attachment that allowed the 
IR of a compound to be detected directing without sample preparation.  
 
Mass spectra (MS) were obtained using a JEOL JMS-700 spectrometer. Ionisation was 
obtained either by electron impact (EI), chemical ionisation (CI), fast atom bombardment 
(FAB) or electrospray ionisation (ESI). Mass spectrum data are reported as m/z.  
 
Melting points (mp) were recorded using an Electrothermal IA 9100 apparatus. 
 
Optical rotations were determined as solutions irradiating with the sodium D line (λ = 589 
nm) using an AA series automatic polarimeter.   
 
Flash chromatography was performed using silica gel (Fluorchem, LC60A, 35-70 micron) 
as solid support and Fisher HPLC solvents as eluent.  
 
Reactions were monitored by thin-layer chromatography (TLC) on Merck silica gel 60 
covered alumina plates F254. TLC plates were developed under UV-light and/or with 
KMnO4, anisaldehyde or ceric ammonium molybdate solutions followed by heating with a 
heat gun if required. 
 
 KMnO4 solution was prepared by dissolving K2CO3 (40 g) and KMnO4 (6 g) in 
water (600 mL), followed by addition of 10 % NaOH(aq) (5 mL). 
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 Anisaldehyde solution was prepared by slow addition of conc. H2SO4 into ethanol 
(1 L) at 0 °C, followed by acetic acid (15 mL) and anisaldehyde (20 mL). The 
solution was stored below 0 °C. 
 Ceric ammonium molybdate solution was prepared by dissolving ammonium 
pentamolybdate (20 g) and cerium sulfate (0.8 g) in 400 mL of dilute H2SO4 (1:9 
with water v/v). 
Purification of solvent and reagents 
 
 Diethyl ether (Et2O), tetrahydrofuran (THF), and dichloromethane was obtained 
from a PureSolv 500 MD solvent purification system. 
 Dimethylformamide (DMF) and dimethylsulfoxide (DMSO) were dried by stirring 
over Na2SO4 overnight, and then distilled under vacuum, discarding the first third. 
 Amines (triethylamine, diisopropylamine, 2,6-lutidine, diisopropylethylamine, 
isopropylamine, TMEDA) and bispidine 243 were distilled over calcium hydride. 
 Titanium tetrachloride (TiCl4) was distilled and stored in a Schlenk flask. 
 N-Methylpyrrolidone (NMP) was dried under vacuum using toluene to form an 
azeotrope with water. 
 HMPA and TMSCl were distilled over calcium hydride. 
 CuBr.SMe2 was purified by dissolving in dimethyl sulfide and triturating with 
pentane. 
All other reagents were used as supplied by chemical companies (Acros, Alfa Aesar, 
Aldrich etc.). 
 
General Procedure 
All air and/or water sensitive reactions were carried out in oven dried glassware (oven set 
at 140 °C) under an argon atmosphere, using dry solvent and standard syringe-
cannula/septa techniques. 
 
Yields refer to chromatographically and spectroscopically homogenous materials, unless 
otherwise stated. 
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Titration of organometallic bases followed this general procedure – To a solution of (−)-
menthol (100 mg, 0.64 mmol) and a catalytic amount of phenanthroline in THF or Et2O 
(25 mL) at −78 °C was added by syringe the solution to be titrated. The addition was 
stopped when the colourless solution turned dark purple which persisted for longer than 5 
minutes. 
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(R)-4-Benzylthiazolidine-2-thione (133).
34
 
 
 C10H11NS2 
Mol. Wt. = 209.34g 
 
In a 3-necked flask, sodium borohydride (5.67 g, 150 mmol, 2.44 equiv) was dissolved in 
THF (150 mL). (R)-Phenylalanine (10.16 g, 61.50 mmol) was added in one portion, and 
the flask was flushed with argon and then cooled to 0 °C. A solution of I2 (15.67 g, 61.50 
mmol, 1.00 equiv) in THF (50 mL) was added dropwise by syringe over 30 min. After the 
addition was complete the flask was heated under reflux and left overnight. The flask was 
then allowed to cool and methanol was cautiously added until the mixture became clear. 
The solvent was then removed under vacuum yielding a white paste, which was then 
dissolved in 20% KOH solution. This was left to stir at 20 °C for 3 h, and then the aqueous 
phase was extracted with CH2Cl2 (3 × 100 mL). The organic extract was dried over 
Na2SO4 and concentrated in vacuo giving (R)-phenylalaninol 132 as a white solid which 
was used in the next step without purification. 
Crude (R)-phenylalaninol 132 was dissolved in 1 M KOH solution (220 mL) and left to stir 
for 10 min. Carbon disulfide (17.5 g, 230 mmol, 5.00 equiv) was then added dropwise, and 
the mixture heated under reflux overnight. The flask was cooled to 20 °C and the reaction 
mixture was extracted with CH2Cl2 (3 × 150 mL), then the combined organic extracts were 
dried over Na2SO4, filtered and concentrated in vacuo. The crude product was then 
recrystallised from acetonitrile yielding 133 as an off-white solid (12.0 g, 93%). 
Rf 0.25 (6:4 PE/EtOAc) 
mp - 84–87 °C, lit 79 °C 
[α]D
25 
+136 (c 1.0, CHCl3), lit. +117 (c 1.45, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 7.42–7.22 (m, 5H, H
Ar
), 7.11 (brs, 1H, NH), 4.50 (quin, J = 
7.4 Hz, 1H, H
3
), 3.67 (dd, J = 11.1, 7.4 Hz, 1H, H
2
), 3.38 (dd, J = 11.1, 7.4 Hz, 1H, H
2
), 
3.04 (m, 2H, H
4
). 
13
C NMR (CDCl3, 100 MHz) δ 201.8 (C
1
), 135.9 (C
Ar
), 129.3 (C
Ar
), 129.1 (C
Ar
), 127.6 
(C
Ar
), 65.1 (C
3
), 40.2 (C
2
 or C
4
), 38.4 (C
2
 or C
4
). 
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MS (EI) m/z 209.06 (M
+
) 
HRMS (EI) for C10H11NS2: 209.0333, found: 209.0336. 
In agreement with literature data.
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(R)-4-Benzyl-3-propionylthiazolidine-2-thione (127).
79
 
 
C13H15NOS2 
Mol. Wt = 265.35g 
 
(R)-4-Benzylthiazolidine-2-thione 133 (3.78 g, 18.1 mmol) was dissolved in CH2Cl2 (50 
mL), followed by addition of propionyl chloride (2.51 g, 27.2 mmol, 1.50 equivalents) and 
freshly distilled triethylamine (4.5 mL, 33 mmol, 1.8 equiv). The reaction was left to stir at 
20 °C overnight, after which the mixture was diluted with CH2Cl2 and water. The aqueous 
phase was extracted with CH2Cl2 (3 × 50 mL), dried with MgSO4, filtered and concentrated 
in vacuo. The crude product was purified by recrystallisation from acetonitrile to furnish 
127 as a bright yellow solid (4.27 g, 89%). 
Rf 0.23 (9:1 PE/EtOAc) 
mp - 93–95 °C, lit. 105 °C. 
[α]D
20 −123 (c 1.1, CHCl3), lit. −114 (c 1.64, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 7.40–7.26 (m, 5H, H
Ar
), 5.47–5.37 (m, 1H, H6), 3.53–3.38 
(m, 3H, H
2
/H
5
), 3.27–3.04 (m, 2H, H5/H7), 2.91 (d, J = 11.6 Hz, 1H, H7), 1.22 (t, J = 7.3 
Hz, 3H, H
3
). 
13
C NMR (CDCl3, 100 MHz) δ 201.2 (C
4
), 175.0 (C
1
), 136.6 (C
Ar
), 129.5 (C
Ar
), 129.0 
(C
Ar
), 127.3(C
Ar
), 68.7 (C
6
), 36.8 (C
2
), 32.4 (C
5
 or C
7
), 31.9 (C
5
 or C
7
), 8.9 (C
3
). 
MS (EI) m/z 265 (M
+
) 
HRMS (EI) calculated for C13H15NOS2: 265.0595, found: 265.0594. 
In agreement with literature data.
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(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2-methyl-pent-4-en-1-one 
(134).
4f
 
 
 
C16H19NO2S2 
Mol Wt = 321.46 g  
 
 
To a solution of 127 (7.60 g, 29 mmol) in CH2Cl2 (150 mL) at −10 °C was added dropwise 
TiCl4 (3.3 mL, 30 mmol, 1.1 equivalents). This was left to stir for 15 min followed by 
addition of freshly distilled N-diisopropylethylamine (5.0 mL, 29 mmol, 1.0 equiv). After 
stirring for 1 h, the flask was cooled to −78 °C and NMP (2.8 mL, 29 mmol, 1.0 equiv) 
was added dropwise and left to stir for a further 1 h. Acrolein (2.1 mL, 32 mmol, 1.1 
equiv) was introduced by syringe and the mixture left at −78 °C for 1 h, followed by 
gradual warming to 0 °C. The reaction was quenched by addition of saturated aqueous 
NH4Cl solution (150 mL). The aqueous phase was extracted with CH2Cl2 (3 × 100 mL), 
and the combined organic extracts were dried over Na2SO4, filtered and concentrated in 
vacuo. Purification by flash chromatography (8:2 PE/EtOAc) afforded product 134 as a 
yellow oil (6.99 g, 75%). 
Rf 0.25 (8:2 PE/EtOAc). 
[α]D
20 −166 (c 1.00, CHCl3), lit. −152 (c 1.95, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 7.40–7.29 (m, 5H, H
Ar
), 5.84 (ddd, J = 17.2, 10.4, 5.5 Hz, 
1H, H
4
), 5.23 (ddd, J = 17.2, 1.5, 1.5 Hz, 1H, H
5
), 5.23–5.15 (m, 1H, H9), 5.10 (ddd, J = 
10.4, 1.5, 1.5 Hz, 1H, H
5
), 4.48 (qd, J = 6.8, 4.5 Hz, 1H, H
2
), 4.36 (ddd, J = 5.5,  4.5, 1.5 
Hz, 1H, H
3
), 3.29 (dd, J = 11.3, 7.1 Hz, 1H, H
10
), 3.15 (dd, J = 13.1, 3.8 Hz, 1H, H
8
), 2.95 
(dd, J = 13.1, 10.6 Hz, 1H, H
8
), 2.80 (d, J = 11.3 Hz, 1H, H
10
), 1.16 (d, J = 6.8 Hz, 3H, 
H
6
). 
13
C NMR (CDCl3, 100 MHz) δ 201.6 (C
7
), 178.3 (C
1
), 137.2 (C
4
), 136.4 (C
Ar
), 129.5 
(C
Ar
), 129.0 (C
Ar
), 127.3 (C
Ar
), 116.8 (C
5
), 77.0 (C
3
), 68.9 (C
9
), 43.3 (C
2
), 37.9 (C
8
), 29.7 
(C
10
), 10.6 (C
6
). 
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IR 2957 (CH), 1695 (C=O), 1604 (C=C), 1494, 1448, 1427, 1345, 1285, 1255, 1193, 1165, 
1140, 1038 cm
-1
. 
MS (EI) m/z 321 (M
+
). 
HRMS (EI) calculated for C16H19NOS2: 321.0857, found: 321.0860. 
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(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-(tert-Butyldimethylsilyloxy)-2-
methyl-pent-4-en-1-one (135). 
 
C22H33NS2SiO2 
Mol Wt = 435.72 g  
 
 
A solution of 134 (4.00 g, 11.5 mmol) and TBSCl (6.93 g, 46.0 mmol, 4.0 equiv) in 
anhydrous DMF (40 mL) was cooled to 0 °C and 2,6-lutidine (6.16 g, 57.5 mmol, 5.0 
equiv) was added dropwise. The mixture was left to stir at 20 °C for 3 days and was 
quenched by addition of ice water. The mixture was extracted with Et2O (3 × 50 mL), and 
the combined organic extracts washed with saturated aqueous CuSO4 solution (2 × 15 mL). 
The organic extracts were then dried over Na2SO4, filtered and the solvent removed in 
vacuo. The crude product was purified by flash chromatography (97:3 PE/EtOAc) 
furnishing 135 as a bright yellow oil (4.86 g, 97%). 
Rf 0.3 (97:3 PE/EtOAc) 
[α]D
25 −180 (c 1.0, CHCl3), lit. −173 (c 1.1, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 7.42–7.31 (m, 5H, H
Ar
), 5.85 (ddd, J = 17.2, 10.4, 6.8 Hz, 
1H, H
4
), 5.16 (ddd, J = 17.2, 1.6, 1.2 Hz, 1H, H
5
), 5.15–5.09 (m, 2H, H5/H9), 4.58 (quin, J 
= 6.6 Hz, 1H, H
2
), 4.31 (ddt, J = 6.8, 6.6, 1.2, 1H, H
3
), 3.33–3.25 (m, 2H, H8/H10), 3.10 
(dd, J = 13.4, 10.9 Hz, 1H, H
10
), 2.87 (d, J = 11.4 Hz, 1H, H
8
), 1.22 (d, J = 6.6 Hz, 3H, 
H
6
), 0.87 (s, 9H, H
14
), 0.02 (s, 3H, H
11
) 0.00 (s, 3H, H
12
).  
13
C NMR (CDCl3, 100 MHz) δ 201.2 (C
7
), 176.3 (C
1
), 139.2 (C
4
), 136.7 (C
Ar
), 129.5 
(C
Ar
), 128.9 (C
Ar
), 127.2 (C
Ar
), 115.7 (C
5
), 76.4 (C
3
), 69.5 (C
9
), 45.9 (C
2
), 36.5 (C
10
), 32.3 
(C
8
), 25.8 (C
14
), 18.1 (C
13
), 11.6 (C
6
), −4.3 (C11), −5.0 (C12). 
IR 2957(CH), 2858, 1699 (C=O), 1459, 1345, 1287, 1265, 1254, 1192, 1140 (C-O), 1084, 
1030 cm
-1
. 
MS (FAB) m/z  435 (M
+
) 
HRMS (FAB) calculated for C22H33NS2SiO2: 435.1722, found: 435.1730. 
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(2R,3S)-3-(tert-Butyldimethylsilyloxy)-2-methyl-4-pentenal (136). 
 
C12H24SiO2 
Mol Wt = 228.40 g  
 
 
A solution of 135 (4.70 g, 10.8 mmol) in CH2Cl2 (110 mL) was cooled to −78 °C and a  
1M solution of DIBAL-H in hexanes (21.6 mL, 21.6 mmol, 2.0 equiv) was added 
dropwise. The mixture was left to stir until the bright yellow colour disappeared, then the 
reaction was quenched with EtOAc. The mixture was then diluted with 10% aqueous 
Rochelle’s salt solution and stirred for 1 h until the organic phase went clear. The mixture 
was then extracted with Et2O (3 × 100 mL), and the combined organic extracts were dried 
over Na2SO4, filtered and concentrated in vacuo. The crude material was purified by flash 
chromatography (98:2 PE/EtOAc) switching up to (8:2 PE/EtOAc) to collect 133 (1.92 g, 
85%) and 136 as a colourless oil (2.42 g, 85%). 
Rf 0.4 (98:2 PE/EtOAc) 
[α]D
25 −87 (c 1.00, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 9.76 (d, J = 1.3 Hz, 1H, H
1
), 5.86 (ddd, J = 17.2, 10.4, 6.0 
Hz, 1H, H
4
), 5.29 (ddd, J = 17.2, 1.6, 1.3 Hz, 1H, H
5
), 5.20 (ddd, J = 10.4, 1.6, 1.3 Hz, 1H, 
H
5
), 4.71 (ddt, J = 6.0, 4.3, 1.3 Hz, 1H, H
3
), 2.50 (qdd, J = 7.0, 4.3, 1.3 Hz, 1H, H
2
),  1.07 
(d, J = 7.0 Hz, 3H, H
6
), 0.88 (s, 9H, H
10
), 0.05 (s, 3H, H
7
), 0.03 (s, 3H, H
8
).  
13
C NMR (CDCl3, 100 MHz) δ 204.8 (C
1
), 138.4 (C
4
), 116.1 (C
5
), 76.7 (C
3
), 52.7 (C
2
), 
25.9 (C
9
), 18.3 (C
10
), 8.5 (C
6
), −4.1 (C7), −4.9 (C8). 
IR 2932 (CH), 1728 (C=O), 1255, 1151 (C-O), 1084, 1002 cm
-1
. 
MS (FAB) m/z 228 (M+) 
HRMS (FAB) calculated for C12H24SiO2: 228.1546, found: 228.1551. 
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N-Acetylsulfaninyl azide (138).
39
 
 
C8H8N4O3S 
Mol. Wt. = 240.24 g 
 
In HPLC grade acetone (150 mL) was dissolved N-acetylsulfaninyl chloride 137 (20.3 g, 
87.0 mmol) and left to stir for 5 min. A solution of sodium azide (6.77 g, 104 mmol, 1.2 
equiv) in H2O (50 mL) was added slowly over 10 min and the reaction mixture was left to 
stir overnight. The solution was then split into 3 portions and each one diluted with H2O 
(160 mL) and left to stir for 1 h. The precipitate formed was isolated by filtration and 
recrystallisation from toluene afforded the product 138 as a fluffy white solid (8.70 g, 
36%). 
mp - 102–103 °C, lit. 106-108 °C80 
1
H NMR (CDCl3, 400MHz) δ 7.93 (d, J = 8.1 Hz, 2H, H
4
), 7.79 (d, J = 8.1 Hz, 2H, H
5
), 
7.45 (br s, 1H, NH), 2.27 (s, 3H, CH3). 
13
C NMR (CDCl3, 100 MHz) δ 169.9 (C
2
), 144.1 (C
6
), 132.8 (C
4
), 127.8 (C
4
), 119.0 (C
5
), 
25.0 (C
1
). 
In agreement with literature data. 
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tert-Butyl diazoacetate (140).
40
 
 
C6H10N2O2 
Mol Wt = 142.16 g  
 
 
tert-Butyl acetoacetate (5.20 g, 37.5 mmol), N-acetylsulfaninyl azide 138 (9.61 g, 40.1 
mmol, 1.07 equivalents) and NBu4Br (4.74 g, 15.0 mmol, 0.4 equivalents) were dissolved 
in pentane (380 mL) and left to stir at 20 °C for 3 min. A 3M aqueous NaOH solution (70 
mL, 2.8 equiv) was added slowly over 10 min and the mixture left to stir for 1 h. Once the 
reaction was complete the mixture was diluted with H2O (100 mL) and Et2O (100 mL). 
The organic phase was isolated and aqueous layer extracted with Et2O (3 × 200 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo to 
give 140 as a bright yellow oil (3.20 g, 60%). 
 
Rf  0.45 (8:2 PE:EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 4.62 (br s, 1H, H
2
), 3.76 (s, 9H, H
4
). 
In agreement with literature data. 
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tert-Butyl 5-(tert-Butyldimethylsilyloxy)-4-methyl-3-oxohept-6-enoate (142). 
 
C18H34SiO4 
Mol Wt = 342.54 g  
 
       
To a solution of SnCl2 (0.88 g, 4.6 mmol, 0.5 equiv) in CH2Cl2 (28 mL) was added tert-
butyl diazoacetate 140 (2.64 g, 18.6 mmol, 2.0 equiv) and 136 (2.12 g, 9.28 mmol) in 
CH2Cl2 (10 mL). The mixture was left to stir at 20 °C for 3 h, filtered and the solvent 
reduced in vacuo. The product was then purified by flash chromatography (95:5 
PE/EtOAc) to give product 142 as a pale yellow oil, as inseparable mixture in a 3.5:1 ratio 
with the enol form 142’ (2.32 g, 73%). 
Rf 0.25 (95:5 PE/EtOAc). 
[α]D
20 −67 (c 1.00, CHCl3). 
β-ketoester form 
1
H NMR (CDCl3, 400 MHz) δ 5.74 (ddd, J = 17.2, 10.4, 6.1 Hz, 1H, H
6
), 5.18 (ddd, J =  
17.2, 1.3, 0.8 Hz, 1H, H
7
), 5.11 (ddd, J = 10.4, 1.3, 0.8 Hz, 1H, H
7
), 4.26 (ddt, J = 6.1, 5.5, 
1.3 Hz, 1H, H
5
), 3.51 (d, J = 15.6 Hz, 1H, H
2
), 3.41 (d, J = 15.6 Hz, 1H, H
2
), 2.87 (qd, J = 
7.0, 5.5 Hz, 1H, H
4
), 1.48 (s, 9H, H
10
), 1.09  (d, J = 7.0 Hz, 3H, H
8
), 0.90 (s, 9H, H
14
), 0.07 
(s, 3H, H
12
), 0.03 (s, 3H, H
12
). 
13
C NMR (CDCl3, 100 MHz) δ 204.8 (C
3
), 178.3 (C
1
), 139.3 (C
6
), 114.9 (C
7
), 82.0 (C
9
), 
77.3 (C
5
), 53.3 (C
2
), 49.6 (C
4
), 28.2 (C
10
), 24.7 (C
14
), 18.1 (C
13
), 12.5 (C
8
), −4.0 (C11), −4.3 
(C
12
). 
IR 2932 (CH), 1728 (C=O), 1680 (C=O), 1255, 1151 (C-O), 1084, 1002 cm
-1
. 
MS (CI) m/z 343 (MH
+
) 
HRMS (CI) calculated for C18H35SiO4: 343.5554, found: 343.5555. 
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tert-Butyl 5-(tert-Butyldimethylsilyloxy)-2-ethylidene-4-methyl-3-oxohept-6-enoate 
(143). 
 
C20H36SiO4 
Mol Wt = 368.58 g  
To a stirred solution of TiCl4 (4.6 mL, 42 mmol, 1.8 equiv) in THF (85 mL) at 0 °C was 
successfully added freshly distilled acetaldehyde (5.8 mL, 104 mmol, 4.5 equiv), a solution 
of 142 (7.90 g, 23.1 mmol) in THF (35 mL), and pyridine (6.5 mL, 81 mmol, 3.5 equiv). 
The reaction was allowed to warm to 20 °C and stirred for 3 h. The mixture was then 
quenched by a slow addition of water and extracted with Et2O (3 × 100 mL). The organic 
extracts were then dried over Na2SO4, filtered and the solvent removed in vacuo. The crude 
material was then purified by column chromatography (95:5 PE/EtOAc) to furnish the 
product 143 as a colourless oil (7.49 g, 88%). Isolated as an inseperable mixture of E/Z 
diastereomers. 
Rf 0.3 (95:5 PE/EtOAc). 
[α]D
20 −44 (c 1.00, CHCl3). 
Diastereomer A 
1
H NMR (CDCl3, 400 MHz) δ 6.94 (q, J = 7.3 Hz, H
9
), 5.82 (ddd, J = 17.1, 10.4, 6.8 Hz 
1H, H
6
), 5.18 (ddd, J = 17.1, 1.5, 1.3 Hz, 1H, H
7
), 5.13–5.06 (m, 1H, H7), 4.32–4.25 (m, 
1H, H
5
), 3.13 (dq, J = 7.1, 6.9 Hz, 1H, H
4
), 1.96 (d, J = 7.3 Hz, 3H, H
10
), 1.51 (s, 9H, H
12
). 
1.16 (d, J = 7.1 Hz, 3H, H
10
), 0.90 (s, 9H, H
16
), 0.08 (s, 3H, H
13
), 0.04 (s, 3H, H
14
).  
13
C NMR (CDCl3, 100 MHz) δ 205.4 (C
3
), 164.1 (C
1
), 144.3 (C
9
), 138.8 (C
6
), 138.1 (C
2
), 
115.7 (C
7
), 81.7 (C
11
), 75.5 (C
5
), 52.1 (C
4
), 28.0 (C
12
), 25.2 (C
16
), 18.2 (C
15
), 15.6 (C
10
), 
12.9 (C
8
), −4.3 (C13), −4.9 (C14). 
Diastereomer B 
1
H NMR (CDCl3, 400 MHz) δ 6.79 (q, J = 7.3 Hz, 1H, H
9
), 5.75 (ddd, J = 17.1, 10.4, 6.8 
Hz 1H, H
6
), 5.17 (ddd, J = 17.1, 1.5, 1.3 Hz, 1H, H
7
), 5.13–5.06 (m, 1H, H7), 4.35–4.24 
111 
 
(m, 1H, H
5
), 3.13 (dq, J = 6.9, 6.9 Hz, 1H, H
4
), 1.85 (d, J = 7.3 Hz, 3H, H
8
), 1.55 (s, 9H, 
H
12
). 1.15 (d, J = 7.2 Hz, 3H, H
10
), 0.90 (s, 9H, H
16
), 0.05 (s, 3H, H
13
), 0.02 (s, 3H, H
14
).  
13
C NMR (CDCl3, 100 MHz) δ 200.1 (C
3
), 165.8 (C
1
), 142.0 (C
9
), 139.4 (C
2
), 139.0 (C
6
), 
115.0 (C
7
), 82.1 (C
11
), 75.2 (C
5
), 48.8 (C
4
), 27.9 (C
12
), 25.8 (C
16
), 18.0 (C
15
), 15.3 (C
10
), 
13.4 (C
8
), −4.2 (C13), −4.9 (C14). 
IR 2955 (CH), 2930, 2858, 1722 (C=O), 1697 (C=O), 1643 (C=C), 1462, 1392, 1367, 
1249, 1151 (C-O), 1070, 1026, 1005 cm
-1
. 
MS (ESI) m/z 391 (MNa
+
) 
HRMS (ESI) – for C20H36SiO4Na: 391.2275, found 391.2271. 
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tert-Butyl 5-(tert-Butyldimethylsilyloxy)-4-methyl-3-oxohept-6-enoate (113c). 
 
C17H30SiO4 
Mol. Wt. = 326.50 g  
 
In a vacuum-dried two-necked flask, 143 (2.00 g, 5.43 mmol) was dissolved in dry 
degassed CH2Cl2 (108 mL). Grubbs 2
nd
 generation catalyst (230 mg, 0.27 mmol, 5 mol%) 
was added in one portion and the solution was heated under reflux for 24 h. An additional 
portion of Grubbs 2
nd
 generation catalyst was added (230 mg, 0.27 mmol, 5 mol%) and the 
mixture heated under reflux for a further 12 h. Once the reaction had cooled to room 
temperature, DMSO was added and the mixture was stirred overnight, after which the 
solvent was removed in vacuo and the product purified by column chromatography (8:2 
PE/EtOAc) furnishing the product 113c as a viscous pale brown oil (1.19 g, 67%). 
Rf 0.25 (8:2 PE/EtOAc). 
[α]D
20  
+ 91
 
(c 1.0, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ  7.67 (d, J = 2.1 Hz, 1H, H
4
), 4.33 (dd J = 3.1, 2.1 Hz, 1H, 
H
3
), 2.26 (qd, J = 7.5, 3.1 Hz, 1H, H
2
), 1.45 (s, 9H, H
9
), 1.13 (d, J = 7.5 Hz, 3H, H
7
) 0.78 
(s, 9H, H
13
), 0.02 (s, 3H, H
10
), 0.00 (s, 3H, H
11
). 
13
C NMR (CDCl3, 100 MHz) δ 201.1 (C
1
), 166.0 (C
4
), 160.9 (C
6
), 137.2 (C
5
), 82.2 (C
8
), 
76.1 (C
3
), 52.6 (C
2
), 28.8 (C
9
), 25.7 (C
14
), 18.0 (C
11
), 12.5 (C
7
), −4.6 (C10), −4.7 (C11).  
IR 2955 (CH), 2930 (CH), 2858, 1751 (C=O), 1736 (C=O), 1716, 1626 (C=C), 1460, 
1342, 1251, 1155 (C-O), 1109, 1072, 1055, 1006 cm
-1
. 
MS (ESI) m/z 349 (MNa
+
) 
HRMS (ESI) for C17H30SiO4Na: 349.1811, found: 349.1806. 
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Methyl diazoacetate (144).
81
 
 
C3H4N2O2 
Mol. Wt. = 100.08 g  
 
In a solution of pentane (500 mL), methyl acetoacetate (8.0 g, 61.5 mmol), 138 (15.8 g, 
65.8 mmol, 1.07 equiv) and TBAB (7.93 g, 24.6 mmol, 0.4 equiv) were dissolved and left 
to stir at 20 °C for 3 min. A 3 M NaOH solution (74 mL, 1.8 equiv NaOH) was added 
slowly over 10 min and the mixture left to stir for 1 h. Once the reaction was complete the 
mixture was diluted with H2O and Et2O. The organic phase was isolated and aqueous layer 
extracted with Et2O (2 × 200 mL). The combined organic extracts were dried over Na2SO4. 
Filtration followed by very careful reduction of the solvent gave the product 144 in ether as 
yellow solution (0.59 g, 49%). Yield measured by 
1
H NMR. 
Rf 0.2 (98:2 PE/EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 4.75 (br s, 1H, H
2
), 3.74 (s, 3H, H
3
). 
In agreement with literature data. 
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Methyl (4R,5S)-5-(tert-butyldimethylsilyloxy)-4-methyl-oxohept-6-enoate (145). 
 
 
C15H28O4Si 
Mol Wt = 300.46 g  
 
 
To a suspension of SnCl2 (0.14 g, 0.75 mmol, 0.5 equiv) in CH2Cl2 (10 mL) was added a 
solution of methyl diazoacetate 144 (>5.0 equiv) in diethyl ether (5 mL), followed by 136 
(350 mg, 1.5 mmol) in CH2Cl2 (4 mL). The mixture was left to stir at 20 °C for 3 h, filtered 
and the solvent was reduced in vacuo. The product was then purified by flash 
chromatography (95:5 PE/EtOAc) to give product 145 as a pale yellow oil in a 3:1 ratio 
with the enol form (315 mg, 70%). 
Rf 0.35 (95:5 PE/EtOAc) 
[α]D
20 −41 (c = 1.0, CHCl3), lit. −46 (c = 1.02, CHCl3).
81
 
β-ketoester form 
1
H NMR (CDCl3, 400 MHz) δ 5.75 (ddd, J = 17.2, 10.4, 6.8 Hz, 1H, H
6
), 5.16 (ddd, J = 
17.2, 1.4 Hz, 1.4 Hz, 1H, H
7
), 5.13 (ddd, J = 10.4, 1.4, 1.4 Hz, 1H, H
7
), 4.31–4.25 (m, 1H, 
H
5
), 3.75 (s, 3H, H
9
), 3.60 (d, J = 16.0 Hz, 1H, H
2
), 3.49 (d, J = 16.0 Hz, 1H, H
2
), 2.88 (qd, 
J = 7.0, 5.6 Hz, 1H. H
4
), 1.11 (d, J = 7.0 Hz, 3H, H
8
), 0.90 (s, 9H, H
13
), 0.05 (s, 3H, H
10
), 
0.02 (s, 3H, H
11
).   
13
C NMR (CDCl3, 100 MHz) δ 204.4 (C
3
), 167.6 (C
1
), 138.1 (C
6
), 116.3 (C
7
), 75.4 (C
5
), 
52.1 (C
9
), 52.0 (C
4
), 49.7 (C
2
), 25.7 (C
13
), 17.6 (C
12
), 12.0 (C
8
), −4.3 (C10), −4.5 (C11). 
IR 2957 (CH), 2931, 2858, 1749 (C=O), 1716 (C=O), 1648 (C=C), 1625, 1472, 1422, 
1366, 1307, 1258, 1225, 1154 (C-O), 1073, 1029 cm
-1
. 
MS (CI) m/z 300 (M
+
). 
HRMS (CI) for C15H28SiO4: 300.4657, found: 300.4655. 
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2-(Trimethylsilyl)ethyl (4R,5S)-5-(tert-butyldimethylsilyloxy)-4-methyl-oxohept-6-
enoate (146). 
 
 
C19H38O4Si2 
Mol Wt = 386.67 g  
 
 
To a solution of 145 (250 mg, 0.83 mmol) and 2-(trimethylsilyl)ethanol (0.98 g, 8.3 mmol, 
10 equiv) in toluene (5 mL) was added ZnO (14 mg, 0.17 mmol, 20 mol%). The mixture 
was heated under reflux for 12 hours, after which the solvent was removed in vacuo and 
the crude material was purified by column chromatography (95:5 PE/EtOAc) to furnish the 
transesterification product 146 (253 mg, 79%) 
Rf 0.3 (95:5 PE/EtOAc). 
[α]D
20 −77 (c = 1.0, CHCl3). 
β-ketoester form 
1
H NMR (CDCl3, 400 MHz) δ  5.74 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H, H
6
), 5.18 (ddd, J = 
17.0, 1.4 Hz, 1.4 Hz, 1H, H
7
), 5.12 (ddd, J = 10.4, 1.4, 1.4 Hz, 1H, H
7
), 4.26 (dd, J = 6.7, 
6.5 Hz 1H, H
5
), 4.20 (dd, J = 9.0, 8.3 Hz, 2H, H
9
), 3.57 (d, J = 15.8 Hz, 1H, H
2
), 3.49 (d, J 
= 15.8 Hz, 1H, H
2
), 2.87 (qd, J = 7.1, 6.7 Hz, 1H, H
4
), 1.08 (d, J = 7.1 Hz, 3H, H
8
), 1.00 
(dd, J = 9.0, 8.3 Hz, 2H, H
10
), 0.86 (s, 9H, H
15
), 0.05 (s, 3H, H
12
), 0.02 (s, 3H, H
13
), 0.01 
(s, 9H, H
11
).   
13
C NMR (CDCl3, 100 MHz) δ 206.5 (C
3
), 169.1 (C
1
), 139.5 (C
6
), 117.8 (C
7
), 78.8 (C
5
), 
65.0 (C
9
), 54.3 (C
4
), 51.9 (C
2
), 29.6 (C
14
), 27.4 (C
15
), 18.8 (C
10
), 13.5 (C
8
), 0.00 (C
11
), −2.9 
(C
12
), −3.6 (C13). 
IR 2956 (CH), 2930, 2858, 1745 (CO), 1714 (CO), 1645 (C=C), 1463, 1250, 1224, 1028 
cm
-1
. 
MS (ESI) m/z 409 (MNa
+
). 
HRMS (ESI) for C19H38Si2O4: 409.2207, found: 409.2210. 
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2-(Trimethylsilyl)ethyl (4R,5S)-5-(tert-butyldimethylsilyloxy)-2-ethylidene-4-methyl-
oxohept-6-enoate (147). 
 
 
C21H40O4Si2 
Mol Wt = 412.71 g  
 
 
To a stirred solution of TiCl4 (60 uL, 0.93 mmol, 1.8 equiv) in THF (1 mL) at 0 °C was 
successfully added freshly distilled acetaldehyde (145 uL, 2.34 mmol, 4.5 equiv), a 
solution of 146 (200 mg, 0.52 mmol) in THF (3 mL), and pyridine (146 uL, 1.82 mmol, 
3.5 equiv). The reaction was allowed to warm to 20 °C and stirred for 3 h. The mixture was 
then quenched by a slow addition of water and extracted with Et2O (3 × 10 mL). The 
organic extracts were then dried over Na2SO4, filtered and the solvent removed in vacuo. 
The crude material was then purified by column chromatography (95:5 PE/EtOAc) to 
furnish the product 147 as a colourless oil (182 mg, 85%). Inseperable 1.7:1 mixture of 
diastereomers. 
Rf 0.4 (95:5 PE/EtOAc). 
Diastereomer A 
1
H NMR (CDCl3, 400 MHz) δ 7.02 (q, J = 7.3 Hz, 1H, H
9
), 5.82 (ddd, J = 17.2, 10.4, 6.8 
Hz 1H, H
6
), 5.21–5.04 (m, 2H, H7), 4.36–4.22 (m, 3H, H5/H11), 3.11 (quin, J = 7.0 Hz, 
1H, H
4
), 1.87 (d, J = 7.3 Hz, 3H, H
10
), 1.15 (d, J = 7.0, 3H, H
8
), 1.10–1.00 (m, 2H, H12), 
0.88 (s, 9H, H
17
), 0.06 (s, 9H, H
13
), 0.04 (s, 3H, H
14
), 0.02 (s, 3H, H
15
).  
13
C NMR (CDCl3, 100 MHz) δ 206.2 (C
3
), 166.6 (C
1
), 146.6 (C
9
), 140.7 (C
6
), 140.0 (C
2
), 
117.1 (C
7
), 76.9 (C
5
), 65.0 (C
11
), 53.8 (C
4
), 27.4 (C
17
), 19.8 (C
16
), 19.0 (C
12
), 17.2 (C
10
), 
15.2 (C
8
), 0.0 (C
13), −2.7 (C14), −3.4 (C15). 
Diastereomer B 
1
H NMR (CDCl3, 400 MHz) δ 6.86 (q, J = 7.3 Hz, 1H, H
9
), 5.75 (ddd, J = 17.2, 10.4, 6.8 
Hz 1H, H
6
), 5.21–5.04 (m, 2H, H7), 4.36–4.22 (m, 3H, H5/H11), 3.11 (quin, J = 7.0 Hz, 
1H, H
4
), 1.98 (d, J = 7.3 Hz, 3H, H
10
), 1.14 (d, J = 7.0, 3H, H
8
), 1.10–1.00 (m, 2H, H12), 
0.88 (s, 9H, H
17
), 0.05 (s, 9H, H
13
), 0.04 (s, 3H, H
14
), 0.01 (s, 3H, H
15
).  
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13
C NMR (CDCl3, 100 MHz) δ 201.6 (C
3
), 168.1 (C
1
), 145.0 (C
9
), 140.8 (C
6
), 138.3 (C
2
), 
117.2 (C
7
), 76.9 (C
5
), 64.9 (C
11
), 50.5 (C
4
), 27.4 (C
17
), 19.7 (C
16
), 19.0 (C
12
), 17.3 (C
10
), 
14.5 (C
8
), 0.0 (C
13), −2.7 (C14), −3.4 (C15). 
IR 2955 (CH), 2857, 1764 (CO), 1726 (CO), 1697 (C=C), 1449, 1387, 1274, 1248, 1131 
(C-O), 1057 cm
-1
. 
MS (ESI) m/z 435 (MNa
+
). 
HRMS (ESI) for C21H40Si2O4: 435.2365, found: 435.2373. 
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2-(Trimethylsilyl)ethyl 5-(tert-Butyldimethylsilyloxy)-4-methyl-3-oxohept-6-enoate 
(113d). 
 
C18H34Si2O4 
Mol. Wt. = 370.63 g  
 
In a vacuum-dried two-necked flask, 147 (108 mg, 0.26 mmol) was dissolved in dry 
degassed CH2Cl2 (10 mL). Grubbs’ 2
nd
 generation catalyst (11 mg, 0.013 mmol, 5 mol%) 
was added in one portion and the solution was heated under reflux for 24 h. Once the 
reaction had cooled to room temperature, the solvent was removed in vacuo and the 
product purified by column chromatography (92:8 PE/EtOAc) furnishing the product 113d 
as a viscous pale brown oil (69 mg, 72%). 
Rf 0.25 (92:8 PE/EtOAc). 
[α]D
20 
+113 (c = 1.0, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ  7.87 (d, J = 2.3 Hz, 1H, H
4
), 4.33 (dd J = 3.0, 2.3 Hz, 1H, 
H
3
), 4.13 (dd, J = 8.9, 8.1 Hz, 2H, H
8
), 2.37 (qd, J = 7.2, 3.0 Hz, 1H, H
2
), 1.14 (d, J = 7.2 
Hz, 3H, H
7
), 0.99 (dd, J = 8.9, 8.1 Hz, 2H, H
9
), 0.78 (s, 9H, H
14
), 0.05 (s, 9H, H
11
), 0.02 (s, 
3H, H
12
), 0.00 (s, 3H, H
10
). 
13
C NMR (CDCl3, 100 MHz) δ 201.9 (C
1
), 164.7 (C
4
), 160.0 (C
6
), 134.6 (C
5
), 76.1 (C
3
), 
66.3 (C
8
), 51.6 (C
2
), 25.7 (C
14
), 18.9 (C
13
), 17.4 (C
9
), 12.5 (C
7
), 0.0 (C
10), −4.2 (C11), −4.6 
(C
12
). 
IR 2955 (CH), 2930, 2858, 1749 (CO), 1724 (CO), 1621 (C=C), 1460, 1342, 1251, 1155, 
1139, 1055, 1012 cm
-1
. 
MS (ESI) m/z 393 (MNa
+
) 
HRMS (ESI) for C18H34Si2O4Na: 393.1893, found: 393.1899. 
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1-[(4R,5S)-5-ethenyl-2,2-dimethyl-1,3-dioxolan-4-yl]ethan-1,2-diol (151).
42, 82
 
 
C9H16O4 
Mol Wt = 188.10 g  
 
 
To a stirred suspension of D-ribose (50.0 g, 333 mmol) in acetone (625 mL) was added 
dropwise concentrated H2SO4 (1.5 mL, 28.0 mmol, 0.08 equiv). The mixture was then 
stirred at room temperature for 3 h until all the solid had gone into solution. The solution 
was then neutralised with solid NaHCO3, filtered and the solvent reduced in vacuo to give 
the product 152 as a colourless syrup (58.3 g, 93%) which was used in the next step 
without purification. 
 
To a stirred suspension of methyltriphenylphosphonium bromide (386 g, 1.08 mol, 3.5 
equiv) in THF (1.08 L) at 0 °C was added potassium tert-butoxide (121 g, 1.08 mol, 3.5 
equiv). The bright yellow mixture was then stirred at 0 °C for a further 20 min and then at 
room temperature for 1 h. The solution was then cooled to 0 °C and a solution of 152 (58.0 
g, 308 mmol) in THF (180 mL) was added by cannula and the reaction stirred at 20 °C for 
12 h. The mixture was then poured carefully into water (1.0 L) and extracted with ethyl 
acetate (3 × 500 mL). The organic extracts were then dried over Na2SO4, filtered and 
concentrated in vacuo. The residue was then purified by column chromatography (2:1 to 
2.5:1 EtOAc:PE), followed by trituration with cold Et2O to remove any remaining solid 
triphenylphosphine oxide to furnish the product 151 as a pale yellow oil (38.2 g, 68%) 
contaminated with a little triphenylphosphine oxide. 
An analytical sample was prepared by a further column chromatography (2:1 EtOAc/PE) 
giving the product as a colourless oil. 
Rf (2:1 EtOAc/PE) 
[α]D
25  
+ 37
 
(c 1.00, CHCl3), lit. + 25 (c 1.00, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 5.99 (ddd, J = 17.2, 10.4, 6.8 Hz, 1H, H
5
), 5.42 (ddd, J = 
17.2, 1.4, 1.4 Hz, 1H, H
6
), 5.29 (ddd, J = 10.4, 1.4, 1.4 Hz, 1H, H
6
), 4.68 (br t, J = 6.4 Hz, 
1H, H
4
), 4.06 (dd, J = 8.4, 6.4 Hz, 1H, H
3
), 3.81-3.64 (m, 3H, H
1
/H
2
), 2.9 (br s, 2H, OH), 
1.44 (s, 3H, H
8
), 1.34 (s, 3H, H
9
). 
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13
C NMR (CDCl3, 100 MHz) δ 133.7 (C
5
), 118.3 (C
6
), 108.9 (C
7
), 78.5 (C
4
), 77.9 (C
3
), 
69.9 (C
2
), 64.3 (C
1
), 27.7 (C
8
), 25.3 (C
9
). 
MS (CI) m/z 189 (MH
+
). 
In agreement with literature data. 
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1-[(4R,5S)-5-Ethenyl-2,2-dimethyl-1,3-dioxolan-4-yl]prop-2-en-1-ol (149).
41a
 
 
C10H16O3 
Mol Wt = 184.23 g  
 
To a stirring solution of 151 (36.0 g, 198 mmol) in CH2Cl2 (750 mL) was added a solution 
of NaIO4 (63.5, 297 mmol, 1.5 equiv) in distilled water (470 mL). The reaction mixture 
was then stirred at 20 °C for 1 h. The reaction was then diluted with CH2Cl2 and water and 
the two layers were separated. The organic layer was dried over MgSO4 and carefully 
evaporated under reduced pressure at 0 °C. The residue was then purified by column 
chromatography using a very short column (1:1 PE/Et2O) to yield the product 150 as a 
colourless oil (17.0 g, 55%). Due to its instability the aldehyde was used immediately in 
the next step. 
To a stirred solution of 150 (17.0 g, 108 mmol) in THF (440 mL) at −78 °C was added 
dropwise a 0.7M solution of vinylmagnesium bromide (231 mL, 162 mmol, 1.5 equiv). 
The reaction was stirred at −78 °C and then slowly warmed to 0 °C and stirred for a further 
1 h. The mixture was quenched with saturated aqueous NH4Cl solution and warmed to 20 
°C. The layers were separated and the aqueous layer extracted with Et2O (3 × 250 mL). 
The organic layers were then combined, dried over Na2SO4, filtered and reduced in vacuo, 
with the crude material being purified by column chromatography giving the product 149 
as a colourless oil as a 2:3 inseparable mix of diastereomers (17.3 g, 80%). 
Major diastereomer 
1
H NMR (CDCl3, 400 MHz) δ 6.08-6.05 (m, 1H, H
6
), 5.95 (ddd, J = 17.2, 10.6, 5.4 Hz,  
1H, H
6
), 5.48-5.25 (m, 4H, H
1
/H
7
), 4.70 (dd, J = 7.5, 6.5 Hz, 1H, H
3
), 4.20–4.10 (m, 2H, 
H
5
), 4.20-3.98 (m, 2H, H
4
/H
5
), 1.55 (s, 3H, H
9
), 1.41 (s, 3H, H
10
). 
13
C NMR (CDCl3, 100 MHz) δ 137.5 (C
2
), 133.9 (C
6
), 119.9 (C
1
), 117.2 (C
7
), 108.9 (C
8
), 
80.5 (C
5
), 79.1 (C
3
), 71.1 (C
4
), 27.2 (C
9
), 25.7 (C
10
). 
MS (CI) m/z 185 (MH
+
). 
In agreement with literature data. 
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(3aS,6aS)-2,2-Dimethyl-2H,3aH,4H,6aH-cyclopenta[d][1,3]dioxol-4-one (148).
83
 
 
 
C8H10O3 
Mol Wt = 154.16 g  
 
To a solution of 149 (7.10 g, 38.6 mmol) in degassed CH2Cl2 (500 mL) was added Grubbs’ 
1
st
 generation catalyst (161 mg, 0.20 mmol, 0.5 mol%) in one portion. The reaction was 
left to stir at 20 °C for 12 h, after which the solvent was removed in vacuo. The residue 
was then dissolved in EtOAc (275 mL) and IBX (19.5 g, 69.5 mmol, 1.8 equiv) was added 
in one portion. The reaction was heated under reflux for 3 h, cooled to 0 °C and filtered. 
The solvent was evaporated in vacuo and the crude material was purified by column 
chromatography (8:2 PE:EtOAc) to furnish the product 148 as a white solid (4.82 g, 81%). 
Rf 0.25 (8:2 PE:EtOAc). 
[α]D
25 
+73 (c 1.0, CHCl3), lit. +69 (c 1.0, CHCl3). 
mp - 55–58 °C, lit. 68–69 °C. 
1
H NMR (CDCl3, 400 MHz) δ 7.62 (dd, J = 5.9, 2.3 Hz, 1H, H
3
), 6.21 (dd, J = 5.9, 0.6 Hz, 
1H, H
2
), 5.28 (ddd, J = 5.5, 2.3, 0.6 Hz, 1H, H
4
) 4.46 (d, J = 5.5 Hz, 1H, H
5
), 1.42 (s, 3H, 
H
7
), 1.41 (s, 3H, H
8
). 
13
C NMR (CDCl3, 100 MHz) δ 203.3 (C
1
), 157.8 (C
3
), 132.1 (C
2
), 114.7 (C
6
), 79.2 (C
4
), 
72.0 (C
2
), 28.5 (C
7
), 27.9 (C
8
). 
MS (CI) m/z 155 (MH
+
). 
In agreement with literature data. 
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((3aS,6S,6aS)-6-Isopropenyl-2,2-dimethyl-6,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-
yloxy)trimethylsilane (118).
4f
 
 
C14H24SiO3 
Mol. Wt. = 268.42 g 
 
At 0 °C a 0.5 M solution of isopropenylmagnesium bromide (50.4 mL, 25.2 mmol, 1.4 
equiv) was subsequently added dry TMEDA (7.55 ml, 50.4 mmol, 2.8 equiv) and 
CuBr.DMS (370 mg, 1.8 mmol, 0.1 equiv). The mixture was then cooled to −78 °C and a 
solution of 148 (2.78 g, 18.0 mmol) and TMSCl (6.85 ml, 54.0 mmol, 3 equiv) in THF (50 
mL) was added by syringe over 20 minutes, and the reaction was stirred at −78 °C for 1.5 
h, and then at −40 °C for 1 h. The reaction was then quenched with saturated aqueous 
NH4Cl solution, warmed to room temperature and filtered through Celite
®
 with ether 
washes. The mixture was the diluted with water and the layers separated. The aqueous 
phase was extracted with Et2O (3 × 40 mL) and the organic layers were combined, dried 
over Na2SO4, filtered and reduced in vacuo. The crude material was purified by column 
chromatography using oven dried silica to give a mixture of 118 (1.64g, 34%) and 118’ 
(2.08g, 59%). 
A 0.1 M solution of LDA was prepared by dropwise addition of a 1.6 M n-BuLi (8 mL, 
12.9 mmol) to a solution of freshly distilled diisopropylamine (2 mL, 14 mmol, 1.1 equiv) 
in THF (121 mL) at 0 °C.
84
 The solution was left to stir at 0 °C for 1 h and then cooled to 
−78 °C. A solution of 118’ (0.5 g, 2.6 mmol) and TMSCl (1.57 mL, 12 mmol, 5 equiv) in 
THF (30 mL) was cooled to −78 °C and the LDA solution (91 mL, 9.1 mmol, 3.5 equiv) 
was added dropwise by syringe. The mixture was stirred at −78 °C for 1 h and then slowly 
warmed to 0 °C. The reaction was quenched by addition of saturated aqueous NaHCO3 
solution, the layers separated and the aqueous layer extracted with Et2O (3 × 50 mL). The 
combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. The 
crude material was purified by column chromatography using oven dried silica to give the 
product as a colourless oil (0.63 g, 90%). 
Rf 0.5 (95:5 PE:EtOAc) 
[α]D
25  −32.8 (c 1.00, CHCl3) lit. −54.3 (c 1.34, CHCl3). 
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1
H NMR (CDCl3, 400 MHz) δ  4.80 (dd, J = 6.1, 1.4 Hz, 1H, H
4
), 4.75 (s, 2H, H
7
), 4.62 
(m, 1H, H
2
), 4.31 (brd, J = 6.1, 0.9 Hz, 1H, H
5
), 3.20 (brs, 1H, H
3
), 1.75 (t, J = 1.1 Hz, 3H, 
H
8
), 1.47 (s, 3H, H
10
), 1.35 (s, 3H, H
11
), 0.26 (s, 9H, H
12
). 
13
C NMR (CDCl3, 100 MHz) δ 155.0 (C
1
), 146.7 (C
9
), 111.0 (C
7
), 110.6(C
6
), 105.9 (C
2
), 
82.7 (C
4
), 81.0 (C
5
), 54.5 (C
3
), 27.1 (C
8
), 26.2 (C
10
), 21.0 (C
11
), 0.0 (C
12
).  
IR 3048, 2995 (CH), 2941 (CH), 1647 (C=C), 1432, 1371, 1281, 1261, 1250, 1200, 1156 
(C-O), 1080, 1051 cm
-1
. 
MS (EI) m/z 268. 
In agreement with literature data. 
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(3aS,6S,6aS)-6-Isopropenyl-2,2-dimethyltetrahydrocyclopenta[1,3]dioxol-4-one 
(118’).4f 
 
C11H16O3 
Mol Wt = 196.24 g 
 
Rf 0.25 (95:5 PE:EtOAc) 
[α]D
25  
+ 167 (c 1.0, CHCl3) lit +188 (c 2.2, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 4.83 (brs, 1H, H
7
) 4.64 (d, J = 5.4 Hz, H
5
), 4,60 (s, 1H, H
7
), 
4.11 (dd, J = 5.4, 1.0 Hz, 1H, H
4
), 2.92 (m, 1H, H
3
), 2.70 (dd, J = 18.1, 9.3 Hz, 1H, H
2
), 
2.20 (dd, J = 18.1, 0.8 Hz, 1H, H
2
), 1.78 (s, 3H, H
8
), 1.41 (s, 3H, H
10
), 1.31 (s, 3H, H
11
). 
13
C NMR (CDCl3, 100 MHz) δ 213.3 (C
1
), 144.8 (C
9
), 112.3 (C
6
), 111.6 (C
7
), 80.8 (C
3
), 
78.0 (C
2
), 63.3 (C
4
), 39.5 (C
5
), 27.3 (C
10
), 25.2 (C
11
), 22.0 (C
8
). 
IR 2896 (C-H), 2934, 1756 (C=O), 1647 (C=C), 1450, 1378, 1241, 1155 (C-O), 1076, 
1050 cm
-1
. 
MS (EI) m/z 196 (M+). 
In agreement with literature data. 
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tert-Butyl (1S,2S,3S,4R)-[(3aS, 6S, 6aS)-2,2-dimethyl-4-oxo-6-(prop-1-en-2-yl)-
hexahydrochloropenta(d)[1,3]dioxol-5-yl]-3-(tert-butyldimethylsiloxy)-4-methyl-5-
oxocyclopentane-1-carboxylate (119c). 
 
 
C28H46O7Si 
Mol Wt = 522.75 g 
 
 
To a solution of 118 (620 mg, 2.31 mmol, 3.3 equiv) in THF (1.8 mL) at 0 °C was added 
dropwise 1.6 M n-BuLi (1.43 mL, 2.31 mmol, 3.3 equiv) and the mixture being stirred at 0 
°C for a further 1.5 h. Under vacuum ZnCl2 was melted using a Bunsen burner, and a 
solution of 113c (230 mg, 0.70 mmol) in DMF (7.5 mL) was added and the solution stirred 
until all the ZnCl2 had dissolved. The flask containing the THF solution was cooled to −78 
°C and the DMF solution was added dropwise by syringe over 30 minutes. The mixture 
was then stirred at −78 °C for 1 hour and then warmed to −40 °C and stirred for a further 
hour. The reaction was then warmed slowly to 0 °C over 2 h. Once the reaction had 
completed by TLC it was quenched by addition of a saturated aqueous NH4Cl solution (5 
mL) and THF (5 mL). The layers were separated and the aqueous phase extracted with 
Et2O (3 × 10 mL). The combined organic extracts were then washed with saturated NaCl 
solution (1 × 10 mL) and water (2 × 10 mL) sequentially. The organic phase was then dried 
over Na2SO4, filtered and the solvent reduced in vacuo. The crude material was purified by 
column chromatography (8:2 PE:EtOAc) to furnish the product 119c as a pale yellow oil 
(183 mg, 50%).  
Rf 0.40 (8:2 PE:EtOAc) 
[α]D
25  
 −25 (c 1.0, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 5.01 (t, J = 0.8 Hz, 1H, H
20
), 4.94 (s, 1H, H
20
), 4.57 (dd, J 
= 6.4, 1.2 Hz, 1H, H
16
), 4.07 (dd, J = 6.4, 3.0 Hz, 1H, H
17
), 3.62 (dd, J = 9.0, 8.0 Hz, 1H, 
H
4
), 3.06 (dd, J = 8.0, 3.0 Hz, 1H, H
18
) 3.04 (d, J = 1.6 Hz, 1H, H
2
), 2.86 (ddd, J = 10.0, 
3.0, 1.6 Hz, 1H, H
3
), 2.71 (dd, J = 10.0, 3.0 Hz, 1H, H
14
), 2.34 (dq, J = 9.0, 7.0Hz, 1H, H
5
), 
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1.91 (brs, 3H, H
21
), 1.57 (s, 6H, H
23
/H
24
), 1.37 (s, 9H, H
9
), 1.16 (d, J = 7.0 Hz, 3H, H
6
), 
0.88 (s, 9H, H
13
), 0.09 (s, 3H, H
10
), 0.08 (s, 3H, H
11
). 
13
C NMR (CDCl3, 100 MHz) δ 212.2 (C
15
), 209.5 (C
1
), 168.2 (C
7
), 145.4 (C
22
), 139.6 
(C
19
), 118.8 (C
20
), 82.8 (C
8
), 80.1 (C
16
), 79.8 (C
17
), 74.5 (C
4
), 55.5 (C
2
), 53.3 (C
5
), 50.2 
(C
14
), 46.8 (C
18
), 44.8 (C
3
), 27.2 (C
24
), 26.0 (C
13
), 25.8 (C
23
), 23.4 (C
21
), 17.7 (C
12
), 13.3 
(C
6
), 10.6 (C
9
), −3.9 (C10), –4.3 (C11). 
IR 2945 (CH), 2934, 2860, 1755 (C=O), 1724 (C=O), 1699 (C=O), 1641 (C=C), 1462, 
1375, 1311, 1210, 1220, 1147 (C-O), 1041 cm
-1
. 
MS (EI) m/z 522 (M
+
). 
HRMS (EI) calculated for C28H44O7Si: 522.7330, found: 522.7336. 
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tert-Butyl  (1S,2R,3aR,5aS,5bS,8aS,9aS,9bR)-1-[(tert-butyldimethyl)siloxy]-2,7,7-
trimethyl-5-methylene-3,9-dioxodecahydro-1H-as-indaceno[2,3-d][1,3]dioxole-3a-
carboxylate (157). 
 
 
C28H44O7Si 
Mol Wt = 520.73 g 
 
 
 
To a solution of 119c (28 mg, 54 umol) in a 10:1 degassed mixture of 2,2,2-
trifluoroethanol/acetic acid (0.5 mL) was added Cu(OAc)2.H2O (21 mg, 108 umol). The 
mixture was stirred at 20 °C for 30 minutes until all Cu(OAc)2.H2O had dissolved. To the 
reaction mixture was added Mn(OAc)3.2H2O (29 mg, 108 umol) and the reaction was 
stirred for 1.5 h. The mixture was diluted with water (5 mL) and Et2O (5 mL), and solid 
K2CO3 was carefully added to neutralise the acetic acid. The layers were separated and the 
aqueous layer extracted with Et2O (3 × 10 mL). The combined organic layers were dried 
over Na2SO4, filtered and concentrated in vacuo. The crude material was purified by 
column chromatography (9:1 PE:EtOAc) to give the product 157 as a yellow oil (13 mg, 
48%). 
Rf 0.35 (9:1 PE:EtOAc). 
[α]D
25 −32.1 (c 1.0, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 5.02–4.98 (m, 2H, H
21
), 4.79 (dd, J = 9.1, 7.8 Hz, 1H, H
17
), 
4.58 (d, J = 7.8 Hz, 1H, H
16
), 3.98 (dd, J = 3.0, 2.0 Hz, 1H, H
4
), 3.01–2.92 (m, 2H, 
H
3
/H
14
), 2.90 (d, J = 14.8 Hz, 1H, H
20
). 2.71 (dd, J = 9.1, 3.0 Hz, 1H, H
18
), 2.34–2.22 (m, 
2H, H
5
/H
20
), 1.46 (s, 3H, H
23
), 1.43 (s, 9H, H
9
), 1.37 (s, 3H, H
24
), 1.12 (d, J = 7.7 Hz, 3H, 
H
6
), 0.90 (s, 9H, H
13
), 0.08 (s, 3H, H
10
),  −0.01 (s, 3H, H11). 
13
C NMR (CDCl3, 100 MHz) δ 212.5 (C
15
), 209.9 (C
1
), 167.7 (C
7
), 140.4 (C
22
), 121.6 
(C
19
), 108.8 (C
21
), 87.9 (C
8
), 80.1 (C
16
), 79.8 (C
17
), 75.0 (C
4
), 66.2 (C
2
), 53.0 (C
14
), 52.7 
(C
5
), 48.9 (C
18
), 48.6 (C
3
), 36.5 (C
20
), 27.7 (C
9
), 26.2 (C
43
), 26.0 (C
23
), 18.0 (C
12
), 15.0 
(C
13
), 11.1 (C
6
), −4.6 (C10), −5.3 (C11). 
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IR 2954 (CH), 2930, 2860, 1758 (C=O), 1740 (C=O), 1670 (C=C), 1473, 1465, 1386, 
1650, 1252, 1233, 1160 (C-O), 1042 cm
-1
. 
MS (EI) m/z 520 (M
+
). 
HRMS (EI) calculated for C28H44O7Si: 520.2858, found: 520.2856. 
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4-Pentenal (176).
53
   
 
C5H8O 
Mol Wt. = 84.13g  
 
To a solution of glycidol 178 (17.7 mL, 266 mmol) in THF (400 mL) at −78 °C was added 
by cannula a 2 M solution of allylmagnesium chloride (240 mL, 480 mmol, 1.8 equiv). The 
mixture was stirred at −78 °C for 30 min and then slowly warmed to 0 °C over 1 h. The 
reaction was then quenched by addition of a saturated aqueous NH4Cl solution (300 mL). 
The layers were separated and the aqueous phase was extracted with Et2O (2 × 150 mL). 
The organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo 
to furnish the diol 179 (26.4 g, 86%). The crude 179 was dissolved in a 1:1 mixture of 
CH2Cl2/H2O (640 mL), and NaIO4 (97 g, 454 mmol, 2 equiv) was added in one portion. 
The mixture was stirred for 1 h, after which it was quenched by addition of saturated 
aqueous NaHCO3 solution (200 mL). The layers were separated and the organic layer was 
washed with 10% aqueous Na2SO4 (50 mL). The organic layer was dried over Na2SO4, 
filtered and carefully concentrated in vacuo at 0 °C. The crude material was purified by 
distillation (bp: 102 °C) to afford the aldehyde 176 contaminated with ~5% by weight 
CH2Cl2 (13.6 g, 162 mmol, 71%). 
Rf 0.30 (9:1 PE/EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 9.76 (t, J = 1.55 Hz, 1H, H
1
), 5.76 (ddt, J = 16.6, 10.2, 6.4 
Hz, 1H, H
4
), 5.12–5.03 (m, 2H, H5), 2.59–2.54 (m, 2H, H2), 2.45–2.38 (m, 2H, H3). 
13
C NMR (CDCl3, 100 MHz) δ 201.9 (C
1
), 136.6 (C
4
), 115.9 (C
5
), 42.8 (C
2
), 26.3 (C
3
). 
MS (CI) – m/z 84 (M+). 
In agreement with literature data. 
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(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2-methyl-hept-6-en-1-one 
(180). 
 
C18H23NO2S2 
Mol. Wt. = 349.45 
 
To a solution of 127 (780 mg, 2.90 mmol) in CH2Cl2 (15 mL) at −10 °C was added 
dropwise TiCl4 (0.34 mL, 3.10 mmol, 1.05 equiv). This was left to stir for 15 min followed 
by addition of freshly distilled N-diisopropylethylamine (0.51 mL, 2.9 mmol, 1.00 equiv). 
After stirring for 1 h the flask was cooled to −78 °C and NMP (0.30 mL, 2.9 mmol, 1 
equiv) was added dropwise and left to stir for a further 1 h. Aldehyde 176 (0.28 g, 3.3 
mmol, 1.1 equiv) was introduced by syringe and the mixture left at −78 °C for 1 h, 
followed by gradual warming to 0 °C. The reaction was quenched by addition of saturated 
aqueous NH4Cl solution (15 mL). The aqueous phase was extracted with CH2Cl2 (3 × 20 
mL), and the combined organic extracts were dried over Na2SO4, filtered and concentrated 
in vacuo. Purification by flash chromatography (8:2 PE/EtOAc) product 180 as a yellow 
oil (0.65 g, 70%). 
Rf 0.25 (8:2 PE/EtOAc). 
[α]D
25 −80 (c 0.25, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 7.41–7.12 (m, 5H, H
Ar
), 5.74 (ddt, J = 17.1, 10.2, 6.6 Hz, 
1H, H
6
), 5.27–5.21 (m, 1H, H11), 5.06 (ddt, J = 17.1, 3.4, 1.4 Hz, 1H, H7), 4.99 (ddt, J = 
10.2, 3.4, 1.4 Hz, 1H, H
7
), 4.48 (qd, J = 6.9, 2.9 Hz, 1H, H
2
), 3.88–3.83 (m, 1H, H3),  3.30 
(dd, J = 11.5, 7.1 Hz, 1H, H
10
), 3.05 (dd, J = 13.2, 10.5 Hz, 1H, H
12
), 2.90 (d, J = 11.5 Hz, 
1H, H
10
), 2.88 (brs, 1H, OH), 2.71 (d, J = 3.1 Hz, 1H, H
12
), 2.21–2.08 (m, 1H, H4), 1.80–
1.49 (m, 2H, H
4
/H
5
), 1.45–1.34 (m, 1H, H5), 1.09 (d, J = 6.9 Hz, 3H, H8). 
13
C NMR (CDCl3, 100 MHz) δ 201.6 (C
9
), 178.3 (C
1
), 138.2 (C
6
), 136.4 (C
Ar
), 129.4 
(C
Ar
), 129.0 (C
Ar
), 127.5 (C
Ar
), 115.1 (C
7
), 71.8 (C
11
), 69.9 (C
3
), 43.4 (C
2
), 37.0 (C
10
), 33.5 
(C
12
), 31.9 (C
4
), 29.7 (C
5
), 10.6 (C
8
). 
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IR 3506 (OH), 2972 (CH), 2924, 2856, 2360, 1712 (CO), 1363, 1342, 1288, 1259, 1130 
(C-O), 1107, 1045, 1016 cm
-1
. 
MS (CI) – m/z 350 (MH+). 
HRMS (CI) – calculated for C18H24NO2S2: 350.5213, found: 350.5211. 
  
133 
 
(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-(tert-butyldimethylsilyloxy)-2-
methyl-hept-6-en-1-one (181). 
 
C24H37NO2S2Si 
Mol. Wt. = 463.77 g 
 
A solution of 180 (4.00 g, 11.5 mmol) and TBSCl (6.93 g, 46.0 mmol, 4.0 equiv) in 
anhydrous DMF (40 mL) was cooled to 0 °C and 2,6-lutidine (6.7 mL, 58 mmol, 5.0 
equiv) was added dropwise. The mixture was left to stir at 20 °C for 3 days, followed by 
dilution with ice water. The mixture was extracted with Et2O (3 × 50 mL), and the 
combined organic extracts were washed with saturated aqueous CuSO4 solution (2 × 15 
mL). The organic extracts were then dried over Na2SO4, filtered and the solvent removed 
in vacuo. The crude product was purified by flash chromatography (97:3 PE/EtOAc) 
furnishing 181 as a bright yellow oil (5.17 g, 97%). 
Rf 0.27 (97:3 PE/EtOAc). 
[α]D
20 −67 (c 0.28, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 7.31–7.19 (m, 5H, H
Ar
), 5.76 (ddt, J = 17.1, 10.1, 6.6 Hz, 
1H, H
6
), 5.16–5.10 (m, 1H, H11), 4.99 (ddt, J = 17.1, 3.2, 1.5 Hz, 1H, H7), 4.91 (ddt, J = 
10.1, 3.2, 1.5 Hz, 1H. H
7
), 4.52 (qd, J = 6.6, 5.6 Hz, 1H, H
2
), 3.98 (dt, J = 5.6, 5.6 Hz, 1H, 
H
3
), 3.29–3.20 (m, 2H, H10/H12), 2.98 (dd, J = 13.1, 10.6 Hz, 1H, H12), 2.83 (d, J = 11.6 
Hz, 1H, H
10
), 2.08–2.00 (m, 2H, H4/H5), 1.67–1.57 (m, 1H, H4), 1.57–1.47 (m, 1H, H5), 
1.20 (d, J = 6.6 Hz, 3H, H
8
), 0.85 (s, 9H, H
16
), 0.17 (s, 3H, H
13
), –0.10 (s, 3H, H14). 
13
C NMR (CDCl3, 100 MHz) δ 200.9 (C
9
), 176.8 (C
1
), 138.6 (C
6
), 136.7 (C
Ar
), 129.5 
(C
Ar
), 128.9(C
Ar
), 127.3 (C
Ar
), 114.6 (C
7
), 73.9 (C
11
), 69.5 (C
3
), 44.2 (C
2
), 36.6 (C
10
), 34.4 
(C
12
), 32.1 (C
5
), 29.2 (C
4
), 25.8 (C
16
), 18.4 (C
15
) , 12.6 (C
8
), –4.3(C13), –4.5 (C14). 
IR 2949 (CH), 2928, 1695 (CO), 1454, 1319, 1340, 1249, 1161, 1134, 1028, 1004 cm
-1
. 
MS (EI) m/z 464 (MH
+
), 434 (MH
+
-S), 210 (133
+
),  
134 
 
HRMS (EI) - calculated for C24H37NO2S2Si: 463.7750, found: 463.7753. 
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(2R,3S)-3-(tert-Butyldimethylsilyloxy)-2-methyl-6-heptenal (182).  
 
C14H28O2Si 
Mol. Wt. = 256.45g 
 
A solution of 181 (5.10 g, 11.0 mmol) in CH2Cl2 (150 mL) was cooled to −78 °C and a 1 
M solution of Dibal-H in hexanes (25 mL, 25 mmol, 2.3 equiv) was added dropwise. The 
mixture was left to stir until the bright yellow colour disappeared, then the reaction was 
quenched with EtOAc (50 mL). The mixture was then diluted with a 10% aqueous 
Rochelle’s salt solution and stirred for 1 h until the organic phase went clear. The mixture 
was then extracted with Et2O (3 × 100 mL), and the combined organic extracts were dried 
over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by flash 
chromatography (98:2 PE/EtOAc) switching up to (8:2 PE/EtOAc) collecting 133 (1.95 g, 
85%) and 182 as a colourless oil (2.42 g, 85%). 
Rf 0.23 (98:2 PE/EtOAc) 
[α]D
25 −98 (c 1.0, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 9.73 (d, J = 1.0 Hz, 1H, H
1
), 5.75 (ddt, J = 16.9, 10.4, 6.5 
Hz, 1H, H
6
), 4.95 (ddt, J = 16.9, 3.4, 1.7 Hz, 1H, H
7
), 4.91 (ddt, J = 10.4, 3.4, 1.7 Hz, 1H, 
H
7
), 4.05 (td, J = 6.6, 3.6 Hz, 1H, H
3
), 2.40 (qdd, J = 7.0, 3.6, 1.0 Hz, 1H, H
2
), 2.12–1.95 
(m, 2H, H
4
/H
5
), 1.68–1.50 (m, 2H, H4/H5), 0.99 (d, J = 7.0 Hz , 3H, H8), 0.79 (s, 9H, H12), 
0.00 (s, 3H, H
10
), −0.03 (s, 3H, H9). 
13
C NMR (CDCl3, 100 MHz) δ 205.2 (C
1
), 138.1 (C
6
), 115.0 (C
7
), 72.7 (C
3
), 51.1 (C
2
), 
33.6 (C
5
), 31.9 (C
4
), 25.6 (C
12
), 14.2 (C
11
), 7.7 (C
8
), −3.0 (C9), −3.1 (C10). 
IR 2948 (CH), 1740 (C=O), 1478, 1295, 1119 (C-O), 1090, 1005 cm
-1
. 
MS (EI) m/z 257 (MH
+
). 
HRMS (EI) calculated for C14H29O2Si: 257.1937, found: 257.1936. 
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Ethyl (4R,5S)-5-(tert-butyldimethylsilyloxy)-4-methyl-3-oxonon-8-enoate (184/184’). 
 
C18H34SiO4 
Mol Wt = 342.54 g  
 
To a solution of SnCl2 (0.88 g, 4.8 mmol, 0.5 equivalents) in CH2Cl2 (50 mL) was added 
ethyl diazoacetate (2.76 g, 19.4 mmol, 2.0 equivalents) and 182 (2.48 g, 9.70 mmol) in 
CH2Cl2 (18 mL). The mixture was left to stir at 20 °C for 3 h, filtered and the solvent 
removed in vacuo. The product was then purified by flash chromatography (95:5 
PE/EtOAc) to give product 184 as a pale yellow oil. Formed as an inseperable 3:1 ratio 
with the enol form 184’ (2.48 g, 75%). 
Rf 0.25 (95:5 PE/EtOAc). 
[α]D
25 −187 (c 0.17, CHCl3). 
β-ketoester form 
1
H NMR (CDCl3, 400 MHz) δ 5.71 (ddt, J = 17.2, 10.2, 6.5 Hz, 1H, H
8
), 4.93 (ddt, J = 
17.2, 3.4, 1.5 Hz, 1H, H
9
), 4.89 (ddt, J = 10.2, 3.4, 1.5, 1H, H
9
), 4.10 (q, J = 7.1 Hz, 2H, 
H
11
), 3.82 (td, J = 7.1, 4.4 Hz, 1H, H
5
), 3.50 (s, 2H, H
2
), 2.76 (qd, J = 7.1, 4.4 Hz, 1H, H
4
), 
2.11–1.95 (m, 2H, H7), 1.54–1.42 (m, 1H, H6), 1.40–1.30 (m, 1H, H6), 1.19 (t, J = 7.1 Hz, 
3H, H
12
), 1.00 (d, J = 7.1 Hz, 3H, H
10
), 0.82 (s, 9H, H
16
), 0.01 (s, 3H,  H
13
), 0.00 (s, 3H, 
H
14
). 
13
C NMR (CDCl3, 100 MHz) δ 205.08 (C
3
), 167.41 (C
1
), 137.9 (C
8
), 114.5 (C
9
), 73.2 (C
5
), 
61.2 (C
11
), 51.5 (C
4
), 49.4 (C
2
), 33.54 (C
7
), 29.8 (C
6
), 25.8 (C
16
), 17.74 (C
15
), 14.22 (C
12
), 
11.57 (C
10
), −4.1 (C13), −4.3 (C14). 
IR 3443 (OH), 2953 (CH), 2858, 1745 (CO), 1714 (CO), 1641 (C=C), 1628, 1448, 1381, 
1303, 1251, 1226, 1143, 1095, 1032, 1005 cm
-1
. 
MS (CI) m/z 343 (MH
+
). 
HRMS (CI) – calculated for C18H35SiO4: 343.2305, found: 343.2303.  
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Ethyl (4R,5S)-5-[(tert-butyldimethylsilyl)oxy]-4-methyl-3-oxo-2-(3-oxocyclopentyl) 
non-8-enoate (186). 
 
 
 
C23H40SiO5 
Mol. Wt. = 424.64 g 
 
 
To a solution of 184 (1.33 g, 3.88 mmol, 1.6 equiv) and 2-cyclopentenone (0.20 ml, 2.42 
mmol) in anhydrous EtOH (16 mL) was added K2CO3 (0.84 g, 6.1 mmol, 0.4 equivalents) 
in one portion. The mixture was left to stir for 6 h, after which it was diluted with water 
(20 mL) and Et2O (20 mL). The two layers were separated and the aqueous layer extracted 
with Et2O (3 × 20 mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated in vacuo. The crude material was purified by column chromatography (8:2 
PE:EtOAc) to furnish the product 186 as a colourless oil (1.51 g, 91%). Isolated as an 
inseperable mixture of 4 diastereomers. 
Rf 0.35 (8:2 PE/EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 5.68 (m, 1H, H
8
), 4.90 (m, 2H, H
9
), 4.11 (m, 2H, H
16
), 3.92 
(d, J = 8.0 Hz, 1H, H
2
), 3.75 (m, 1H, H
5
), 3.05−3.00 (m, 1H, H4), 2.95–2.80 (m, 2H, 
H
12
/H
14
 ), 2.60-2.11 (m, 3H, H
12
/H
13
/H
14
), 2.09−1.92 (m, 3H, H7/H15), 1.83–1.78 (m, 1H, 
H
11
), 1.65–1.42 (m, 2H, H6), 1.30–1.25 (m, 3H, H17), 1.17–1.04 (m, 3H. H10), 0.82 (m, 9H, 
H
21
), 0.05 (s, 3H. H
19
), 0.00 (s, 3H, H
18
). 
IR 2950 (C-H), 2932, 1744 (C=O), 1722 (C=O), 1687 (C=O), 1639 (C=C), 1412, 1345, 
1264, 1144 (C-O), 1021, 1005 cm
-1
. 
MS (CI) m/z 425 (MH
+
). 
 
HRMS (CI) calculated for C23H41SiO5: 425.2723, found: 425.2725. 
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Ethyl(4R,5S)-5-[(tert-butyldimethylsilyl)oxy]-4-methyl-3,8-dioxo-2-(3-oxocyclopentyl) 
nonanoate (187). 
 
 
C23H40SiO6 
Mol. Wt. = 440.64 g 
 
 
To a 3:1 mixture of DMF/ H2O (2.1 mL) was added PdCl2 (17 mg, 0.097 mmol, 0.1 equiv) 
and CuCl2 (96 mg, 0.97 mmol, 1.0 equiv) and oxygen was bubbled through the solution for 
1 h. A solution of 186 (0.41 g, 0.97 mmol) in DMF (0.8 mL) was added and the mixture 
was stirred overnight under an oxygen atmosphere. The mixture was then diluted with H2O 
and extracted with Et2O (3 × 10 mL) then filtered on Celite
®
. The combined organic layers 
were washed with saturated aqueous NaCl solution (3 × 10 mL), dried over MgSO4, 
filtered and concentrated in vacuo. The crude material was purified by column 
chromatography (8:2 PE/EtOAc) to furnish the product 187 as a colourless oil (0.30 g, 
72%) as an inseperable mixture of 4 diastereomers. 
 
Rf 0.2 (8:2 PE/EtOAc) 
 
1
H NMR (CDCl3, 400 MHz) δ  4.12–4.00 (m, 2H, H
16
), 3.71 (dd, J = 9.5, 3.5 Hz, 1H, H
2
), 
3.66–3.60 (m, 1H, H5), 2.89–2.82 (m, 1H, H4), 2.80–2.64 (m, 2H, H12/H14 ), 2.43–2.00 (m, 
3H, H
12
/H
14
/H
15
), 1.99 (s, 3H, H
9
), 1.88–1.67 (m, 3H, H7/H15), 1.67–1.52 (m, 1H, H11), 
1.51–1.31 (m, 2H, H6), 1.17–1.10 (m, 3H, H17), 1.02–0.91 (m, 3H. H10), 0.79–0.74 (m, 9H, 
H
21
), −0.05 and −0.10 (2 s, 6H, H18/ H19) 
IR 2957 (C-H), 2930, 2856, 1739 (C=O), 1710 (C=O), 1472, 1463, 1405, 1361, 1253, 
1253, 1191, 1147 (C-O), 1020, 1004 cm
-1
. 
MS (CI) m/z 441 (MH
+
) 
HRMS (CI) calculated for C23H41SiO6: 441.2671, found: 441.2675. 
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Ethyl (4R,5S)-5-[tert-Butyldimethylsilyl)oxy]-4-methyl-3,8-dioxononanoate (190). 
 
 
C18H34SiO5 
Mol. Wt. = 358.54 g 
 
Rf 0.4 (99:1 PE/EtOAc). 
[α]D
20 −122 (c 1.00, CHCl3). 
β-ketoester form 
1
H NMR (CDCl3, 400 MHz) δ 4.10 (q, J = 7.1 Hz, 2H, H
11
), 3.83 (td, J = 6.9, 4.8 Hz, 1H, 
H
5
), 3.50 (s, 2H, H
2
), 2.74 (qd, J = 7.0, 4.8 Hz, 1H, H
4
), 2.40–2.29 (m, 2H, H7), 2.06 (s, 
3H, H
9
), 1.75-1.65 (m, 1H, H
6
), 1.52–1.41 (m, 1H, H6), 1.20 (t, J = 7.1, 3H, H12), 1.02 (d, J 
= 7.0 Hz, 3H, H
10
), 0.82 (s, 9H, H
16
), 0.00 (s, 3H, H
13
), −0.01 (s, 3H, H14).    
 
13
C NMR (CDCl3, 100 MHz) δ 208.1 (C
8
), 205.2 (C
3
), 167.4 (C
1
), 72.2 (C
5
), 61.2 (C
11
), 
50.7 (C
4
), 49.5 (C
2
), 38.1 (C
7
), 28.9 (C
9
), 26.7 (C
6
), 24.8 (C
16
), 17.0 (C
15
), 13.0 (C
12
), 12.2 
(C
10
), −5.5 (C13), −5.6 (C14). 
IR 2951 (CH), 2858, 1742 (CO), 1720 (CO), 1709 (CO), 1645 (C=C), 1628, 1333, 1279, 
1143, 1095, 1040 cm
-1
. 
MS (CI) m/z 359 (MH
+
). 
 
HRMS (CI) calculated for C18H35SiO5: 359.2255, found: 359.2259. 
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cis-4-Cyclopentene-1,3-diol (196).
85
 
 
 
C5H8O2 
Mol. Wt. = 100.12 g  
 
 
In a 1 L photochemistry apparatus, a solution of freshly distilled cyclopentadiene  (6.4 mL, 
75 mmol), Rose Bengal (154 mg, 0.152 mmol, 0.002 equiv) and thiourea (3.92 g, 50.2 
mmol, 6.7 equiv) in methanol (1 L) was cooled to 0 °C and irradiated with a UV mercury 
lamp, while oxygen was bubbled through the solution. After 3 h, irradiation and bubbling 
was stopped and the reaction was stirred in the darkness overnight. The solvent was then 
evaporated and the residue was dissolved in ethyl acetate, silica (5.0 g) and charcoal (2.5 g) 
was added and the solvent was reduced in vacuo. The resulting powder was then deposited 
on a silica gel column and the product purified by column chromatography (9:1 
CH2Cl2/MeOH). Fractions containing the product were combined and evaporated; the 
residue was then dissolved in water so the Rose Bengal impurities precipitated. After 
filtration and evaporation of water, the product was dissolved in ethyl acetate, dried over 
MgSO4, filtered and concentrated in vacuo to give the product 196 as a dark brown oil (4.5 
g, 60%). 
Rf 0.3 (9:1 CH2Cl2/MeOH). 
1
H NMR (CDCl3, 400 MHz) δ 5.89 (d, J = 0.3 Hz, 2H, H
1
), 4.57 (dd, J = 7.3, 5.4 Hz, 2H, 
H
2
), 2.72 (dt, J = 13.4, 7.3 Hz, 1H, H
3
), 1.41 (dt, J = 13.4, 5.4 Hz, 1H, H
3
). 
13
C NMR (CDCl3, 100 MHz) δ 137.1 (C
1
), 75.3 (C
2
), 44.5 (C
3
). 
MS (FAB) – m/z 100 (M+). 
In agreement with literature data. 
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cis-3,5-Diacetoxy-1-cyclopentene (197).
85
 
 
C9H12O4 
Mol. Wt. = 184.19 g  
 
 
Acetic anhydride (19.4 mL, 204 mmol, 4.0 equivalents) was slowly added to a stirred 
solution of diol 196 (5.10 g, 51.0 mmol), pyridine (41 mL, 510 mmol, 10 equiv) and 
DMAP (311 mg, 2.55 mmol, 0.05 equiv) in CH2Cl2 (250 mL) at 0 °C. The mixture was 
stirred at 0 °C for 30 min and then warmed to 20 °C and stirred for a further 5 h, after 
which the reaction was quenched by slow addition of saturated aqueous NaHCO3 solution 
(250 mL). The layers were separated and the organic layer was washed with saturated 
aqueous CuSO4 solution (3 × 150 mL), dried over MgSO4, filtered and concentrated in 
vacuo. The organic residue was then purified by column chromatography (9:1 PE/EtOAc) 
to furnish the product 197 as a colourless oil (7.42 g, 79%). 
Rf 0.3 (9:1 PE/EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 6.12 (d, J = 0.8 Hz, 2H, H
1
), 4.57 (dd, J = 7.5, 3.9 Hz, 2H, 
H
2
), 2.92 (dt, J = 14.9, 7.5 Hz, 1H, H
3
), 2.09 (s, 6H, H
5
), 1.41 (dt, J = 14.9, 3.9 Hz, 1H, 
H
3
). 
13
C NMR (CDCl3, 100 MHz) δ 170.6 (C
4
), 134.5 (C
1
), 76.5 (C
2
), 37.1 (C
3
), 21.0 (C
5
). 
MS (FAB) – m/z 184 (M+). 
In agreement with literature data. 
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(1S,4R)-cis-4-Acetoxy-2-cyclopenten-1-ol (198).
86
 
 
C7H10O3 
Mol. Wt. = 142.15 g  
 
 
Compound 197 (6.90 g, 37.4 mmol) was added to a slowly stirred solution of electric eel 
acetylcholineesterase (2.47 mg, 2000 units) and sodium azide (15 mg) in an aqueous 
phosphate buffer (320 mL) at 20 °C. The buffer was prepared by dissolving anhydrous 
Na2HPO4 (32.8 g) in water (400 mL), adjusting the pH to 6.85 by careful addition of a 2 M 
aqueous HCl solution. The reaction was stirred at 20 °C overnight, after which it was 
extracted with 1:1 Et2O/EtOAc (6 × 100 mL). The combined organic extracts were dried 
over Na2SO4, filtered and concentrated in vacuo to give the product 198 as a white solid 
(5.15 g, 97%,). 
Rf 0.4 (6:4 PE/EtOAc). 
mp - 52–53°C, lit. 49–51°C. 
[α]D
20 
+64.3
 
(c 1.00, CHCl3); lit +73.8 (c 1.25, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 6.14–6.12 (m, 1H, H
3
), 6.02–5.99 (m, 1H, H2), 5.53–5.49 
(m, 1H, H
1
), 4.76–4.70 (m, 1H, H4), 2.84 (dt, J = 14.6, 7.4 Hz, 1H, H5), 2.11 (s, 3H, H7), 
1.70 (dt, J = 14.6, 3.9 Hz, 1H, H
5
).  
13
C NMR (CDCl3, 100 MHz) δ 170.8 (C
1
), 138.5 (C
3
), 132.7 (C
2
), 77.1 (C
1
), 74.9 (C
4
), 
40.6 (C
5
), 21.2 (C
7
). 
MS (CI) – m/z 143 (MH+). 
In agreement with literature data. 
  
143 
 
(4R)-4-Acetoxy-2-cyclopenten-2-one (199).
87
 
 
C7H8O3 
Mol. Wt. = 140.14 g  
 
 
To a solution of 198 (3.2 g, 23 mmol) in ethyl acetate (450 mL) was added IBX (18.9 g, 
67.5 mmol, 3 equiv). The mixture was then stirred vigorously under reflux for 3 h. The 
reaction was then cooled to 0 °C and the solid residue removed by filtration. The solvent 
was then concentrated in vacuo and the organic residue purified by column 
chromatography (8:2 PE/EtOAc) to yield 199 as a colourless oil (2.87 g, 91%). 
 
Rf 0.3 (8:2 PE/EtOAc). 
[α]D
20 
+87
 
(c 1.00, CHCl3), lit +100 (c 1.4, MeOH). 
1
H NMR (CDCl3, 400 MHz) δ 7.56 (dd, J = 5.7, 2.4 Hz, 1H, H
3
), 6.34 (dd, J = 5.7, 1.2 Hz, 
1H, H
2
), 5.86–5.74 (m, 1H, H4), 2.84 (dd, J = 18.7, 6.3 Hz, 1H, H5), 2.34 (dd, J = 18.7, 2.2 
Hz, 1H, H
5
), 2.11 (s, 3H, H
7
). 
13
C NMR (CDCl3, 100 MHz) δ 203.9 (C
1
), 169.4 (C
6
), 158.9 (C
3
), 132.0 (C
2
), 72.0 (C
4
), 
41.0 (C
5
), 20.8 (C
7
). 
MS (CI) – m/z 141 (MH+). 
In agreement with literature data. 
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(4R)-4-Isopropyl-2-cyclopenten-2-one (195).
59
 
 
C8H12O 
Mol. Wt. = 124.18 g  
 
 
A solution of isopropylmagnesium bromide was prepared from 2-bromopropane (20.0 mL, 
213 mmol) and magnesium (5.44 g, 224 mmol) in THF (180 mL). The solution was 
standardised using the titration method. Any precipitate formed was redissolved prior to 
use by gentle heating and swirling. At 0 °C a solution of the Grignard reagent in THF (1.3 
M, 25 mL, 32 mmol, 1.4 equiv) was diluted further with THF (75 mL), and dry HMPA (11 
mL, 65 mmol, 2.8 equiv) and CuBr.DMS (475 mg, 2.31 mmol, 0.1 equiv) was 
subsequently added. The mixture was then cooled to −78 °C and a solution of 199 (3.2 g, 
23 mmol) and BF3.OEt2 (8.6 mL, 69 mmol, 3 equiv) in THF (61 mL) was added by syringe 
over 20 minutes, and the reaction was stirred at −78 °C for 1 hour, and then at −40 °C for 
30 minutes. The reaction was then quenched with saturated NH4Cl solution, warmed to 
room temperature and filtered through Celite
®
 with ether washings. The mixture was the 
diluted with water and the layers separated. The aqueous phase was extracted with ether (3 
× 80 mL) and the organic layers were combined, dried over Na2SO4, and carefully 
evaporated. The crude material was dissolved in CH2Cl2 (50 mL), 1 M acetic acid (15 mL) 
was added and the mixture was stirred for 2 h. The solution was then diluted with CH2Cl2 
and NaHCO3 solution, the layers separated and the aqueous phase extracted with CH2Cl2 (3 
× 30 mL). The organic layers were combined and dried over Na2SO4, and the solvent was 
removed very carefully in vacuo. The crude material was purified by column 
chromatography (9:1 PE:Et2O) and careful evaporation of the fractions containing product 
92 was obtained as a colourless oil (2.1 g, 72%). 
Rf  0.2 (9:1 PE/Et2O) 
[α]D
20 
+162
 
(c 1.1, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ  7.67 (dd, J = 5.7, 2.5 Hz, 1H, H
3
), 6.15 (dd, J = 5.7, 2.1 
Hz, 1H, H
2
), 2.83–2.77 (m, 1H, H4), 2.40 (dd, J  = 18.8, 6.4 Hz, 1H, H5), 2.05 (dd, J  = 
145 
 
18.8, 2.5 Hz, 1H, H
5
), 1.75 (oct, J = 6.8 Hz, 1H. H
6
), 0.94 (d, J = 6.8 Hz, 3H, H
7
), 0.89 (d, 
J = 6.8 Hz, 3H, H
7
). 
13
C NMR (CDCl3, 100 MHz) δ 210.0 (C
1
), 167.5 (C
3
), 134.5 (C
2
), 49.0 (C
4
), 37.5 (C
6
), 
31.7 (C
5
), 20.1 (C
7
), 19.8 (C
8
). 
MS (EI) - m/z 124 (M
+
). 
In agreement with literature data. 
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Ethyl (4R,5S)-5-[(tert-Butyldimethylsilyl)oxy]-4-methyl-3-oxo-2-[(1R,2S)-4-oxo-2-
(propan-2-yl)cyclopentyl]non-8-enoate (200). 
 
 
C26H46SiO5 
Mol. Wt = 466.73 g 
 
 
 
To a solution of 184 (2.06 g, 6.0 mmol, 1.5 equiv) and 195 (500 mg, 4.00 mmol) in 
anhydrous EtOH (25 mL) was added K2CO3 (0.22 g, 1.6 mmol, 0.4 equiv) in one portion. 
The mixture was left to stir for 6 h, after which it was diluted with water (100 mL) and 
Et2O (50 mL). The two layers were separated and the aqueous layer extracted with Et2O (3 
× 50 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated 
in vacuo. The crude material was purified by column chromatography (8:2 PE/EtOAc) to 
furnish the product 200 as a colourless oil (1.68 g, 90%) as an inseperable 3:1 mixture of 
diastereomers. 
 
Rf  0.3 (8:2 PE/EtOAc). 
[α]D
20 
+37
 
(c 1.0, CHCl3). 
Major diastereomer 
1
H NMR (CDCl3, 400 MHz) δ 5.77 (ddt, J = 17.1, 10.3, 6.6 Hz, 1H, H
8
), 5.03–4.92 (m, 
2H, H
9
), 4.20 (q, J = 7.1 Hz, 2H, H
11
), 3.99 (d, J = 4.5 Hz, 1H, H
2
), 3.76 (dt, J = 4.2, 4.2 
Hz, 1H, H
5
), 2.93 (qd, J = 7.0, 4.2 Hz, 1H, H
4
), 2.68 (dddd, J = 16.9, 12.9, 8,5, 4.5 Hz, 1H, 
H
13
), 2.54–2.48 (m, 2H, H14), 2.02–1.80 (m, 6H, H7/H16/H18), 1.50–1.47 (m, 2H, H6), 1.28 
(t, J = 7.1 Hz, 3H, H
12
), 1.06 (d, J = 7.0 Hz, 3H, H
10
), 0.94 (d, J = 6.8 Hz, 3H, H
20
), 0.92 (s, 
9H, H
24
), 0.83 (d, J = 6.8 Hz, 3H, H
19
), 0.10 (s, 3H, H
21
), 0.09 (s, 3H, H
22
).  
13
C NMR (CDCl3, 100 MHz) δ 217.4 (C
15
), 206.1 (C
3
), 168.8 (C
1
), 137.9 (C
8
), 114.9 (C
9
), 
74.2 (C
5
), 61.4 (C
11
), 60.8 (C
2
), 51.6 (C
4
), 45.5 (C
18
), 41.8 (C
16
), 38.8 (C
14
), 37.1 (C
13
), 
33.2 (C
7
), 30.1 (C
6
), 28.0 (C
17
), 25.9 (C
24
), 21.7 (C
19
), 18.1 (C
23
), 16.3 (C
20
) ,14.2 (C
12
), 
13.1 (C
10
), −4.2 (C21), –4.5 (C22). 
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IR 2957 (CH), 2930, 2886, 2843, 1740 (CO), 1712 (CO), 1440, 1463, 1402, 1354, 1253, 
1150, 1005 cm
-1
. 
MS (ESI) – m/z 489 (MNa+). 
HRMS (ESI) – calculated for C26H46SiO5Na: 489.7183, found: 489.7188. 
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Ethyl(4R,5S)-5-[(tert-Butyldimethylsilyl)oxy]-4-methyl-3,8-dioxo-2-(3-oxocyclopentyl) 
nonanoate (201). 
 
 
C26H46SiO6 
Mol. Wt = 482.72 g 
 
 
To a 3:1 mixture of DMF/water (30 mL) was added PdCl2 (148 mg, 0.83 mmol, 0.4 equiv) 
and CuCl2 (419 mg, 3.12 mmol, 1.5 equivalents) and oxygen was bubbled through the 
solution for 5 min. A solution of 200 (0.97 g, 2.1 mmol) in DMF (5 mL) was added and the 
mixture was stirred for 12 h under an oxygen atmosphere. The mixture was then diluted 
with water and extracted with Et2O (3 × 30 mL). The combined organic layers were 
washed with saturated aqueous NaCl solution (1 × 30 mL) and water (2 × 30 mL), dried 
over Na2SO4 and concentrated in vacuo. The crude material was purified by column 
chromatography (8:2 PE/EtOAc) to furnish the product 201 as a colourless oil (0.73 g, 
72%). Inseparable 3:1 mixture of 2 diastereomers. 
Rf 0.2 (8:2 PE/EtOAc). 
[α]D
20 
+57
 
(c 1.0, CHCl3). 
Major diastereomer 
1
H NMR (CDCl3, 400 MHz) δ 4.20 (q, J = 7.1 Hz, 2H, H
11
), 4.02 (d, J = 4.6 Hz, 1H, H
2
), 
3.80–3.74 (m, 1H, H5), 2.84 (qd, J = 7.0, 4.5 Hz, 1H. H4), 2.79-2.74 (m, 1H, H17), 2.63 
(dddd, J = 17.0, 12.9, 6.4, 4.6 Hz, 1H, H
13
), 2.56–2.48 (m, 3H, H7/H16), 2.43–2.35 (m, 3H, 
H
7
/H
14
), 2.26-2.16 (m, 1H, H
18
), 2.13 (s, 3H, H
9
), 1.80–1.71 (m, 1H, H16), 1.60–1.70 (m, 
1H, H
6
), 1.33–1.30 (m, 1H, H6), 1.28 (t, J = 7.1 Hz, 2H, H12), 1.08 (d, J = 7.0 Hz, 3H, H10), 
0.94 (d, J = 6.8 Hz, 3H, H
19
), 0.92 (s, 9H, H
24
), 0.84 (d, J = 6.8 Hz, 3H, H
20
), 0.11 (s, 3H, 
H
21
), 0.07 (s, 3H, H
22
).  
13
C NMR (CDCl3, 100 MHz) δ 217.4 (C
15
), 208.2 (C
8
), 206.5 (C
1
), 168.4 (C
3
), 71.2 (C
5
), 
61.5 (C
11
), 61.2 (C
2
), 51.5 (C
4
), 45.5 (C
13
), 41.7 (C
16
), 39.4 (C
14
), 38.9 (C
7
), 37.1 (C
17
), 
29.9 (C
18
), 28.2 (C
9
), 27.6 (C
6
), 25.9 (C
24
), 21.7 (C
12
), 17.3 (C
23
), 16.4 (C
10
), 14.2 (C
19
), 
13.3 (C
20
), −4.3 (C21), −4.7 (C22). 
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IR 2948 (C-H), 2932, 1745 (C=O), 1710 (C=O), 1689 (C=O), 1465, 1399, 1364, 1252, 
1191, 1149 (C-O), 1031, 1005 cm
-1
. 
MS (ESI) m/z 505 (MNa
+
). 
HRMS (ESI) – calculated for C26H46SiO6Na: 505.2961, found: 505.2968. 
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1-Phenylhex-5-en-3-ol (236).
88
 
 
C12H16O  
Mol Wt = 176.25 g  
 
To a solution of hydrocinnamaldehyde 235 (5.0 mL, 37.8 mmol), allyl bromide (4.2 mL, 
45.4 mmol, 1.2 equiv) and zinc (3.0 g, 45.0 mmol, 1.2 equiv) in THF (50 mL) at 0 °C was 
added dropwise saturated aqueous NH4Cl solution (15 mL) over a period of 30 minutes. 
The mixture was allowed to warm to room temperature and stirred overnight. The mixture 
was then filtered through a pad of Celite
®
, washing with Et2O. The aqueous phase was 
extracted with Et2O (3 × 50 mL) and the organic layers were combined, dried over MgSO4, 
filtered and the solvent reduced in vacuo. The crude product was purified by column 
chromatography (8:2 PE:EtOAc) to give 236 as a yellow oil (5.32 g, 80%). 
 
Rf 0.35 (8:2 PE/EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 7.42–7.29 (m, 3H, H
Ar
), 7.20–7.09 (m, 2H, HAr), 5.85 
(dddd, J = 16.1, 9.6, 7.9, 6.5 Hz, 1H, H
2
), 5.19–5.09 (m, 2H, H1), 3.71–3.62 (m, 1H, H4), 
2.85–2.62 (m, 2H, H6), 2.38–2.20 (m, 2H, H3), 1.82–1.75 (m, 2H, H5), 1.65 (brs, 1H, OH).  
13
C NMR (CDCl3, 100 MHz) δ 142.1 (C
Ar
), 134.6 (C
Ar
), 128.7 (C
Ar
), 128.2 (C
Ar
), 126.0 
(C
2
), 118.4 (C
1
), 69.9 (C
4
), 42.1(C
6
), 38.5 (C
3
), 31.9 (C
5
). 
IR 3375 (OH), 3010 (CH), 2951 (CH), 1545, 1096 cm
-1
.  
MS (CI) m/z 177 (MH
+
). 
 
In agreement with literature data. 
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(2E)-Methyl 5-hydroxy-7-phenylhept-2-enoate (237).
67
 
 
 
C14H18O2 
Mol Wt = 234.29 g  
 
 
To a solution of 236 (300 mg, 1.7 mmol) and methyl acrylate (0.77 mL, 8.5 mmol, 5 
equiv) in degassed CH2Cl2 (8 mL) was added in one portion of Grubbs’ 2
nd
 generation 
catalyst (72 mg, 0.09 mmol, 5 mol%). The mixture was stirred under reflux overnight, after 
which it was cooled to room temperature, and the solvent evaporated. The crude material 
was purified by column chromatography (8:2 PE:EtOAc) to furnish 237 as a brown oil 
(370 mg, 93%).  
Rf 0.35 (8:2 PE/EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 7.24–7.11 (m, 5H, H
Ar
), 6.91 (dt, J = 15.6, 7.6, 1H, H
3
), 
5.84 (dt, J = 15.6 Hz, 1.4 Hz, 1H, H
2
), 3.78–3.74 (m, 1H, H5), 3.66 (s, 3H, H12), 2.77–2.58 
(m, 2H, H
7
), 2.30–2.25 (m, 2H, H4), 1.85–1.81 (m, 2H, H6), 1.54 (br s, 1H, OH). 
 
13
C NMR (CDCl3, 100 MHz) δ 166.7 (C
1
), 145.2 (C
3
), 141.6 (C
Ar
), 128.5 (C
Ar
), 128.4 
(C
Ar
), 126.0 (C
Ar
), 123.7 (C
2
), 69.8 (C
5
), 51.6 (C
12
), 40.4 (C
7
), 38.7 (C
4
), 32.0 (C
6
). 
 
IR 3445 (OH), 3043 (CH), 2952 (CH),  1723 (CO), 1642 (C=C), 1473, 1328, 1041 cm
-1
. 
 
MS (CI) m/z 235 (MH
+
). 
 
In agreement with literature data. 
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Methyl 2-(6-phenethyl-2-phenyl-2-(trifluoromethyl)-1,3-dioxan-4-yl)acetate (240). 
 
 
C22H23F3O2  
Mol Wt = 408.41 g  
 
 
To a solution of 237 (100 mg, 0.43 mmol) and trifluoroacetophenone 239 (223 mg, 1.3 
mmol, 3 equiv) in THF (5 mL) at 0 °C was added KOt-Bu (19 mg, 0.17 mmol, 0.4 equiv). 
The mixture was warmed to room temperature and stirred for a further 12 h. The reaction 
was quenched with saturated aqueous NH4Cl solution (10 mL), the layers separated and the 
aqueous layer extracted with Et2O (3 × 10 mL). The organic layers were combined, dried 
over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by 
column chromatography (9:1 PE:EtOAc) to furnish 240 as an off-white solid (149 mg, 
85%). 
Rf 0.25 (9:1 PE/EtOAc) 
1
H NMR (CDCl3, 400 MHz) δ 7.48 (m, 2H, H
Ar
), 7.34 (m, 3H, H
Ar
), 7.21 (m, 2H, H
Ar
), 
7.13 (m, 3H, H
Ar
), 4.19–4.13 (m, 1H, H3), 3.77 (m, 1H, H5), 3.70 (s, 3H, H12) 2.90–2.84 
(m, 1H, H
7
), 2.70–2.61 (m, 2H, H2/H7), 2.39 (dd, J = 16.0, 5.2 Hz, 1H, H2), 1.98-1.85 (m, 
1H, H
6
), 1.80–1.72 (m, 1H, H6), 1.46 (m, 2H, H4). 
 
13
C NMR (CDCl3, 100 MHz) δ 170.7 (C
1
), 141.4 (C
Ar
), 140.7 (C
Ar
), 127.3 (C
Ar
), 127.1 
(C
Ar
), 123.4 (C
Ar
), 119.9 (C
Ar
), 117.9 (C
Ar
), 112.3 (C
Ar
), 98.6 (q, J = 31 Hz, C
10
), 91.0 (C
9
), 
70.0 (C
3
), 67.7 (C
5
), 52.1 (C
8
), 40.7 (C
7
), 37.3 (C
2
), 35.5 (C
6
), 31.0 (C
4
). 
IR 2949 (CH), 1738 (CO), 1497, 1484, 1398 (CF), 1358, 1337, 1217, 1188, 1177, 1109, 
1092, 1061, 1032 cm
-1
. 
MS (EI) m/z 409 (MH
+
). 
HRMS (EI) calculated for C22H24F3O2: 409.4254, found: 409.4257. 
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3,7-Diisopropyl-3,7-diazabicyclo[3.3.1]nonan-9-one (245).
76
 
 
 
C13H24N2O 
Mol Wt = 224.19 g  
 
To a solution of N-isopropyl-4-piperidone 234 (20 mL, 134 mmol), paraformaldehyde 
(12.1 g, 402 mmol, 3 equiv) and acetic acid (8 mL) in methanol (190 mL) was added 
dropwise i-propylamine (11.5 mL, 134 mmol, 1 equiv). The mixture was stirred and heated 
at reflux for 16 h, after which the solvent was removed in vacuo and the residue was 
dissolved in Et2O (450 mL) and 50% w/v KOH solution (450 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (2 × 300 mL). The combined 
organic layers were dried over Na2SO4, filtered and the solvent evaporated under reduced 
pressure to give the crude product, which was purified by vacuum distillation (bp 110-113 
°C - 1mm Hg) to furnish the product 235 as a colourless oil (18.9 g, 63%). 
1
H NMR (CDCl3, 400 MHz) δ 2.99 (dd, J = 10.5, 2.9 Hz, 4H, H
3
), 2.88 (dd, J = 10.5, 7.0 
Hz, 4H, H
3
), 2.82–2.79 (m, 2H, H4), 2.60–2.58 (m, 2H, H2), 1.05 (d, J = 6.5 Hz, 12H, H5). 
13
C NMR (CDCl3, 100 MHz) δ 215.7 (C1), 53.5 (C
3
), 53.4 (C
2
), 47.1 (C
4
), 18.3 (C
5
). 
MS (CI) m/z 225 (MH
+
) 
 
In agreement with literature data. 
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3,7-Diisopropyl-3,7-diazabicyclo[3.3.1]nonane (243).
76
 
 
C13H26N2  
Mol Wt = 210.36 g  
 
Hydrazine monohydrate (20.2 mL, 369 mmol, 5 equiv) was added dropwise to a solution 
of 235 (15 g, 67 mmol) and KOH (39.9 g, 777 mmol, 11.6 equiv) in ethylene glycol (385 
mL). The mixture was then stirred at heated at 180 °C for 20 h, then cooled to 60 °C and 
diluted with water. The mixture was then transferred to a separating funnel and extracted 
with Et2O (6 × 300 mL). The combined organic extracts were washed with 20% aqueous 
KOH solution (6 × 100 mL), dried over Na2SO4, filtered and evaporated under reduced 
pressure. The crude product was purified by distillation (bp, 105-108 °C – 1mm Hg) to 
afford the product 233 as a colourless oil (13.1 g, 93%). 
1
H NMR (CDCl3, 400 MHz) δ 2.60 (hept, J = 6.5 Hz, 2H, H
4
), 2.50 (dd, J = 10.5, 5.5 Hz, 
4H, H
1
), 2.42 (dd, J = 10.5, 2.8 Hz, 4H, H
1
), 1.92–1.86 (m, 2H, H2), 1.43–1.40 (m, 2H, 
H
3
), 0.94 (d, J = 6.5 Hz, 12H, H
5
). 
13
C NMR (CDCl3, 100 MHz) δ 53.8 (C
1
), 52.3 (C
4
), 28.1 (C
3
), 27.6 (C
2
), 18.1 (C
5
). 
MS (CI) m/z 211 (MH
+
). 
In agreement with literature data. 
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(2R,3S)-1-[(4R)-4-Benzyl-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-hydroxy-2-methyl-5-
phenylpentan-1-one. 
 
C22H25NO2S2 
Mol Wt = 399.13 g  
 
 
To a solution of 127 (100 mg, 0.37 mmol) in CH2Cl2 (2 mL) at −10 °C was added 
dropwise TiCl4 (44 uL, 0.39 mmol, 1.05 equiv). This was left to stir for 15 min followed 
by addition of freshly distilled bispidine 233 (78 mg, 0.37 mmol, 1.00 equiv). After stirring 
for 1 h the flask was cooled to −78 °C and NMP (38 uL, 0.37 mmol, 1 equiv) was added 
dropwise and left to stir for a further 1 h. Hydrocinnamaldehyde 120 (50 mg, 0.37 mmol, 
1.1 equiv) was introduced by syringe and the mixture left at −78 °C for 1 h, followed by 
gradual warming to 0 °C. The reaction was quenched by addition of saturated aqueous 
NH4Cl solution (10 mL). The aqueous phase was extracted with CH2Cl2 (3 × 10 mL), and 
the combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
Purification by flash chromatography (8:2 PE/EtOAc) affords the product as a yellow solid 
(106 mg, 72%) with 98:2 dr. 
Rf 0.25 (8:2 PE/EtOAc). 
[α]D
25 −104 (c 1.00, CHCl3). 
1
H NMR (CDCl3, 400 MHz) δ 7.51–7.04 (m, 10H, H
Ar
), 5.35−5.29 (m, 1H, H9), 4.47 (qd, 
J = 6.9, 3.4 Hz, 1H, H
2
), 3.98 (dt, J = 8.6, 3.4 Hz, 1H, H
3
), 3.22 (dd, J = 13.0, 3.8 Hz, 1H, 
H
8
), 3.04 (dd, J = 13.0, 10.4 Hz, 1H, H
8
), 2.90–2.75 (m, 3H, H5/H10), 2.72–2.63 (m, 1H, 
H
5
), 1.93–1.83 (m, 1H, H4), 1.75–1.65 (m, 1H, H4), 1.29 (d, J = 6.9 Hz, 3H, H6). 
13
C NMR (CDCl3, 100 MHz) δ 201.6 (C
7
), 178.3 (C
1
), 138.2 (C
Ar
), 135.4 (C
Ar
), 129.4 
(C
Ar
), 129.1 (C
Ar
) 129.0 (C
Ar
), 127.5 (C
Ar
), 124.4 (C
Ar
), 115.1 (C
Ar
), 71.8 (C
9
), 70.7 (C
3
), 
43.4 (C
2
), 37.0 (C
8
), 33.5 (C
10
), 32.3 (C
5
), 29.9 (C
4
), 15.3 (C
6
). 
IR 3950 (OH), 2973 (CH), 2949 (CH), 2928, 1710 (CO), 1621 (C=C), 1325, 1250, 1167, 
1134, 1011 cm
-1
. 
MS (ESI) – m/z 422 (MNa+). 
156 
 
HRMS (ESI) calculated for C22H25NO2S2Na: 422.1224, found: 422.1230. 
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(2R,3S)-1-[(4R)-4-Benzyl-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-hydroxy-2,4-
dimethylpentan-1-one.
36b
 
 
C17H23NO2S2 
Mol Wt = 337.50 g  
 
To a solution of 127 (100 mg, 0.37 mmol) in CH2Cl2 (2 mL) at −10 °C was added 
dropwise TiCl4 (44 uL, 0.39 mmol, 1.05 equiv). This was left to stir for 15 min followed 
by addition of freshly distilled bispidine 233 (78 mg, 0.37 mmol, 1.0 equiv). After stirring 
for 1 h the flask was cooled to −78 °C and NMP (38 uL, 0.37 mmol, 1 equiv) was added 
dropwise and left to stir for a further 1 h. Isobutyraldehyde (26 mg, 0.37 mmol, 1.1 equiv) 
was introduced by syringe and the mixture left at −78 °C for 1 h, followed by gradual 
warming to 0 °C. The reaction was quenched by addition of saturated aqueous NH4Cl 
solution (10 mL). The aqueous phase was extracted with CH2Cl2 (3 × 10 mL), and the 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
Purification by flash chromatography (8:2 PE/EtOAc) gives the product as a yellow oil (70 
mg, 56%) with >99:1 dr. 
Rf 0.25 (8:2 PE/EtOAc) 
[α]D
25 −69 (c 0.25, CHCl3), lit. −39 (c 8.3, CH2Cl2). 
1
H NMR (CDCl3, 400 MHz) δ 7.40–7.19 (m, 5H, H
Ar
), 5.31–5.22 (m, 1H, H10), 4.68 (qd, J 
= 7.0, 2.4 Hz, 1H, H
2
), 3.59 (dd, J = 8.8, 2.4 Hz, 1H, H
3
), 3.33 (m, 2H, H
9
/H
11
), 3.12–3.01 
(m, 1H, H
9
/H
11
), 2.87 (d, J = 11.8 Hz, 1H, H
11
), 1.56–1.52 (m, 1H, H4), 1.10 (d, J = 7.0 Hz, 
3H, H
7
), 1.00 (d, J = 6.9 Hz, 3H, H
5
), 0.97 (d, J = 6.9 Hz, 3H, H
6
). 
13
C NMR (CDCl3, 100 MHz) δ 201.2 (C
8
), 179.5 (C
1
), 136.7 (C
Ar
), 129.5 (C
Ar
), 128.9 
(C
Ar
), 127.2 (C
Ar
), 77.1 (C
3
), 68.7 (C
10
), 46.0 (C
2
), 36.5 (C
9
), 32.5 (C
11
), 28.4 (C
4
), 19.5 
(C
7
), 10.2 (C
5
), 10.0 (C
6
). 
MS (CI) – m/z 338 (MH+) 
In agreement with literature data. 
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(2R,3S)-1-[(4R)-4-Benzyl-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-hydroxy-2-
methylbutan-1-one.
89
 
 
C15H19NO2S2 
Mol Wt = 309.45 g  
 
To a solution of 127 (100 mg, 0.37 mmol) in CH2Cl2 (2 mL) at −10 °C was added 
dropwise TiCl4 (44 uL, 0.39 mmol, 1.05 equiv). This was left to stir for 15 min followed 
by addition of freshly distilled bispidine 233 (78 mg, 0.37 mmol, 1.0 equiv). After stirring 
for 1 h the flask was cooled to −78 °C and NMP (38 uL, 0.37 mmol, 1.0 equiv) was added 
dropwise and left to stir for a further 1 h. Acetaldehyde (21 uL, 0.37 mmol, 1.1 equiv) in 
CH2Cl2 (100 uL) was introduced by syringe and the mixture left at −78 °C for 1 h, 
followed by gradual warming to 0 °C. The reaction was quenched by addition of saturated 
aqueous NH4Cl solution (10 mL). The aqueous phase was extracted with CH2Cl2 (3 × 10 
mL), and the combined organic extracts were dried over Na2SO4, filtered and concentrated 
in vacuo. Purification by flash chromatography (8:2 PE/EtOAc) gives the product as a 
yellow oil (26 mg, 23%) with 97:3 dr. 
Rf 0.28 (8:2 PE/EtOAc) 
[α]D
20 −67 (c 0.01, CHCl3) lit −107 (c = 18.5, CH2Cl2) 
1
H NMR (CDCl3, 400 MHz) δ 7.32–7.22 (m, 5H, H
Ar
), 5.34–5.29 (m, 1H, H8), 4.68 (qd, J 
= 7.2, 2.3 Hz, 1H, H
2
), 3.59 (qd, J = 6.8, 2.3 Hz, 1H, H
3
), 3.25–3.19 (m, 2H, H7/H9), 3.08–
2.97 (m, 1H, H
9
), 2.76–2.71 (m, 1H, H7), 1.28 (d, J = 6.8 Hz, 3H, H4), 1.21 (d, J = 7.2 Hz, 
3H, H
5
).  
13
C NMR (CDCl3, 100 MHz) δ 201.8 (C
8
), 178.0 (C
1
), 137.0 (C
Ar
), 129.3 (C
Ar
), 129.0 
(C
Ar
), 127.4 (C
Ar
), 71.8 (C
3
), 68.7 (C
8
), 46.0 (C
2
), 36.5 (C
7
), 32.5 (C
9
), 24.8 (C
4
), 11.2 (C
5
). 
MS (CI) – m/z 310 (MH+) 
 
In agreement with literature data 
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MM-05-WACKER.010.esp
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
6.093.038.813.092.583.240.942.622.390.750.730.670.841.072.01
 
 
 
  
174 
 
MM-05-WACKER.010.esp
4.30 4.25 4.20 4.15 4.10 4.05 4.00 3.95 3.90 3.85 3.80 3.75 3.70
Chemical Shift (ppm)
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
0.841.072.01
MM-05-WACKER.010.esp
2.175 2.170 2.165 2.160 2.155 2.150 2.145 2.140 2.135 2.130
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.62
 
